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ABSTRACT 
By targeting Hepatitis B surface antigen (HBsAg) production through the secretory 
pathway in Aspergillus niger, completely assembled and properly folded HBsAg, was 
obtained. This was achieved by implementing a gene fusion strategy using the highly 
expressed catalytic domain of the glucoamylase gene (GlaAG2) fused to the HBsAg S 
gene.  The inducible glucoamylase promoter (GlaAp) was used to control transcription 
in A. niger. The gene fusion strategy resulted in the cleavage of the fused product by 
the KEX2-like protease, and intracellular accumulation of HBsAg was observed, while 
glucoamylase was secreted. Full assembly and maturation of HBsAg occurred after 
cleavage of the fused product in the Golgi complex. Several intracellular glucoamylase 
degradation products indicated bottlenecks/ limitations in the secretory pathway caused 
by the over-expression of the fused GlaAG2::S gene.  These findings were demonstrated 
by increases in HBsAg production through over-expression of protein disulfide 
isomerase (PDI) and calnexin (CLX) as well as in cultivations at reduced growth rates 
(µ).  
An improved methodology using the gene fusion technology to identify and select high 
HBsAg producing transformants was developed through the use of a double mutant A. 
niger host strain, MGG029-∆aamA, lacking two major amylolytic enzymes, 
glucoamylase and acid amylase. The screen based selection on high extracellular 
glucoamylase production on solid state cultures using starch as a selection pressure. 
The high efficiency obtained through selecting for high extracellular glucoamylase 
transformants and the associated correlation between intracellular HBsAg production 
and secreted glucoamylase in batch/ fed-batch fermentation reflected the ability of the 
screen to indirectly quantify high HBsAg producing transformants through 
extracellular glucoamylase determination. 
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Through the application of the glucoamylase screen two high HBsAg producing 
transformants varying in µmax were identified; (1) the ‘fast-growing high-biomass 
producing’ transformant (µmax = 0.11 h-1), and (2) the ‘slow-growing high-
glucoamylase producing’ transformant (µmax = 0.08 h-1). These two transformants were 
evaluated in carbon-limited exponential fed-batch fermentations as well as used as 
hosts together with the A. niger D15 strain in chaperone/ foldase over-production 
studies. In carbon-limited exponential fed-batch fermentations HBsAg production was 
most efficient at 0.07 < µ <0.08 h-1, and provided a method for increasing HBsAg 
production levels up to 81 %.  
The over-production of CLX and PDI resulted in the highest percentage increase (88 % 
and 107 %, respectively) and therefore reflected their critical involvement with regards 
to efficient HBsAg assembly using gene fusion. The combinations of BiP and 
associated combinations with CLX and PDI failed to improve HBsAg production 
levels. Reductions of up to 40 % where observed upon BiP over-production and 
therefore indicated unfavourable responses towards HBsAg assembly and production, 
which were triggered upon BiP over-expression using gene fusion. HBsAg production 
levels were further increased through the cultivation of the CLX and PDI over-
producing transformants in carbon-limited exponential fed-batch fermentation. Highest 
HBsAg production levels of 352 ± 21.3 µgHBsAg.gDW-1(6237.2 ± 437.2 µgHBsAg.kgBroth-1) 
and 330.2 ± 24.4 µgHBsAg.gDW-1 (5760.4 ± 531.9 µgHBsAg.kgBroth-1) in CLX and PDI 
over-expressing transformants were observed. These findings, together with the 
potential application of the solid-state glucoamylase screen for the identification of 
high HBsAg producers over-producing chaperones/ foldases, demonstrates the 
usefulness and application of gene fusion in A. niger MGG029-∆aamA transformants 
as a technology for other recombinant virus like particles (VLPs). 
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OPSOMMING 
Die produksie van Hepatis B oppervlak antigeen (HBsAg) deur middel van die 
uitskeidingsmeganisme in Aspergillus niger, het verseker dat die geproduseerde 
HBsAg struktureel korrek en volledig gevou was. Hierdie resultaat is verkry deur 
geenfusie waartydens die katalitiese domain van die glukoamilase geen (GlaAG2), wat 
in hoë konsentrasies uitgedruk word, verbind is aan die HBsAg S geen. Transkripsie in 
A niger is gekontroleer deur die induseerbare glukoamilase promoter (GlaAp). Hierdie 
geenfusie strategie het veroorsaak dat die saamgesmelte produk deur ‘n KEX2 
gelykvormige protease gesny is en intrasellulêre akkumulasie van HBsAg waargeneem 
is, terwyl glukoamilase uitgeskei is. Struktureel volledige montering van HBsAg het 
voorgekom nadat die saamgevoegde produk in die Golgi apparaat gesny is. Die 
vorming van verskeie intrasellulêre glukoamilase afbraak-produkte het gedui op 
beperkinge in die uitskeidingsmeganisme, wat veroorsaak is deur die oormatige 
uitdrukking van die saamgevoegde GlaAG2::S geen. Hierdie bevindinge is gestaaf deur 
verhoogde HBsAg produksie as gevolg van oormatige uitdrukking van proteïen 
disulfied isomerase (PDI) en calnexin (CLX) asook kultivering teen verlaagde groei 
tempo’s (µ). 
Die gebruik van die geenfusie strategie deur gebruik te maak van ‘n dubbel mutante A. 
niger gasheer stam, MGG029-∆aamA, waarvan twee hoof amolitiese ensieme – 
glukoamilase en suur amilase nie uitgedruk word nie -  het aanleiding gegee tot die 
ontwikkeling van ‘n verbeterde metode om hoë produserende HBsAg transformante te 
identifiseer en uit te kies. Selektering vir hoë ekstrasellulêre glukoamilase produksie 
was gedoen deur die beskikbaarheid van stysel aan te wend as seleksie meganisme op 
soliede kulture. Die hoë effektiwiteit verkry deur seleksie van transformante met hoë 
ekstrasellulêre glukoamilase aktiwiteit en die geassosieerde korrelasie tussen 
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intrasellulêre HBsAg produksie en glukoamilase uitskeiding in geenvoer of voer 
fermentasie, het die vermoë van die siftingsmetode aangedui om indirek hoë HBsAg-
produserende transformante te kwantifiseer deur ekstrasellulêre glukoamilase te bepaal. 
Deur die aanwending van bogenoemde glukoamilase siftingsmetode, is twee hoë 
HBsAg-produserende transformante met verskille in µmaks geïdentifiseer: (1) die vinnig 
groeiende transformant wat hoë biomassa produseer (µmaks = 0.11 h-1) en (2) die stadig 
groeiende transformant met hoë glukoamilase produksie (µmaks = 0.08 h-1).  
Laasgenoemde twee transformante is geëvalueer in koolstofbeperkte eksponensiële 
voerfermentasies en ook as gebruik tesame met die A. niger D15 stam in 
“chaperone/foldase” verhoogde produksie studies. Tydens koolstofbeperkte 
voerfermentasies was HBsAg produksie die hoogste teen 0.07 < µ <0.08 h-1. Sodoende 
is ‘n metode ontwikkel  om HBsAg produksie met tot soveel as 81 % te verhoog. 
Oormatige produksie van CLX en PDI het gelei tot die hoogste persentasiegewyse 
verhoging (88 % en 107 %, respektiewelik) en sodoende hul betrokkenheid by korrekte 
HBsAg formasie deur middel van geenfusie bevestig. Kombinasies van BiP en 
geassosieerde kombinasies met CLX en PDI kon nie HBsAg produksie verhoog nie. 
Oormatige produsie deur middel van geenfusie van BiP het tot verminderings van tot 
40 % in HBsAg produksie gelei en sodoende ongunstige toestande ten opsigte van 
effektiewe HBsAg formasie en produksie aangedui. HBsAg produksie is verder 
verhoog deur die kweek van die CLX en PDI oormatig produserende transformante in 
koolstofbeperkte eksponensiële voerfermentasies. Die hoogste HBsAg produksie van 
352 ± 21.3 µgHBsAg.gDW-1(6237.2 ± 437.2 µgHBsAg.kgBroth-1) en 330.2 ± 24.4 
µgHBsAg.gDW-1 (5760.4 ± 531.9 µgHBsAg.kgBroth-1) is waargeneem in CLX en PDI 
oormatig produserende transformante. Hierdie bevindinge, tesame met die potensiële 
aanwendig van die glukoamilase siftingsmetode vir die identifikasie van hoë HBsAg 
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produseerders wat “chaperone/foldase” oormatig produseer, illustreer die 
bruikbaarheid en aanwending van geenfusie in A. niger MGG029-∆aamA 
transformante, as ‘n metode vir die produksie van ander rekombinante virusagtige 
deeltjies. 
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PREFACE 
This dissertation is presented as a compilation of manuscripts.  Each manuscript is 
introduced separately and is written accordingly to reflect a ‘stand alone’ 
representation for journal submission. 
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INTRODUCTION 
The development of non-replicating vaccines is an emerging option for safe, effective 
vaccines, several of which contain virus-like particles (VLPs). Considerable attention 
is being paid to the development of such vaccines as a means of curbing the spread of 
infectious disease (Hansson et al., 2000). VLPs, including the Hepatitis B surface 
antigen (HBsAg) have been efficiently produced in microbial systems such as Pichia 
pastoris, Hansenula polymorpha and Saccaromyces cerevisiae.  
 
The filamentous fungus Aspergillus niger has gained much interest as an alternative 
host to the commonly employed yeasts for the production of mammalian and higher 
eukaryotic gene products achieving varying degrees of success (Gwyne et al., 1987; 
Upshall et al., 1987; Ward et al., 1995; Gouka et al., 1997a; Svetina et al., 2000; James 
et al., 2007), and has previously been identified as a candidate VLP expression system 
through the evaluation of HBsAg (Plüddemann and van Zyl, 2003). Plüddemann and 
van Zyl, (2003), demonstrated the ability of A. niger to synthesize and assemble 
complex intracellular HBsAg into correctly-folded VLPs. However, despite high 
expression levels of the HBsAg S gene, production levels were low amounting to 0.4 
mg.Lculture -1 (Plüddemann and van Zyl, 2003). These results suggest that limitations 
with the production of recombinant HBsAg do not appear to be at the level of 
transcription but rather on a (post)translational level as observed in other studies 
expressing higher recombinant eukaryotic gene products (Jeenes et al., 1994; 
Nyyssönen and Keränen, 1995; Gouka et al., 1997a; Plüddemann and van Zyl, 2003).  
 
In direct contrast to the process mechanisms of the Hepatitis B virus in infected cells 
where efficient secretion is observed (Simon et al., 1988; Ganem and Prince, 2004), 
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intracellular accumulation of HBsAg is observed in A. niger (Plüddemann and van Zyl, 
2003). Similar findings have been observed in S. cerevisiae (Hamsa and Chattoo, 
1994), P. pastoris (Cregg et al., 1987), H. polymorpha (de Roubin et al., 1991) and 
plant cells (Smith et al., 2002), and therefore is indicative of the limitations realized in 
recombinant microbial expression systems. 
 
With the continuous development and improvement of gene technology, several 
strategies have been developed, serving as tools for enhancing heterologous protein 
production levels. These include, vector design and construction, codon optimization 
(Gouka et al., 1996), choice of promoter (Van den Hondel et al., 1991), the generation 
of fusion constructs (Jeenes et al., 1993; Gouka et al., 1997b; Spencer et al., 1998), 
over expression of chaperone proteins (Ngiam et al., 2000; Punt et al., 1998), the 
isolation of protease deficient mutants (Archer and Peberdy, 1997; van den Hombergh 
et al., 1997) high-throughput screening for hyper-producing transformants/ mutants 
(Weenink et al., 2006), and the optimisation of media and cultivation conditions 
(Schrickx et al., 1993; MacKenzie et al., 1994; Xu et al., 2000; Conesa et al., 2001; 
James et al., 2007).   
 
The dissertation includes a Literature Review, which provides an introduction to VLP 
vaccine systems with specific reference to HBsAg as a model VLP. The significance of 
VLP technology is also discussed and the potential expression systems evaluated. This 
also includes the possible challenges and solutions involved in recombinant production 
of higher eurkaryotic gene products and VLPs in filamentous fungi with specific focus 
on Aspergillus. In this dissertation A. niger is used as the production host. HBsAg is 
used as a model VLP and production is targeted through the secretory pathway as 
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performed by Hepatitis B infected cells with the main aim of further developing the 
VLP technology in A. niger. In Manuscript 1 a gene fusion approach is evaluated as a 
means of targeting HBsAg production through the secretory pathway. In Manuscript 2 
an improved methodology to identify and select high HBsAg producing transformants 
is evaluated. The effects of growth rate (µ) in glucose-limited exponential fed-batch 
fermentations on HBsAg production is evaluated in Manuscript 3 and in Manuscript 
4 the effects of modifying chaperone/ foldase levels on HBsAg production levels is 
evaluated. Finally, in Concluding remarks and Prospects, the results of this 
dissertation are discussed in more general terms with a summary of the major 
conclusions as well as recommended future prospects. 
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VLPs as vaccine production systems 
Vaccination is considered as an efficient means of preventing infectious diseases and 
through vaccination programmes, the incidence of several fatal diseases has drastically 
decreased (Liljeqvist and Stahl, 1999).  Vaccines have often been based on attenuated 
or chemically inactivated live viruses. However, the potential for incomplete 
inactivation of the virus or reversion of an attenuated vaccine strain to a more virulent 
state has lead to some concern (Smithburn, 1949; Caplen et al., 1985; Noad and Roy, 
2003). The potential development of disease in vaccinated individuals, with the use of 
attenuated or chemically inactivated live viruses, is particularly relevant for viruses 
with a high degree of genetic exchange (Noad and Roy, 2003). Given these 
circumstances, the development of non-replicating vaccines is an emerging option for 
safe and effective vaccines, several of which contain virus-like particles (VLPs). 
 
VLPs are a highly effective type of subunit vaccine, which are produced by 
recombinant expression of viral capsid proteins or envelope proteins (Miyanohara et 
al., 1986; Delchambre et al., 1989; Gheysen et al., 1989; French et al., 1990). VLPs 
are highly ordered, repetitive structures mimicking the native structural assembly and 
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antigenic properties of the parental virus. The VLPs are devoid of viral genetic material 
but have the authentic conformation of viral capsid proteins seen with attenuated virus 
vaccines, without any of the risks associated with viral reversion, recombination or re-
assortment (Noad and Roy, 2003). Additional benefits of VLP vaccines include high 
efficiency in eliciting a protective response, where VLPs not only stimulate B-cell-
mediated immune responses, but have also shown to be highly effective at stimulating 
CD4 proliferative responses and cytotoxic T lymphocyte (CTL) responses (Schirmbeck 
et al., 1996; Boisgerault et al., 2002; Paliard et al., 2000; Murata et al., 2003). 
Furthermore, a high immunogenic response would result in lower vaccine doses and is 
likely to be a major contribution towards VLP effectiveness (Noad and Roy, 2003).   
 
VLP based vaccines for many diseases affecting humans and animals have been 
licensed or are in pipeline development (Noad and Roy, 2003; Grgacic and Anderson, 
2006) (Table 1). These VLP based vaccines can be categorized as lipid-envelope VLPs 
and non-envelope VLPs (Noad and Roy, 2003) (Table 2). The hepatitis B vaccine, 
among others (Table 2), is an example of a lipid-envelope VLP vaccine, which was 
first licensed for use in humans in 1984 by Merk (Recombivax HB®) (Valenzuela et 
al., 1982; McAleer et al., 1984; Hilleman, 2001; Hilleman, 2003) (Table 1). These 
enveloped VLPs are assembled from envelope proteins, which bud from intracellular 
compartments and thus contain the cellular lipids that make up the viral lipoprotein 
envelope (Grgacic and Anderson, 2006). The expression and assembly of the major 
capsid proteins of papillomaviruses, parvoviruses, caliciviruses, circoviruses and 
polyomaviruses are examples of non-enveloped VLPs (Table 2).  These non-enveloped 
VLPs are relatively robust and simple in structure and comprise of one or two major 
capsid proteins of viruses which do not have a lipid envelope. Recently, VLP vaccines 
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against the human papillomavirus (HPV), Gardasil® and Cerevix® by Merck and 
GlaxoSmithKline (GSK), respectively were licensed (Andrawiss, 2005; Schiller and 
Lowly, 2006) (Table 1). 
 
The successful development of VLPs as candidate vaccines has initiated interest in 
chimeric VLPs as novel and effective carrier systems or fusion platforms for the 
delivery of protein epitopes targeted at other diseases. Chimeric VLPs provide a means 
for the incorporation of heterologous antigens or proteins into VLPs. The formation of 
chimeric VLPs is possible through the genetic engineering of VLP gene sequences and 
co-expression of fused antigens or protein epitopes directly to VLP-forming proteins. 
This strategy offers enormous potential through the implementation of a chimeric VLP 
that carries multiple protein or antigen epitopes eliciting an immune response to 
multiple diseases simultaneously (Bisht et al., 2001; Netter et al., 2001; Noad and Roy, 
2003; Grgacic and Anderson, 2006; Greco et al., 2007; Michel et al., 2007). The full 
account of the range of chimeric vaccines, vaccine status in the developmental 
pipeline, the advantages and disadvantages and technical considerations have 
previously been described (Boisgerault et al., 2002; Grgacic and Anderson, 2006). 
Alternative applications of VLPs involve the in vitro assembly and disassembly of 
VLPs through chemical manipulation. This quality could be exploited for conjugation 
purposes of foreign genes or chemical agents to reassembled VLPs (Goldmann et al., 
1999; Goldmann et al., 2000).  
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Tabel 1. Examples of VLPs used for vaccines and vaccine development (Noad and Roy, 2003). 
Virus Particle composition Type/expression system Size Vaccine Status References
Small envelope protein 
(HBsAg) rec VLP (yeast) (Recombivax-HB; Engerix-B)22 nm Licensed
McAleer et al ., 1984; Andre and Safary, 1987
Small envelope protein 
(HBsAg) rec VLP (potato) 17 nm Preclinical
Kong et al ., 2001
PreS1+2 and HBsAg rec VLP (CHO cells) (sci-B Vac; BioHepB)22 nm Licensed
Yap et al ., 1992; Shouva l  et al ., 1994; Madal inski  
et al ., 2001; Yap et al ., 1996
HBsAg Native SVP (plasma) 22 nm
Licensed
(developing 
world)
Krugman et al ., 1971
HPV L1, major capsid protein
rec VLP (mammalian cells; 
baculovirus; yeast) gardasil, 
Cervarix
40 - 50 nm Licenced
Zhou et al ., 1991; Kirnbauer et al ., 1992; Koutsky 
et al ., 2002; Vi l l a  et al ., 2005
HEV
Truncated major capsid 
protein (ORF2)
rec VLP (baculovirus) 23.7 nm
Li  et al ., 1997; Li  et al ., 2005; Purcel l  et al ., 2003; 
Emerson and Purcel l , 2001
Influenza HA, NA, matrix rec VLP (baculovirus) 80 - 120 nm Preclinical
Pushko et al ., 2005; Gal arza  et al ., 2005; Latham 
and Galarza, 2001
HCV Core, E1, E2 rec VLP (baculovirus) 40 - 60 nm Preclinical
Baumert et al ., 1998; Jeong et al ., 2004; Lechmann 
et al ., 2001; Murata et al ., 2003
Poliovirus Capsid (VP0,1,3) rec VLP (baculovirus) 27 nm None Brauti gam et al ., 1993
HIV Pr55gag, envelope
rec VLP (baculovirus; 
mammalian cells; yeast)
100 - 120 nm Preclinical
Sakuragi  et al ., 2002; Gheysen et al., 1989; shioda  
and Shibuta, 1990; Deml  et al ., 2005; Doan et al ., 
2005
Ebola virus; Marburg virus
Glycoprotein (GP) and 
matrix (VP40)
rec VLP (mammalian cells)
Filovirus-like 
particle
Preclinical
Swenson et al ., 2005; Warfield et al ., 2003; 
Warfield et al ., 2005
Norwalk virus capsid  
rec VLP (baculovirus; transgenic 
potatoes)
38 nm Phase I
Bal l  et al ., 1999; Mason et al ., 1996; Tacket et al ., 
2003
Rotavirus VP2, VP6, VP7 rec VLP (baculovirus) 70 - 75 nm Preclinical
Viei ra  et al ., 2005; Bertolotti -Ciarlet et al ., 2003; 
Crawford et al ., 1994
SARS coronavirus S, E and M rec VLP (baculovirus) 100 nm Preclinical Mortola  and Roy, 2004
HBV
 
Abbreviations: HBV, hepatitis B virus; HPV, human papilloma virus; HEV, hepatitis E virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; SARS, severe acute respiratory syndrome; 
rec, recombinant. 
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Tabel 2. VLP production for structurally diverse virus families (Grgacic and Anderson, 2006). 
Virus Genome Envelope Major Proteins Minor Proteins References
Caliciviridae
Norwalk, Hawaii, Grimsby, 
Burwash Landing, White 
Rivier, Florida, rabbit 
haemorrhagic disease, 
Hepatitis E
SsRNA No 1 1-2
Jiang et al ., 1992; Laurent et al ., 1994; Pletneva  et 
al ., 1998; Ha le et al ., 1999; Bel l iot et al ., 2001; Li  
et al ., 1997
Picornaviridae Polio SsRNA No 4 0 Brauti gam et al ., 1993
Flaviviridae Hepatitis C SsRNA Yes, 2 proteins 1 Baumert et al ., 1998
Retroviridae
HIV, SIV, FIV, BIV, visna, 
FeLV, BLV, rous sarcoma
SsRNA Yes, 2 proteins 1 0
Delchambre et al ., 1989;  Gheysen et al ., 1989; 
Yamshchikov et al ., 1995; Overton et al ., 1989; 
Rasmussen et al ., 1990; Morikawa et al ., 1991; 
Thomsen et al ., 1992; Rafnar et al ., 1998; Kakker 
et al ., 1999; Johnson et al ., 2001
Paramyxoviridae Newcastle disease SsRNA Yes, 2 proteins 4 0 Nagy et al ., 1991
Bunyaviridae Hantaan Segmented ssRNA Yes, 2 proteins 1 0 Betenbaugh et al ., 1995
Orthomyxoviridae Influenza A Segmented ssRNA Yes, 3 proteins 2 3 Latham and Ga larza , 2001
Birnaviridae Infectious bursal disease Segmented ssRNA No 3 0 Kibenge et al ., 1999; Fernandez-Arias  et al ., 1998
Reoviridae Bluetongue, rotavirus Segmented ssRNA No 4 2-4
French et al ., 1990; French and Roy, 1990; 
Crawford et al ., 1994
Parvoviridae
Porcine parvovirus, mink 
enteritis parvovirus, canine 
parvovirus, B19, adeno-
associated
SsDNA No 1 2
Lopez de Turi so et al ., 1992; Martinez et al ., 1992; 
Brown et al ., 1991; Chris tensen et al ., 1994; 
Hoque et al ., 1999
Circoviridae
Chicken anaemia, porcine 
circovirus
SsDNA No 1 0 Noteborn et al ., 1998; Nawagitgul  et al ., 2000
Papillomaviridae Papillomavirus SsDNA No 1 1
Zhou et al ., 1991; Ki rnbauer et al ., 1992; 
Ki rnbauer et al ., 1993
Polyomaviridae SV40, JC SsDNA No 1 2 Kosukegawa et al ., 1996; Chang et al ., 1997
Hepadn aviridae Hepatitis B Discontinuous dsDNA Yes, 3 proteins 1 0
Miyanohara  et al ., 1986; McAl eer et al ., 1984; 
Kunke et al ., 1993
Family
Capsid structure
 
Abbreviations: BIV, bovine immunodeficiency virus; BLV, bovine leukemia virus; FeLV, feline leukemia virus; FIV, feline immunodeficiency virus; HIV, human immunodeficiency virus; SIV, simian 
immunodeficiency virus; SV40, simian virus-40. 
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The Hepatitis B virus and Hepatitis B Surface Antigen 
Hepatitis B, caused by the infectious Hepatitis B virus (HBV), is a serious liver 
infection causing liver failure, cirrhosis or cancer of the liver (Hepatitis B Foundation, 
http://www.hepb.org), and is often characterized by jaundice, abdominal pain, liver 
enlargement and fever. HBV interferes with the function of the liver in replicating 
hepatocytes causing the immune system to be activated leading to liver inflammation. 
An estimated 400 million people are chronically infected with HBV worldwide, of 
which 1 million carriers are estimated to die annually due to HBV and its consequences 
(WHO, 2004). This disease is transmitted by blood and body fluids including urine, 
saliva/nasopharyngeal fluids, semen, and menstrual fluids (Alter et al., 1977; Davison 
et al., 1987). Treatment is generally ineffective (Hepatitis B Foundation, 
http://www.hepb.org/) and thus prevention and vaccination remain the best alternative 
to curb the spread of disease. The World Health Organisation (WHO) has 
recommended that a Hepatitis B vaccine be included in routine immunization schedules 
for all children in all countries (Vryheid et al., 2001).   
 
Hepatitis B virus 
HBV, classified in the family Hepadnaviridae (hepatropic DNA viruses), genus 
Orthohepadnavirus, is a small envelope virus containing a partially double stranded, 
circular DNA genome (Huovila et al., 1992; Purcell, 1994; Shepard et al., 2006). The 
Hepatitis B virion, known as the Dane particle, is a spherical particle (diameter of 42 – 
47 nm), comprising of a central core and external envelope. The central core or capsid 
comprises of ~ 180 Hepatitis B core proteins arranged in an icosahedral arrangement 
(Nassal and Schaller, 1993; Crowther et al., 1994), which surrounds at least one 
Hepatitis B polymerase protein as well as the infectious HBV genome (Gerlich and 
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Robinson, 1980). The external envelope consists of three proteins, designated major 
(S), middle (M) and large (L) protein, respectively.  One Dane particle contains 300 to 
400 major protein molecules and 40 to 80 middle and large protein molecules (Tiollais 
et al., 1985), which together with the central core form the infectious viral particle 
(virion) (Ganem and Varmus, 1987). All three envelope proteins are glycosylated, type 
II transmembrane proteins that form multimers, and with further self assembly form 
non-infectious spherical or tubular particles that stimulate the production of antibodies 
in the infected host. These multimers are stabilised by disulphide bridges, which are 
formed by cysteine residues (Seeger and Mason, 2000). A schematic of the cross 
section of the hepatitis B virus is as shown in Figure 1A while Figure 1B shows the 
3D structure of the virus resolved from X-ray crystallography studies.  
 
The majority of these non-infectious self-assembling particles are in the spherical form, 
and termed hepatitis B surface antigens (HBsAg) (Peterson, 1987). These 22 nm 
subviral particles consist almost entirely of S proteins with approximately 100 
monomers forming the HBsAg particle (Ganem and Varmus, 1987).  HBsAg 
characterisation studies have revealed that the HBsAg S protein consists of 226 amino 
acids presented in an unglycosylated form (24 kDa) and a N-glycosylated form 
(27 kDa) (Huovila et al., 1992).  The primary structure includes three significant 
hydrophobic regions involved in HBsAg S protein characterization, intra- and inter-
HBsAg assembly, and intracellular transport and secretion (Berting et al., 1995; Prange 
et al., 1995a).  The HBsAg S protein is initially synthesised as a transmembrane 
polypeptide, where both translocation and export of the protein can proceed in the 
absence of any other viral gene products (Eble et al., 1987).  With a composition of ~ 
75 % protein and ~ 25 % lipid by mass (Gavilanes et al., 1982), the lipid-protein 
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interactions are responsible for HBsAg structural assembly and antigenecity (Gavilanes 
et al., 1990; Gomez-Gutierrez et al., 1994; Prange et al., 1995b).  
 
A 
 
 
 
 
 
 
 
 
 
B 
 
Figure 1. (A ) a schematic of the cross section of a hepatitis B virus.  (B) the structure of the hepatitis B 
virus as solved by x-ray crystallography, (taken from http://www.virology.wisc.edu/-
virusworld/covers.php). 
 
Large protein
Major (S) protein
Middle protein
Capsid
Central core
External 
envelope
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In the HBV life cycle, the synthesis of HBsAg S proteins is tightly regulated at the 
transcriptional and translational level (Tiollais and Buendia, 1991).  Newly synthesised 
HBsAg S proteins are translocated into the lumen of the ER where disulphide-linked 
dimers are rapidly formed (Huovila et al., 1992). Dimers are then transported to a post-
ER/pre-Golgi compartment, where higher oligomers are formed resulting in the 
assembly of the HBsAg particle. The HBsAg particle matures by budding into this 
post-ER/pre-Golgi compartment (Huovila et al., 1992; Prange and Streeck, 1995).  The 
particle is then rapidly exported from the cell via the constitutive pathway of vesicular 
transport and the Golgi where further modification of the oligosaccharides occurs 
(Simon et al., 1988). HBsAg particles are produced in excess of 103- to 106-fold in 
comparison to the infectious virion (Ganem and Prince, 2004), forming an effective 
shielding strategy contributing towards the survival of the virus against the antibodies 
produced by the infected host.  
 
Brief history of treatment for the Hepatitis B disease 
The first Hepatitis B vaccine (HEPTAVAX®) was licensed in 1981 and was a subunit 
vaccine isolated from the blood of hepatitis B infected donors (Prince, 1982). In 
hepatitis B patients, non-infectious 22 nm HBsAg particles are expressed in significant 
amounts, eliciting a strong immune response (Dekleva, 1999). These blood-derived 
particles were purified to levels exceeding 99 % and used as a vaccine. However the 
supply of suitable human plasma was inconsistent and unreliable. Together with 
extensive purification methods and product screening requirements, manufacturing lead 
times of more than 1 year for the production of 1 batch were of the norm (Dekleva, 
1999). During the 1980s there was also growing concerns about HIV infection through 
blood-derived products (Francis et al., 1986) which led to pressures to develop 
Stellenbosch University http://scholar.sun.ac.za
 16 
 
 
recombinant vaccines for human use. The first commercially manufactured 
recombinant hepatitis B VLP (RECOMBIVAX HB®, Merck), which was licensed in 
1984 (Valenzuela et al., 1982; McAleer et al., 1984; Hilleman, 2001; Hilleman, 2003), 
was cloned and expressed in Saccharomyces cerevisiae (Miyanohara et al., 1983; 
McAleer et al., 1984). GSK has produced a recombinant hepatitis B vaccine, 
ENGERIX B®, which is also currently in the market, among others. In addition, there 
is now a combined vaccine for both hepatitis A and B, known as TWINRIX®, which is 
bivalent in nature, containing antigenic components used in producing HAVRIX® 
(Hepatitis A inactivated vaccine) and ENGERIX-B® (Hepatitis B, recombinant 
vaccine), by GSK. 
 
Potential expression systems for VLP vaccines 
Various expression systems have demonstrated the ability to produce VLPs and these 
include: (1) Escherichia coli and other bacteria (Liew et al., 2010); (2) various species 
of yeast including S. cerevisiae (Miyanohara et al., 1983; McAleer et al., 1984), Pichia 
pastoris (Cregg et al., 1987), and Hansenula polymorpha (de Roubin et al., 1992) ; (3) 
the baculovirus/insect cell system (Crawford et al., 1994; Bertolotti-Ciarlet et al., 2003; 
Mortola and Roy, 2004; Vieira et al., 2005); (3) transgenic plant systems (Mason et al., 
1996; Smith et al., 2002); and (4) various mammalian cell lines (Warfield et al., 2003; 
Swenson et al., 2005; Warfield et al., 2005). Each expression system offers its own 
advantage, however there are also limitations which have to be considered when 
choosing the expression system (Awram et al., 2002) (Table 3).  
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Tabel 3. Comparison of various systems for expression of foreign proteins (Awram et al., 
2002). 
Growth 
media/ 
expense
Equipment 
costs
Level of 
protein 
production
Purification 
difficulty
Sensitivity 
to growth 
conditions*
Post 
translational 
Processing#
Bacteria Moderate Moderate High Easy to moderate Moderate Poor
Insect cells Moderate to 
high Moderate
Moderate to 
high Easy to moderate Moderate Moderate
Animal cells High High Low Moderate to difficult High Excellent
Yeast cells Moderate Moderate High Easy to moderate Moderate Moderate to 
excellent
Plants Low Low Low Moderate to difficult Low Moderate
 
*Shear forces, pH, temperature, oxygen; #expression of mammalian proteins 
 
The advantage of using E. coli for heterologous protein production is its ability to grow 
rapidly to high densities on inexpensive substrates.  Genetic tools are well characterised 
(Baneyx, 1999) and large scale cultivation technologies are readily available. However, 
limitations regarding glycosylation and accumulation of misfolded proteins exist 
(Baneyx, 1999) (Table 3).  
 
Ease of expression and cultivation, ability to scale-up and cost of production on 
inexpensive media have made yeast systems a popular choice (Sudbery, 1996) (Table 
3). These systems include S. cerevisiae, P. pastoris and H. polymorpha, which 
generally provide an appropriate environment for eukaryotic post-translational 
processing and secretion, resulting in a product that is often similar to the native protein 
(Sudbery, 1996). Production of VLPs in yeast systems include the HIV-1 Gag protein 
(Jacobs et al., 1989; Sakuragi et al., 2002), anti-malarial antigens (Brady et al., 2001), 
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poliovirus subviral proteins (Rombaut and Jore, 1997), HBsAg (Valenzuela et al., 
1982), and HPV-16 vaccine (Koutsky et al., 2002). With respect to HBsAg production, 
in batch cultivations, S. cerevisiae has obtained yields of ~ 2 mg.L-1culture (280 µg.gDW-1) 
(Gu et al., 1991), which has been significantly improved by using a fed-batch process, 
resulting in HBsAg levels of 10 to 20 mg.L-1culture (670 µg.gDW-1) (Hsieh et al., 1988; 
Gu et al., 1991). Similar results were obtained with H. polymorpha: in batch cultures, 
HBsAg production reached levels of 1.6 mg.L-1culture (46 µg.gDW-1), while the 
implementation of fed-batch cultivation substantially increased HBsAg production 
levels to 8 to 9 mg.L-1culture (225 µg.gDW-1) (de Roubin et al., 1992). In shake flask 
cultivation, recombinant P. pastoris obtained HBsAg production levels of 270 µg.gDW-1 
while large scale fed-batch cultivation resulted in a significant increase in HBsAg 
production to 380 mg.L-1culture (6.4 mg.gDW-1) (Cregg et al., 1987).  
 
Recombinant baculovirus (rBV) expression vectors are extensively used for the 
expression of a variety of recombinant proteins in insect cells. These include cytosolic, 
nuclear, mitochondrial, membrane-bound and secreted proteins (Kost and Condreay, 
1999). Recombinant BVs have been extensively used to express a variety of viral 
proteins such as VP1, VP2 and VP3 of the polyomavirus (Chang et al., 1997; An et al., 
1999), Norwalk virus capsid protein (Bertolotti-Ciarlet et al., 2002), HIV-1 Gag protein 
(Nermut et al., 1994; Zhao et al., 1994) and HPV capsid proteins (Kirnbauer et al., 
1993; Christensen et al., 1994; Touze et al., 1998; Baek et al., 2010 ). Despite the high 
level of expression of recombinant proteins, the baculovirus system in terms of growth 
medium is relatively expensive (Table 3). Similar to yeast systems, baculoviruses are 
limited to high mannose glycoprotein modification, and this is sometimes inconsistent 
in comparison to mammalian cell lines. Nonetheless, baculovirus expression systems 
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provide a great tool for the investigation of functional and antigenic properties of rBV 
expressed proteins (Possee, 1999) and are currently leading the field, along with yeast 
in VLP production (Harro et al., 2001, Koutsky et al, 2002; Grgacic and Anderson, 
2006). 
 
Mammalian cells have also been used in the production of VLPs (MacNab et al., 1976; 
Michel et al., 1984) and have been successful due to appropriate modifications and 
authentic assembly of higher eurkaryotic gene products. One commonly used cell line 
that has successfully produced VLPs is the Chinese Hamster Ovary (CHO) cell line 
(Michel et al., 1984).  HBsAg vaccine production in these cells as a vaccine proved to 
be highly immunogenic in humans and provided rapid protection against HBV (Tron et 
al., 1989).  Other mammalian cell lines include African green monkey kidney CV-1 
cells transformed with an origin-defective SV-40 mutant virus and murine-fibroblasts 
(Shibahara et al., 1985; Kaufman, 1990).  However, the production of vaccines using this 
expression platform requires both complex and costly equipment, methodology and culture 
media (Marino, 1991).  These cells are sensitive to shear forces, culture pH and 
temperature and therefore scale-up to large-scale production levels is complex and 
costly (Table 3). Mammalian cells grow significantly slower than microbial cells 
(average doubling time of 18 to 48 hours compared to 20 to 90 minutes for microbial 
cells) with production levels that are relatively low compared to other expression 
platforms. There are also fears relating to the safety of vaccines derived from mammalian 
cell lines. Retroviruses in particular also tend to include unwanted host cell membrane 
proteins in their envelope during assembly (Grgacic and Anderson, 2006). Due to these 
complications mammalian cell cultures are not always preferred for VLP production. 
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The rational of producing VLPs in plants is significant and thus has gained much 
interest recently. The local production of recombinant plants producing VLPs would 
reduce logistics concerning distribution, cold-chain storage and transport, and costs 
significantly (Mett et al., 2008; Sharma et al.,2010). The scale of production is flexible 
and easily changed to market requirements (Herbers and Sonnewald, 1999). Giddings et 
al., (2000) estimated that the cost of producing recombinant proteins in plants could be 
10 to 50 - fold lower than in E. coli. In addition, plants do not harbour human infectious 
pathogens therefore sterility is not a big concern. VLP production in plants has been 
evaluated for HBsAg (Richter et al., 2000), Norwalk virus (Tacket et al., 2000), HIV 
(Zhang et al., 2002), influenza (Beachy,, 1999; D’ Aoust et al., 2008), and Rotavirus 
(O’ Brien et al., 2000). Mason et al., (1992) demonstrated the assembly of HBsAg 
particles in transgenic tobacco, and even though production levels were lower 
compared to other expression systems, oral administration of raw potatoes induced an 
antibody response that was greater than those required for protection (Kong et al., 
2001). This technology is promising, taking into account the long culturing times and 
low production levels, but there are issues regarding regulatory affairs, which include 
quality control and validation of the manufacturing process. 
 
In comparison to the aforementioned expression systems, filamentous fungi are hosts 
that have gained much interest for expressing mammalian and higher eukaryotic gene 
products, due to several potentially advantageous characteristics. The genus Aspergillus 
is a prodigious exporter of homologous protein and is able to produce a broad range of 
different enzymes in large quantities (Jeenes et al. 1991; Van den Hondel and Punt 
1991). Through advancements in fungal genetics and the knowledge gained of the 
biochemical pathways, is has been demonstrated that Aspergillus have the ability to 
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express mammalian and higher eukaryotic gene products in a stable, correctly folded 
and functional form, through efficient post-translational modifications. 
Hyperglycosylation and disulfidation appears to be less of a problem in comparison to 
that in yeast and bacterial expression systems. Most filamentous fungi are transformed 
by plasmids that integrate into the fungal genome, suggesting potentially superior long-
term stability of the fungal transformants. Examples of  mammalian and higher 
eukaryotic gene products produced in Aspergillus include: insulin, human interferon α-
2, interleukin-6, human lactoferrin, hen egg white lysozyme (HEWL), β2-
microglobulin, mucus proteinase inhibitor, porcine pancreatic phospholipase A2, 
thaumatin, pancreatic phospholipase, tissue plasminogen activator, and bovine 
chymosin (Table 4). In addition, Aspergillus is generally robust during cultivation and 
can grow on various substrates and organic compounds (Jeenes et al. 1991; Van den 
Hondel and Punt 1991), resulting in cultivation methods that are substantially cheaper 
than various other expression systems. Detailed safety evaluations and toxicity tests of 
various homologous and heterologous protein preparations from Aspergillus niger and 
Aspergillus oryzae have indicated that there are no reasons for safety concerns in the 
human consumption of these products (Barbesgaard et al., 1992; Greenough et al., 
1996; Lane et al., 1997; Coenen et al., 1998). A. niger has therefore been granted 
GRAS (Generally Regarded As Safe) status since 1973 by the United States Food and 
Drug Administration (FDA). For these reasons, filamentous fungi have been identified 
as acceptable candidate hosts, for the production of recombinant proteins of 
pharmaceutical interest.  
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Table 4.  Mammalian and higher eukaryotic gene products expressed in Aspergillus  
Product Source Expression host Production levels Reference 
Insulin Human A. niger 776 mU.L-1 Mestric et al., 1996 
Interferon alpha-2 Human Aspergillus nidulans 0.2 mg.L-1 MacRae et al., 1993 
   1 mg.L-1 Gwynne et al., 1989 
Interleukin-6 Human A. nidulans 4.8 mg.L-1 Contreras et al., 1991 
Lactoferrin Human Aspergillus oryzae 2 g.L-1 Ward et al., 1995 
Lysozyme HEWL A. niger 1 mg.L-1 Archer et al., 1990 
microglobulin Human A. nidulans 117g.L-1 O'Herrin et al., 1996 
Mucus proteinase inhibitor Human A. niger 3 mg.L-1 Mikosch et al., 1996 
Porcine pancreatic phospholipase A2 Human A. niger 10 mg.L
-1
 
Roberts et al., 1992 
Thaumatin 
Plant 
(Thaumatococcus danielli) 
A. oryzae 50 ng.L-1 Hahm and Batt, 1990 
  Aspergillus awamori 5 - 7 mg.L-1 Faus et al., 1998 
   100 mg.L-1 Moralejo et al., 1999 
Pancreatic phospholipase Pig A. niger 10 mg.L-1 Roberts et al., 1992 
Chymosin Calf A. oryzae 0.16 mg.L-1 Dunn-Colemann et al., 1991 
  A. awamori 1.3 g.L-1 Tsuchiya et al., 1993 
Tissue plasminogen activator Human A. nidulans 1 mg.L-1 Upshall et al., 1987 
  A. niger 12 - 25 mg.L-1 Wiebe et al., 2001 
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Consequently, filamentous fungi have been identified as potential platforms for 
recombinant VLP production. Plüddemann and van Zyl, (2003) demonstrated A. 
niger’s ability to synthesize and assemble complex immunogenic viral proteins into 
correctly-folded VLPs. HBsAg, which is well documented and characterised, was used 
as the model VLP in the study. A. niger was transformed with the HBV S gene 
encoding the major viral envelope protein under control of the constitutive A. nidulans 
glyceraldehyde-3-phosphate dehydrogenase (gpdA) promoter (Plüddemann and van 
Zyl, 2003). Production of the 24 kDa HBsAg S protein, as well as a 48 kDa dimer was 
observed. HBsAg was localized in the intracellular membrane-associated protein 
fraction. Similar findings have been observed in S. cerevisiae (Hamsa and Chattoo, 
1994), P. pastoris (Cregg et al., 1987), H. polymorpha (de Roubin et al., 1991) and 
plant cells (Smith et al., 2002). The yield of HBsAg, with a diameter of 22 nm, from 
mycelium of the recombinant Aspergillus strain was estimated to be 0.4 mg.L-1culture in 
shake flask cultivations. HBsAg production in batch culture was enhanced ~ 9-fold by 
optimizing the bioprocessing parameters, agitation intensity and dissolved oxygen 
(dO2) concentration and were low compared to the production of homologous proteins 
(James et al., 2007). Despite these low levels of intracellular HBsAg, high mRNA 
levels were recorded (Plüddemann and van Zyl, 2003). These results suggest that 
limitations with the production of recombinant HBsAg do not appear to be at the level 
of transcription but rather on a (post)translational level as observed in other studies 
expressing higher recombinant eukaryotic gene products (Jeenes et al., 1994; 
Nyyssönen and Keränen, 1995; Gouka et al., 1997a; Plüddemann and van Zyl, 2003). 
Various reasons have been suggested for these low heterologous protein yields 
including incorrect folding or processing of the protein during posttranslational 
modification, up regulation of the unfolded protein response (UPR) and Endoplasmic 
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Reticulum associated degradation (ERAD), and proteolytic degradation (Archer and 
Peberdy, 1997; Gouka et al., 1997a; Plüddemann and van Zyl, 2003).  
 
The aforementioned findings indicate the potential of the filamentous fungi, A. niger, 
as a a host for VLP production. Furthermore, alternate VLPs for emerging diseases 
may also be developed to meet urgent needs of the society by taking advantage of the 
versatility of this platform technology. However, aforementioned findings also reflect 
new challenges and opportunities using biomolecular and bioprocessing methods to 
further develop the VLP technology in the filamentous fungi A. niger. 
 
Challenges and opportunities involved in new research and development 
The improvement of fungal production strains through developing genetic and 
bioprocessing technologies remains an important objective in present and future 
research. These approaches towards fungal strains producing recombinant products will 
be powerful tools for improving production levels, producing novel tailored 
compounds or directing the synthesis of desired products, especially in the context of a 
VLP production platform using the filamentous fungus, A. niger. However, this will 
only become feasible with the development of efficient methods to introduce and 
control gene expression in filamentous fungi (Meyer, 2008). 
 
Classical strain improvement has been used since the early 1950’s to increase yield, 
titre, productivity or general ease of use of filamentous fungi and has been responsible 
for virtually all the published hyper-producers to date. However, before classical strain 
improvement strategies are implemented, introducing the desired gene product of 
interest to the fungus host strain and the selection of hyper-producing transformants 
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often represents a challenge. The manipulation of genomic DNA can be achieved 
through several methods, one of which is of interest in this context, random integration. 
Random integration focuses on introducing DNA into the genome resulting in 
randomly integrated copies of the heterologous gene into the chromosome of the 
transformed strain. A common feature of this process is the duplication of the 
integrated DNA, producing multiple copies of the target gene (Verdoes et al., 1993).  
This strategy is often favoured due to the ease of implementation, as well as the ability 
to attain high copy number insertions. Significant variance in recombinant gene 
products is generally expected amongst transformants through the implementation of 
random integration techniques. This is attributed to vector copy number and/ or site of 
integration (Verdoes et al., 1994).  
 
It has been shown that vector copies generally integrate in only one chromosome 
(Verdoes et al., 1993), and that plasmid vectors can be integrated into regions of the 
chromosome which are transcribed with different efficiencies as suggested in the 
studies of Thompson and Gasson (2001) and Plüddemann and van Zyl (2003). A 
specific risk of random insertion is the possibility of a pleiotropic effect, such as 
disruption of a chromosomal gene that has a central function and thereby the 
transformation negatively influences growth or production. It is therefore essential to 
screen transformants with the objective of selecting hyper-producing transformants. To 
increase the probability of identifying hyper-producers, these screens require a large 
number of transformants. The cultivation and analysis of a large number of 
transformants is often laborious and time consuming. Furthermore, high value 
recombinant products are often costly to assay. Through the implementation of a 
screening strategy that allows for the cost effective, rapid, robust and high-throughput 
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evaluation of transformants, recombinant production levels can be significantly 
increased. Rational selection techniques, not involving the product of interest, but 
associated biochemical characteristics is a possible solution and has been successfully 
implemented in mutagenesis studies. Such techniques involve, for example, direct 
colony selection after a bioassay overlay for better penicillin producers (Vournakis and 
Elander, 1983), laccase production (Weenink et al., 2006), and citrate specific indicator 
(R-di-methylaminobenzaldehyde) assays for citrate hyper-producers (Mattey, 1992). 
 
Considering the high production potential of the fungal cell and the many similarities 
among the protein processing machinery of the filamentous fungi and other expression 
platforms such as yeasts and higher eurkaryotes, the often low production levels 
obtained from heterologous proteins when the A. niger production system is employed, 
poses an intriguing challenge (reviewed by Jeenes et al. 1991; Van den Hondel et al. 
1991; Gwynne and Devchand 1992). This bares some concern considering scale-up 
options. The host cell may not only be stressed by environmental conditions but also by 
the over-expression of the heterologous protein (Mattanovich et al. 2004), where 
limitation can be experienced at levels of transcription, translation, secretion, and 
degradation by proteases. Since usually highly inducible fungal transcription-control 
regions are used, the mRNA levels of heterologous genes, especially in multicopy 
strains, are not considered limiting (Gouka et al., 1997a). However, high transcription 
rates of heterologous genes often overburden the protein production capacity so that 
high intracellular concentrations of misfolded heterologous proteins accumulate, 
leading to stress reactions as well as direct loss of product. Consequently, limitations 
involved with the production of heterologous protein are suggested to be associated at 
the post-translational level, which includes inefficient translation initiation and 
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elongation, translocation, folding, transport, processing or secretion of the protein 
(Ward et al. 1990; Turnbull et al. 1989; Tsuchiya et al. 1992; Broekhuijsen et al. 1993). 
Moreover, when heterologous proteins are finally produced efficiently, the threat of 
degradation by proteases is a major concern. Aspergilli can secrete a diversity of 
proteases (Mattern et al. 1992; Van den Hombergh et al. 1995) and it has been shown 
that proteases are responsible for the degradation of many heterologous proteins 
including human interleukin-6 (Broekhuijsen et al. 1993), bovine chymosin (Van 
Hartingsveldt et al. 1990) and porcine pancreatic phospholipase A (Roberts et al. 
1992).  
 
Appropriate strain improvement strategies for the further development of A. niger as an 
expression host for VLP production. 
On the basis of limitations observed for the production of heterologous proteins, strain 
improvement strategies have been developed to alleviate the limiting factor(s) and 
putative blockages, with the aim of increasing the production yields of heterologous 
proteins in A. niger (Archer et al. 1994). Below several strain improvement strategies 
considered for this study are discussed. 
 
Promoters 
For effective heterologous expression, the common strategy involves the introduction 
of multiple copies of the gene product of interest, expressed under the transcriptional 
control of an efficient promoter into a high-protein-producing strain. Various promoters 
from filamentous fungi have been isolated which include constitutive and inducible 
promoters (Van den Hondel et al., 1991).  Each has their advantages and 
disadvantages: Constitutive promoters are functional during growth and therefore 
Stellenbosch University http://scholar.sun.ac.za
 28 
 
 
unsuitable for over-expression of foreign proteins that might be toxic to the host cells, 
while inducible promoters are repressed by various simple, ready-to-use carbon 
sources. Needless to say, the success of applying either a constitutive or inducible 
promoter often depends on either the protein to be expressed, the fungal host strain 
and/or cultivation conditions. 
 
A commonly used constitutive promoter is the gpdA promoter from A. nidulans (Punt 
et al., 1988). The gpdA promoter is based on the glyceraldehyde-3-phosphate-
dehydrogenase (GPD), which is a key enzyme in glycolysis and gluconeogenesis and in 
A. nidulans up to 5 % of the soluble cellular proteins consists of GPD (Punt et al., 
1990).  The expression signals of the gpdA gene are therefore very strong, making this 
a popular promoter for heterologous expression.  Examples of transcriptional control 
using the gpdA gene promoter include the production of thaumatin (Hahm and Batt, 
1990), human lysozyme and HEWL (Archer et al., 1990), Tissue plasminogen activator 
(t-PA) (Wiebe et al., 2001), and HBsAg particles in A. niger (Plüddemann et al., 2003). 
 
In view of inducible promoters, various options are available: the alcohol 
dehydrogenase I (alcA) promoter, the glucoamylase (glaA) promoter of A. niger, 
A. oryzae and A. awamori; the Taka-amylase A gene promoter (amyB) of A. oryzae and 
the A. awamori 1,4-β-endoxylanaseA (exlA) promoter (Nunberg et al., 1984; Fowler et 
al., 1990; Hata et al., 1992; Gouka et al., 1996; Kanemori et al., 1999). The alcohol 
dehydrogenase I (alcA) promoter is one of the strongest inducible promoters available. 
It shows low expression on glucose, but is strongly induced by ethanol or threonine 
under glucose depleted conditions (Devchand et al., 1989; Gwynne et al., 1989; Hintz 
and Lagosky, 1993).  This expression system was used to produce human lactoferrin in 
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A. nidulans (Ward et al., 1992). Both the glaA and amyB promoters are inducible by 
starch or maltose and repressed by xylose or glycerol, while the exlA promoter is 
strongly inducible by D-xylose.  The glaA promoter has been studied using green 
fluorescent protein (GFP) as a reporter, as well as with the aid of deletion analyses 
(Fowler et al., 1990; Santerre Henriksen et al., 1999).  Studies have revealed that the 
promoter is induced to high levels when the fungus is grown on starch or maltose, to 
intermediate levels when grown on glucose, but that it is repressed in the presence of 
xylose (Santerre Henriksen et al., 1999).  The promoter region is 1966 bp and two 
regions essential for transcription have been identified.  Region I (between position –
318 and –562) is required for high-level expression and region II (which lies within the 
first 214 bp upstream of the translation initiation site) directs low-level expression and 
is the minimum region that can act as a promoter (Fowler et al., 1990).  Putative 
binding sites for the protein that mediates carbon catabolite repression (CREA) have 
also been identified (Archer and Peberdy, 1997; Kelly, 1994).  Examples of 
transcriptional control using the glaA gene promoter include the production of 
chymosin (Cullen et al., 1987; Ward et al., 1990; Tsuchiya et al., 1994), human 
lysozyme and HEWL (Archer et al., 1990; Jeenes et al., 1994; MacKenzie et al., 1994), 
cytokine human interleukin-6 (hIL6) (Broekhuijsen et al., 1993; Gouka et al., 1997a), 
human interferon α-2 (Gwynne et al., 1987), Tissue plasminogen activator (t-PA) 
(Wiebe et al., 2001), Human lactoferrin (hLF) (Ward et al., 1995), Porcine pancreatic 
phospholipase A2 (Roberts et al., 1992), and antibody fragments (Frenken et al., 1998).   
  
Proteases deficient hosts 
Filamentous fungi produce proteases which is one of the major factors contributing 
towards the low yield of heterologous proteins (Archer and Peberdy, 1997; Van den 
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Hombergh et al., 1997). The evaluation of the Aspergillus proteolytic spectrum has 
revealed the presence of a number of aspartic proteases, alkaline and semi-alkaline 
serine proteases and serine carboxypeptidases (Jarai, 1997; Van den Hombergh et al., 
1997). Protease production is either localized intracellularly or in the extracellular 
medium (Jarai, 1997). Intracellular accumulation of proteases can be associated with 
the cell wall or in lytic compartments such as the vacuole (Jarai, 1997). These proteases 
are constitutively expressed and are probably involved in non-specific protein 
degradation and turnover, as well as in the activation of the precursors of several 
vacuolar enzymes (Jarai et al., 1994).  Extracellular protease expression increases 
significantly upon derepression with respect to carbon and/or nitrogen source in A. 
niger (Kudla et al., 1990; Kelly, 1994; Tilburn et al., 1995).  
 
To reduce heterologous protein degradation by proteases, the construction and use of 
protease-deficient host strains has become a favored strategy (Van den Hombergh et 
al., 1997). The construction of protease-deficient host strains has been achieved by 
either disrupting the interfering proteases genes or by classical mutagenesis. Disruption 
of the protease pepA gene in A. awamori reduced extracellular proteolytic activity to 20 
% of that of the wild-type (Berka et al., 1990; Mattern et al., 1992) and the expression 
of chymosin resulted in improved production levels (Ward et al., 1993).  Similar 
studies regarding the deletion of the protease pepE gene resulted in the reduction of the 
total intracellular proteolytic activity to 32 % (Van den Hombergh et al., 1997).  
Several protease-deficient UV mutants of A. niger have also been isolated and 
characterized through mutagenesis studies (Mattern et al., 1992; Van den Hombergh et 
al., 1995; Van den Hombergh et al., 1997).  These mutants have varying levels of 
proteolytic activity ranging from 80 % to as little as 1-2 % of that of the parental wild-
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type strain and when expression of human interleukin-6 and porcine phospholipase A2 
was evaluated active recombinant protein was secreted in both cases (Roberts et al., 
1992; Broekhuijsen et al., 1993).  Mutagenesis has also been employed to yield strains 
that acidify the medium less, thereby preventing induction of acid protease expression 
and degradation of heterologous protein products (Gordon et al., 2000).  This kind of 
protease deficient, non-acidifying strain is commonly used in the expression of 
heterologous proteins, particularly non-fungal proteins, and was also utilized for the 
expression of hepatitis B viral proteins (Pluddeman and van Zyl, 2003; Gordon et al., 
2000; Wiebe et al., 2001).  In general, a mutagenesis-based selection program with 
classical genetic strain improvement coupled to the cloning and targeted disruption of 
certain protease genes can provide a selection of host strains with diverse protease 
spectra and low proteolytic activity which can be employed in heterologous protein 
expression (Jarai, 1997). As already mentioned, yield reduction of target heterologous 
proteins can be attributed not only to co-secreted proteases, but due to intracellular 
degradation (Gouka et al., 1996) and the release of intracellular proteases from hyphal 
disruption (Archer et al., 1992).  A reduction in specific protease activity can be 
dependant on culture morphology and associated level of autolysis in cultivations 
(Papagianni and Young, 2002; Ahamed et al., 2005).  Fungal proteases are also pH 
regulated where acid proteases are only expressed at an acidic pH (Denison, 2000). 
Thus, development of an optimal production medium and improved bioreactor 
operation strategies may benefit the heterologous protein production significantly 
(Wang et al., 2003).  Protease activity was most influenced by initial glucose 
concentration and dissolved oxygen (Wang et al., 2003). Proteolytic activity can be 
reduced by growing cultures of recombinant Aspergillus strains in buffered media 
containing glucose as the carbon source at high concentrations to prevent depletion of 
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preferred carbon source and acidification or alkalinisation of the medium with 
concomitant protease induction (Bartling et al., 1996). Use of rich media, typically 
containing peptide nitrogen, induces protease production by A. niger (Archer et al., 
1990; Ahamed et al., 2005); productivity of secreted egg lysozyme by a recombinant 
strain of A. niger was reduced in such rich media (Ward et al., 2005). Cultivation pH 
control has also been a successful strategy. The study of O’Donnell et al. (2001), 
demonstrated a 6-fold reduction in protease activity and a 10-fold increase in 
recombinant protein yield in cultivations controlled at pH 6 compared to cultivations 
without pH control.  In the case of HEWL production by A. niger HEWL under the 
control of the A. niger glaA promoter, control of pH during filamentous growth at pH 
4.0 reduced protease activity 5-fold (Ward et al., 2005). Protease inhibitors in growth 
medium could potentially reduce protease activity, however for large scale production 
processes this is unlikely to be a cost-effective option (Archer and Peberdy, 1997). 
 
Gene fusion strategies  
Gene fusion is one strategy that has been widely employed to enhance heterologous 
protein production in A. niger as was demonstrated for bovine prochymosin (Ward et al 
., 1990), porcine pancreatic phospholipase A2 (Roberts et al. 1992), human interleukin-
6 (Contreras et al. 1991; Broekhuijsen et al. 1993), HEWL (Jeenes et al., 1993), human 
lactoferrin (Ward et al., 1992; Ward et al., 1995), human tissue plasminogen activator 
(Wiebe et al., 2001), phytases from A. awamori (Martin et al., 2003), and humanized 
immunoglobulin G1-kappa antibodies (Ward et al., 2004) (Table 5). The observed 
increases in heterologous protein production varies from 5 to 1000 -fold, depending on 
the protein and strain, resulting in heterologous protein levels varying from 1 to 2000 
mg.L-1. Levels up to 1–2 g.L-1 were obtained for chymosin (Dunn-Coleman et al., 
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1991) and lactoferrin (Ward et al., 1995) when high-level-production strains were 
subjected to several rounds of mutagenesis. Ward et al., (1995) expressed a gene fusion 
comprising the genes encoding A. niger glaA and bovine chymosin to significantly 
increase chymosin yields.  
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Table 5. Production of heterologous proteins by filamentous fungi using a gene-fusion approach (Gouka, 1996). 
A. nidulans A. niger glaA glaA - 3 mg.l
-1
Cullen et al ., 1987
A. niger glaA chymosin - 6.2 mg.l
-1
A. niger glaA glaA - 11.3 mg.l
-1
A. niger glaA glaA  (prepro) - 4.1 mg.l
-1
A. niger glaA glaA  (prepro) A. niger glaA 1-71 - 10.2 mg.l
-1
A. niger glaA glaA - 8 mg.l
-1
A. awamori glaA glaA  (prepro) A. awamori glaA 1-614 - 140 mg.l
-1 10 - 20 x
A. awamori glaA glaA  (prepro) A. awamori glaA 1-614 - 1 g.l
-1(a,b) 100 x Dunn-Coleman et al ., 1991
A. oryzae glaA chymosin - 70 µ g.l
-1
A. oryzae glaA glaA  (prepro) A. oryzae glaA 1-603 - 30 - 80 µ g.l
-1
A. oryzae glaA glaA  (prepro) A. oryzae glaA 1-511 -  0.1 - 0.3 mg.l
-1 5 x
A. oryzae glaA glaA  (prepro) A. oryzae glaA 1-511 - 150 mg/kg
(c) 500 x
A. awamori A. awamori amyA/B amyA/B A. awamori amyA/B - 50 mg.l
-1
Korman et al ., 1990
T. reesei cbh1 cbh1 - 0.3 - 1 mg.l
-1
T. reesei cbh1 cbh1 T. reesei cbh1 1-466 - 5 - 40 mg.l
-1
5 - 100 x
T. reesei cbh1 cbh1 T. reesei cbh1 1-466 - 50 - 150 mg.l
-1(d)
> 150 x
A. niger glaA HEWL - 12 mg.l
-1
A. nidulans gpdA HEWL - 1 mg.l
-1
A. niger glaA HEWL - 50 mg.l
-1
A. niger glaA glaA (prepro) A. niger glaA 1-498 + 1 g.l
-1 > 20 x
Tsuchiya et al ., 1994
A. awamori
A. oryzae
BOVINE PROCHYMOSIN
A. niger Van Hartingsveldt et al ., 1990
Ward et al ., 1990
Nyyssönen et al ., 1993
Nyyssönen et al., 1995
HEN EGG WHITE LYSOZYME
Fab ANTIBODY FRAGMENTS
T. reesei
A. niger
Archer et al ., 1990b
Jeenes et al ., 1993
KEX2 Protein level
Improvement 
factor 
ReferencesHost Promoter Pre(Pro) seq. 'Carrier"-gene
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Table 5 (continued). Production of heterologous proteins by filamentous fungi using a gene-fusion approach (Gouka, 1996). 
A. niger glaA glaA - 25 µ g.l
-1
A. niger glaA hIL6 - < 1 µ g.l
-1
A. niger glaA glaA (prepro) - 2 µ g.l
-1
A. niger glaA /
A. nidulans gpdA
glaA A. niger glaA 1-614 + 5 mg.l
-1 200 x Contreras et al ., 1991
A. niger glaA glaA - ND
A. niger glaA hIL6 - ND
A. niger glaA glaA (prepro) - ND
A. nidulans gpdA hIL6 (prepro) - ND
(a)
A. nidulans gpdA glaA (prepro) - ND
(a)
A. nidulans gpdA glaA (prepro) A. niger glaA 1-514 + 15 mg.l
-1(a) > 1000 x
A. nidulans gpdA glaA (prepro) A. niger glaA 1-514 - > 40 mg.l
-1(a) > 1000 x
A. nidulans alcA unknown - < 1 - 5 mg.l
-1
A. nidulans alcA unknown A. niger glaA + > 100 mg.l
-1 20 - 100 x
A. nidulans A. nidulans alcA lactoferrin - 5 mg.l
-1 Ward et al ., 1992a
A. oryzae A. oryzae amy amy - 25 mg.l
-1 Ward et al ., 1992b
A. awamori A. awamori glaA glaA (prepro) A. awamori glaA 1-498 + > 250 mg.l
-1 > 10 - 50 x
A. awamori A. awamori glaA glaA (prepro) A. awamori glaA 1-498 + > 2 g.l
-1(b) > 80 - 400 x 
T. reesei TR1 HLz 0.5 - 2 mg.l
-1
T. reesei TR1 Synthetic prepro 0.25 - 2 mg.l
-1
T. reesei  Synthetic prepro S. hindustanus ble - 10 - 150 mg.l
-1
10 - 150 x
A. niger glaA PLA2 - ND
(a)
A. niger glaA glaA (prepro) A. niger glaA 1-614 - 10 mg.l
-1(a)
Host Promoter Pre(Pro) seq. 'Carrier"-gene KEX2 Protein level
Improvement 
factor 
HUMAN INTERLEUKIN-6
References
HUMAN LACTOFERRIN
Carrez et al ., 1990
A. nidulans
A. niger Carrez et al., 1990
Broekhuijsen et al ., 1993A. niger
Hintz et al ., 1995A. nidulans
A. niger Roberts et al ., 1992
Ward et al ., 1995
HUMAN LYSOZYME (HLz)
Baron et al ., 1992T. geodes
PORCINE PANCREATIC PROPHOSHOLIPASE A2
 
ND – Not decetable, (a) Protease mutant strain, (b) high levels obtained by mutagenesis, (c) solid state fermentation, (d) submerged fermentation
Stellenbosch University http://scholar.sun.ac.za
 36 
 
 
The gene fusion strategy fuses the genomic sequences encompassing the complete or 
partial coding region of a homologous, highly expressed and well secreted protein often 
termed ‘the carrier protein’ to the N-terminal end of the heterologous protein of interest 
(Ward et al., 1990). The highly expressed and well secreted glucoamylase gene (glaA) 
of A. niger and A. awamori are commonly used as the ‘carrier protein’ for gene fusions. 
The glucoamylases can be divided into three domains: an N-terminal catalytic domain, 
a C-terminal starch-binding domain and a flexible O-glycosylated linker region that 
separates the two domains (Archer, 1994).  The starch-binding domain shuffling in A. 
niger glucoamylase significantly affects the insoluble starch binding and hydrolysis 
(Cornett et al., 2003), while the C-terminal starch-binding domain can be efficiently 
replaced by the heterologous protein (Broekhuijsen et al., 1993; Jeenes et al ., 1993; 
Ward et al., 1995) and the linker region permits the catalytic domain and the rest of the 
fusion protein to fold independently. A positive effect of the fusion is caused through 
the identification of the genomic sequences encompassing the coding region of the 
highly expressed carrier protein by the host cells protein processing machinery, and 
therefore encouraging high expression of the fused cassette (Le Loir et al., 2005). The 
N-terminal carrier protein is then believed to facilitate passage of the heterologous 
protein through the processing machinery of the host, aiding heterologous protein 
maturation and stabilization by facilitating translocation and subsequent folding in the 
Endoplasmic Reticulum (ER) (Gouka et al., 1997b; Bermudez-Humaran et al., 2003). 
Also, by creating a passage through the fungal protein processing pathway for the 
heterologous protein under the mask of the carrier protein, intracellular proteolytic 
degradation is reduced (Gouka et al., 1997b), and protein localization such as secretion 
(Le Loir et al., 2005) or intracellular accumulation (Gordon et al., 2000; Sojikul et al., 
2002) can be realized. The fusion protein is then cleaved further along the protein 
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processing pathway, resulting in the production of the separate proteins. Cleavage 
occurs either by autocatalytic processing of the heterologous protein by an unknown 
fungal protease (Ward et al., 1990; Baron and Tiraby, 1992; Roberts et al., 1992; 
Nyyssönen et al., 1993; Tsuchiya et al., 1994; Nyyssönen and Keränen 1995; Punt et 
al., 2002) or by a KEX2-like protease, for which a dibasic amino acid recognition site 
had been introduced specifically into the fusion protein (Calmels et al., 1991; Contreras 
et al., 1991; Broekhuijsen et al., 1993; Ward et al. 1995; Mikosch et al., 1996; Gouka 
et al., 1997b).  The latter has proven an effective method of obtaining correctly 
processed mature heterologous proteins because an effective kexin-like maturase has 
been identified in A. niger (Jalving et al., 2000). The separation of the heterologous 
protein from the homologous carrier protein is usually achieved by inserting a 
recognition sequence for KEX2-like endopeptidases, which cleaves proteins at two 
adjacently located basic amino acids, preferentially lys-arg (Radzio and Kueck, 1997).  
 
Modifying chaperone levels 
Newly synthesized membrane-bound and/or secreted proteins must fold and assemble 
correctly in order to travel along the secretory pathway and eventually reach their 
appropriate cellular destinations. Unfolded and/or misfolded proteins are prevented 
from leaving the ER, which may lead to the saturation or overloading of the secretory 
pathway (Lodish et al. 1983; Shuster 1991; Parekh et al. 1995; Shusta et al. 1998; 
Smith et al. 2004). This in turn induces the synthesis of folding enzymes (and 
associated UPR) and/or an ER–associated protein degradation response (ERAD), 
which degrades those proteins that fail to reach the correct conformation (Conesa et al., 
2001). This action of folding and/or maturation of proteins into their native form are 
assisted in vivo by helper proteins named chaperones and foldases. Foldases catalyze 
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slow, often rate limiting, covalent changes, such as disulphide bond formation and 
proline isomerisation, which are essential for obtaining a functional conformation. 
Molecular chaperones are not regarded as catalysts but as assisting proteins that 
transiently and non-covalently bind to hydrophobic amino acid stretches, stabilizing the 
immature protein, thus preventing it from aggregating with other unfolded/misfolded 
proteins. In normal cells, the controlled concentrations of foldases and chaperones are 
likely to be sufficient for proper folding and assembly of proteins destined for 
secretion. However, in heterologous expression systems where there is a greater flux of 
proteins being translocated into the ER, the folding, assembly, and secretion machinery 
may become saturated, leading to improperly folded structures or protein aggregates 
that are not secreted (Ngiam et al., 2000).  
 
The overproduction of certain helper proteins has become a plausible strategy in 
reducing UPR and ERAD associated cellular stress and thus enhancing heterologous 
protein production efficiency. The effect of chaperone levels on heterologous protein 
production has been assessed for a number of systems (Dorner et al., 1989; Dorner et 
al., 1992; Hsu and Betenbaugh, 1997). The genes for several ER chaperones and 
foldases have been isolated from filamentous fungi; namely bipA (from a family of 
binding proteins, BiP) (van Gemeren et al., 1997); pdiA (from a family of protein 
disulfide isomerase) (Jeenes et al., 1997; Ngiam et al., 2000); and a family of calnexins 
(Conesa et al., 2001), which have been over-expressed as a strategy to improve the 
heterologous protein production (Table 6).  
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Table 6. Effect of the modification of the levels of ER resident enzymes on heterologous protein production (Conesa et al., 2002). 
Chaperone Protein Organism Effect References
BiP Three human proteins CHO cells Bip levels inversely correlated with protein production levels
Dorner et al ., 1992
Dorner et al ., 1988
BiP
Antibodies Baculovirus BIP overexpression increased intracellular but not secreted Ig protein levels
Hsu et al ., 1994
BiP
GLA:IL6
GLA::scFV4715 A. niger
BIP overexpression increased intracellular but not extracellular levels of fusion 
proteins
Punt et al ., 1998
BiP Cutinase A. awamori BIP overexpression had no effect van Gemeren et al ., 1998
BiP
Three heterologous 
proteins
Yeast
Lower BiP levels resulted in lower secretion levels. Higher BiP levels did not 
increase secretion levels
Robinson et al ., 1996
BiP
Chymosin
TMT
Yeast BiP overexpression increased level of secreted chymosin. TMT unaffected Harmsen et al ., 1996
PDI PDGF Yeast
PDI overexpression increased PDGF secretion and lowered intracellular 
accumulation
Robinson et al ., 1994
PDI Lysozyme Yeast PDI overexpression increased intracellular and secreted protein levels Hayano et al ., 1995
PDI Antistasin Yeast PDI overexpression increased protein production Schultz et al ., 1994
PDI
Lysozyme,
Glucoamylase
A. niger PDIA  overexpression did not influence the secretion levels of both proteins Ngiam et al ., 2000
BiP
Calnexin
MnP A. niger
Calnexin overexpression increases MnP production. BiP overexpression decreases 
MnP production
Conesa et al ., 2002
BiP
Calnexin
Calreticulin
HCV envelope proteins Mammalian 
The three chaperones interact, but when overexpressed, no effect on secretion 
levels
Choukhi et al ., 1998
BiP
Calnexin
Calreticulin
Erp57
Myc-SERT Baculovirus Increased production with Calnexin, less with BiP and Calreticulin. Erp57 no effect Tate et al ., 1999
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The molecular chaperone, BiP (also known as the glucose regulated protein GRP78) is a 
member of the heat shock 70 protein family (HSP70), which is localized in the lumen of the 
ER (Bole et al., 1986; Munro and Pelham, 1986) and is involved in several functions in the 
ER: (1) assists in protein folding, (2) is involved in translocation, and (3) assists in the ERAD 
pathway (Brodsky et al., 1999; Gething, 1999; Matlack et al., 1999). In filamentous fungi, as 
in other organisms, the BiP encoding gene has a basal expression level under normal growth 
conditions and is over-expressed in situations of cellular stress such as glucose starvation, heat 
shock and conditions typical of the UPR (Mori et al., 1992; van Gemeren et al., 1997; Techel 
et al., 1998; Ngiam et al., 2000). The correlation between BiP induction and secretion 
efficiency remains unclear. Enhanced bipA mRNA levels have been observed in various 
Aspergillus strains expressing recombinant extracellular proteins (Punt et al., 1998); 
inefficient secretion of single chain antibodies in A. awamori coincided with an increased BiP 
production (Frenken et al., 1998) and similarly, a two-fold induction in bipA mRNA levels 
was measured in two A. niger strains producing the HEWL (Ngiam et al., 2000). However, 
contradicting results were obtained when the BiP levels remained unchanged when 
interleukin-6 was produced in A. niger (Punt et al., 1998). In terms of over-expressing the Bip 
chaperone, the production of several homologous and heterologous proteins fused to glaA 
were investigated, where the over-expression of bipA resulted in increased levels of 
unprocessed fusion proteins in the cell lysates in A. niger (Punt et al., 1998). However, no 
improvement of the secretion of the fusion proteins was observed. Similar results were 
obtained in A. awamori, where bipA over-expression had no effect on the production of 
cutinase variants (van Gemeren et al., 1998) (Table 6). Although no clear relationship 
between BiP induction and a particular characteristic of the overproduced protein can be 
deduced from this data, they do suggest that protein overproduction may lead to increased 
levels of unfolded proteins, and thus result in bipA over-expression.  
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The foldase, disulphide isomerase (PDI), from the thioredoxin superfamily, is known to be an 
essential protein that catalyzes the refolding of denatured and reduced RNase, through the 
oxidation, reduction and isomerisation of protein disulphides (Laboissiere et al., 1995; Noiva, 
1999; Ngiam et al., 2000; Wilkinson and Gilbert 2004). PDI behaves as a chaperone as it 
inhibits the aggregation of misfolded proteins (Gilbert, 1997; Wang, 1998; Ferrari and Söling, 
1999). These functions are crucial during protein maturation in the ER (Gilbert, 1997; Wang, 
1998; Ferrari and Söling, 1999) as demonstrated by the study of Moralejo et al. (2001) who 
showed that modifying the level of PDI was critical for production of thaumatin in A. 
awamori. Maximum levels of thaumatin (5-fold increase) was obtained in a strain with two to 
four fold more PDI than in the parental strain, with no significant change in production of the 
native proteins acid phosphatase and α-amylase. However, characterization of the pdiA-like 
gene prpA of A. niger var. awamori has also shown that although the prpA gene was induced 
in cells secreting bovine prochymosin, the overproduction of prpA had no effect on chymosin 
production (Wang and Ward, 2003). Similarly, an increased level in pdiA transcripts was also 
observed in two A. niger strains overproducing the heterologous protein, HEWL. However, 
over-expression of pdiA did not increase secreted yields of HEWL in A. niger, suggesting that 
pdiA itself is not limiting for secretion of this protein (Ngiam et al., 2000) (Table 6).  
Calnexin (CLX) is a lectin-like, glycan-dependent molecular chaperone and is a major 
component of the ER quality control system. Similar to BiP, CLX also has several 
intracellular functions; (1) facilitates the folding of glycosylated proteins (Helenius et al., 
1997; Conesa et al., 2002) by slowing folding events and allowing them to occur in a 
controlled manner, (2) retains immature or unassembled structures in the ER, (3) prevents 
aggregation, (4) facilitates the catalysis of disulfide bond formation, and (5) potentially aids in 
the sorting of malformed substrates for degradation (Pearse and Hebert, 2009). Over-
production of CLX has led to improved heterologous protein yields; CLX over-production 
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enhanced the levels of functional serotonin transporter produced using the baculovirus 
expression system (Tate et al., 1999).  Similarly clx over-expression increased manganese 
peroxidase levels in A. niger 5-fold (Conesa et al., 2002). In contrast, a similar approach in 
mammalian cells had no effect on production yields of two hepatitis C (HCV) envelope 
proteins (Choukhi et al., 1998) (Table 6). 
It is clear that results concerning the over-expression of chaperones are far from conclusive 
and frequently seem contradictory. The process of protein folding is a complex network of 
interactions which is dependent on numerous factors which include the characteristics of the 
folding proteins, the environment in the ER and the availability of specific co-factors. 
Chaperones may co-bind or act sequentially in protein folding as reported by Molinari et al. 
(2002), who observed a sequential involvement of the CLX and BiP/PDI chaperone systems 
in mammalian cells. CLX bound to newly synthesized proteins and thus facilitated folding as 
well as prevented aggregation and premature degradation. BiP and PDI were also involved in 
this phase, but were also essential in directing terminally misfolded proteins, after their release 
from CLX, for degradation in the ERAD pathway (Molinari et al., 2002). Similarly, 
Jannaitipour et al., (1998) reported the co-interaction of CLX and BiP in the folding of acid 
phosphatase in Schizosaccharomyces pombe and Gillece et al., (1999) and Mayer et al., 
(2000) report on the synergistic effect and cooperative action of BiP and PDI in protein 
folding.  
 
Appropriate bioprocessing strategies for the further development of A. niger as a production host 
for VLP production. 
In order to develop a successful, cost effective cultivation process for A. niger, cultivation 
parameters as well as the mode of operation are of paramount importance to ensure 
reproducible cultivations and maximizing product yield. This is not a simple task due to the 
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inherent complications in filamentous fungi cultivations. Filamentous fungi are 
morphologically complex organisms, differing in structure during various cultivation periods 
in their life cycle, differing in form between surface and submerged growth, differing also 
with the nature of the cultivation parameters.  
The optimisation and control of cultivation parameters, such as inoculum, temperature, pH, 
agitation, dissolved oxygen (dO2), aeration, and medium composition are critical, as their 
influence on growth, morphology and product formation can be used to provide reproducible 
cultivations and maximize product yield (James, 2006 MSc thesis). However, as illustrated in 
Figure 2, complex interactions exist between the cultivation conditions, the productivity and 
the morphology in fermentations of filamentous microorganisms. Thus extensive knowledge 
of the host strain and product of interest is a prerequisite for the successful development of a 
cultivation process. 
 
 
 
Figure 2. Complex interactions between process conditions, productivity, and morphology in submerged 
fermentations of filamentous microorganisms (adapted from Metz, 1976). 
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Batch, fed-batch, and continuous cultivations are generally the three modes of operation in 
submerged cultivation. Each have their advantages. Batch systems can be used to produce 
different products at different periods of the cultivation and are fairly easy and cost effective 
to execute. Due to the reduced culturing period, batch systems have a lower risk of 
contamination. Batch systems have an increased genetic stability due to a freshly produced 
inoculum used for each batch. 
Continuous cultures are favourable because a steady state is obtainable through stable 
physical, chemical and biological variables. With the advent of the genomic era has come the 
knowledge of microbial genomes, and the technology to study global protein, mRNA and 
metabolite profiles has been developed. These so called ‘omic’ technologies provide the 
possibility to characterize cell physiology at a molecular level, providing temporal, spatial and 
even real-time information. The continuous chemostat is an ideal system for such studies as it 
is a continuous culture system that provides a constant environmental background (Hoskisson 
and Hobbs, 2005). Bull (1974) and Pirt (1975) listed some of the most evident advantages of 
the continuous chemostat cultivation: (1) Environmental conditions can be maintained 
constant; (2) The specific growth rate can be varied by changing the growth-limiting substrate 
made available to the microorganism for consumption, (3) The specific growth rate can be 
maintained for long periods of time; (4) Steady state biomass concentration can be set and 
maintained constant by the use of different concentrations of the growth-limiting substrate in 
the influent medium; and (5) Substrate-limited growth rate can be studied in a constant 
environment, whereas substrate-limited growth in batch culture is transient and is 
accompanied by changing growth rate. 
 
Fed-batch fermentations are used extensively in industrial applications and are often described 
as a production technique between batch and continuous fermentation (Longobardi, 1994). 
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Through an accurate feed rate, and appropriate feed composition (Jong et al., 1995), fed-batch 
offers many advantages over batch and continuous cultures. However, this requires 
knowledge of the microorganism and its requirements as well as batch fermentation data that 
will contribute to the understanding of its physiology with product formation. Through the 
implementation of fed-batch fermentations the cultivation time is often extended in 
comparison to batch, contributing to high biomass concentrations. For growth associated 
products this is often favorable causing volumetric productivity improvements (Agrawal et 
al., 1989). Through the implementation of growth-limiting substrate feed, allowing sufficient 
nutrients solely for the production of the product of interest, catabolic repression and the 
production of by-products that are generally related to the presence of high concentrations of 
substrate can also be avoided. When high concentrations of substrate are present, the oxidative 
capacity of the cells is exceeded, and due to the Crabtree effect, products other than the one of 
interest are produced, reducing the efficacy of the carbon flux. Moreover, these by-products 
prove to even "contaminate" the product of interest, such as ethanol production in baker's 
yeast production, and to impair the cell growth reducing the fermentation time and its related 
productivity (http://userpages.umbc.edu/~gferre1/fedbatch.html). Various feeding strategies 
are available to fed batch cultivations. Some examples include continuous and pulsed feeding 
(Bhargava et al., 2003), pH regulation (Tulin et al., 1992), shot feeding (Larsson et al., 1993), 
single or multi-substrate (Tulin et al., 1992), and a linear increase, or exponential feed (Gu et 
al., 1991; Ramirez  et al., 1995). For a growth-associated product, a direct correlation between 
biomass formation and the product of interest generally exists. This correlation can also relate 
to the specific growth rate of the host. It is therefore beneficial to apply an exponential feeding 
strategy that allows growth at an optimum and constant specific growth rate as demonstrated 
for the production of HBsAg in S. cerevisiae (Agrawal et al., 1989; Alfafara et al., 1992). A 
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10-fold increase in HBsAg was reported using this strategy in comparison to a linear feed to 
which the same volume and total substrate was added.  
 
This could also be achieved using a continuous cultivation, however there are concerns 
regarding the accumulation of undesired mutations in prolonged cultivation (Withers et al., 
1994; Swift et al., 2000; van de Vondervoort et al., 2004). Also, in all filamentous fungi 
cultivations there are complications achieving homogenous cultivations. These complications 
are accentuated in prolonged fungal cultivations as in continuous cultures and are attributed to 
the morphology and surface properties of hyphae and spores. Poulsen (2005) discusses the 
challenges in obtaining and maintaining homogenous submerged cultures of filamentous fungi 
in bioreactors. Mycelia tend to adhere to bioreactor surfaces, such as probes, baffles and on 
walls at and above the liquid-gas interface of the bioreactor. This is termed as wall growth and 
is unfavorable as it contributes to culture heterogeneity. Most problems that lead to culture 
heterogeneity can be alleviated with special cultivation strategies as discussed by Larsen et al. 
(2004) and Poulsen (2005). Variable agitation and cooling of head space are some strategies 
that can be used to reduce wall growth (Larsen et al., 2004), however these strategies do not 
promise 100% success as additional cultivation issues may arise from species- or strain-
specific properties (Zangirolami et al., 2000).  
 
Concluding remarks 
Evidence suggests that the factors influencing heterologous protein yield are complex and 
include biochemical and biophysical properties of the protein itself; its influence on, and 
modification of, the host’s own cellular functions and the choice and deployment of those 
sequences that are necessary for efficient processing and production.  Therefore development 
strategies must be individually designed and assessed for each heterologous protein 
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production system. Apart from implementing the above-mentioned strategies as tools for 
enhancing heterologous protein production levels, other strategies are available. These include 
mutagenesis (MacKenzie et al., 2000; Yaver et al., 2000), signal sequences (Verdoes et al., 
1994; Jarai et al., 1997; Conesa et al., 2002), the introduction of a large number of gene 
copies (Christensen et al., 1988; Finkelstein et al., 1989; Fowler et al., 1990; Punt et al., 
1991b; Verdoes et al., 1994), improving the capacity of the glycosylation machinery (Conesa 
et al., 2002). Another field of research with considerable promise is that of the ‘-omics’ 
technologies. These technologies deal with an overall analysis of gene expression 
(transcriptomics), protein (proteomics) and metabolite (metabolomics) production at the level of 
the complete organism.  Together with advanced microscopy technologies, such as 
fluorescence resonance energy transfer and fluorescent lifetime imaging, these technologies 
will add value in visualizing metabolic pathways and protein–protein interactions in living 
systems and hence direct research towards improved heterologous protein production levels.  
 
This project aims to address the challenges discussed above in an attempt to identify factors 
involved in improving HBsAg production in the expression system A. niger. Specific aims of 
the dissertation are discussed next. 
 
Project Aims 
Manuscript 1 
The intracellular accumulation of recombinant HBsAg in A. niger and similarly in S. 
cerevisiae (Hamsa and Chattoo, 1994), P. pastoris (Cregg et al., 1987), H. polymorpha (de 
Roubin et al., 1991) and plant cells (Smith et al., 2002), suggests that the production process 
in the abovementioned expression systems differs to the efficiently secreted Hepatitis B virus 
in infected cells. This may be indicative of the processing limitations in recombinant 
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microbial systems. In this study we investigate the option of targeting HBsAg production 
through the secretory pathway of A. niger. The gene fusion strategy is implemented using the 
highly expressed glucoamylase gene (GlaA) fused to the HBsAg S gene.  The inducible 
glucoamylase promoter (GlaAp) is used to control transcription in the A. niger D15 host. The 
study focuses on the mechanism of the fusion protein and associated HBsAg processing. 
Further objectives include determining (1) the impact of the glucoamylase promoter on 
HBsAg production, and (2) the stability of the HBsAg product in intracellular and 
extracellular extracts. Batch fermentation data is presented to quantify results. 
 
Manuscript 2 
It is well recognized that the successful enhancement of heterologous protein levels is largely 
based on the development of effective strains, transformants and/ or mutants. In Manuscript 2 
we aim to develop an improved methodology to identify and select high HBsAg producing 
transformants. Three screening methods for the identification of high HBsAg producing 
transformants are evaluated in conjunction with conventional selection (amdS selection 
marker) based on acetamide selection; (1) transformant selection based on acrylamide 
utilization through expression of the amdS gene, (2) transformant selection based on high 
growth on starch as reported by Weenink et al. (2006), and (3) transformant selection based 
on high extracellular glucoamylase activity using starch as a selection pressure. Batch 
fermentation data is included to quantify growth, glucoamylase and HBsAg production levels 
of selected high-HBsAg producing transformants.  
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Manuscript 3 
In this study, we evaluate the effects of growth rate (µ) in glucose-limited exponential fed-
batch fermentations on HBsAg production of two HBsAg producing transformants, previous 
identified (Manuscript 2 of this dissertation); (1) the ‘fast-growing high-biomass producing’ 
transformant, DAHB21#20, and (2) the ‘slow-growing high-glucoamylase producing’ 
transformant, DAHB21#40. Through glucose-limited exponential fed batch fermentation the 
effects of µ over a range of 0.03 to 0.1 h-1 on specific and volumetric intracellular HBsAg 
production as well as biomass concentration and extracellular glucoamylase activity are 
evaluated. Additional analysis on the effect of µ in fed batch fermentation on substrate 
consumption (qs) and the maintenance coefficient (ms) is also performed and provides insight  
towards determining the requirements for efficient HBsAg production. 
 
Manuscript 4 
In this manuscript we test the hypothesis that limitations/ bottlenecks, at a (post)translational 
level in the secretory pathway using gene fusion, are negatively affecting HBsAg production, 
and can be demonstrated by increases in HBsAg production through the over-production of 
chaperones/ foldases. The effects of over-producing the chaperones BiP and CLX, the foldase 
PDI, and the combinations thereof on the production of recombinant HBsAg are evaluated in 
A. niger expressing the HBsAg fusion cassette. Transformants expressing modified chaperone 
and foldase levels created are evaluated for intracellular HBsAg, extracellular glucoamylase 
activity, and biomass production. To compare the strategies of growth regulated cultivations 
and modifying chaperone levels as a means of enhancing HBsAg production levels in A. 
niger, highest HBsAg producing transformants expressing modified chaperone and foldase 
levels are evaluated in batch and glucose-limited exponential fed batch fermentations. As an 
additional objective of this study the potential application of the solid-state glucoamylase 
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screen using starch as a selection pressure (previously described in Manuscript 2 of this 
dissertation) for the identification of high HBsAg producers over-producing chaperones/ 
foldases is evaluated.  
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ABSTRACT 
This study reports that by targeting HBsAg production through the secretory pathway in 
Aspergillus niger, completely assembled and properly folded HBsAg, was obtained. This was 
achieved by implementing a gene fusion strategy using the highly expressed catalytic domain 
of the glucoamylase gene (GlaAG2) fused to the HBsAg S gene.  The inducible glucoamylase 
promoter (GlaAp) was used to control transcription in the A. niger D15 host. The gene fusion 
strategy resulted in the cleavage of the fused product by the KEX2-like protease, and 
intracellular accumulation of HBsAg was observed, while glucoamylase was secreted. Greater 
than 80 % of intracellular HBsAg accumulation was associated with the membrane fraction 
with the remainder resided in the cytoplasmic fraction. Immunodetection using a monoclonal 
HBsAg antibody could not detect the fused GlaAG2::S product in intracellular and 
extracellular fractions, and therefore suggested that full assembly and maturation of HBsAg 
occured after cleavage of the fused product in the Golgi complex. Several breakdown 
products showing an immunoreactive response to the glucoamylase polyclonal antibody, 
indicated a level of intracellular degradation. Intracellular HBsAg extracts were reduced 
significantly in extracellular extracts (91 % degradation), while 77 % of the HBsAg remained 
stable in fresh medium. These findings supported the hypothesis that the glucoamylase 
degradation products were probably not as a result of proteolytic degradation but possibly 
accrued by a protein saturated secretory pathway. The choice of carbon source proved to be 
significant, where HBsAg production levels were affected by the induction levels of the 
glucoamylase promoter. Highest HBsAg production was observed in inducing substrates of 
starch and its degradation products (maltodextrin and maltose). However residual glucose 
accumulation in the mid exponential phase in starch based cultivations reduced HBsAg 
production. In order to further improve HBsAg production in starch based cultures, the rate 
between glucose consumption by the host and hydrolysis of starch by glucoamylase requires 
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optimization. This study demonstrates the potential of A. niger as a candidate expression 
technology for VLP production using gene fusion.   
 
INTRODUCTION 
The development of non-replicating vaccines is an emerging option for safe and effective 
vaccines, several of which contain virus-like particles (VLPs). VLPs are a highly effective 
type of subunit vaccine, which are produced by recombinant expression of viral capsid 
proteins or envelope proteins (Miyanohara et al., 1986; Delchambre et al., 1989; Gheysen et 
al., 1989; French et al., 1990). Various expression systems have demonstrated the ability to 
produce VLPs and these include: (1) Escherichia coli and other bacteria (Liew et al., 2010); 
(2) various species of yeast including Saccharomyces cerevisiae (McAleer et al., 1984; 
Miyanohara et al., 1986), Pichia pastoris (Cregg et al., 1987), and Hansenula polymorpha (de 
Roubin et al., 1991); (3) the baculovirus/insect cell system (Crawford et al., 1994; Bertolotti-
Ciarlet et al., 2003; Mortola and Roy, 2004; Vieira et al., 2005); (3) transgenic plant systems 
(Mason et al., 1996; Smith et al., 2002); and (4) various mammalian cell lines (Warfield et al., 
2003; Swenson et al., 2005; Warfield et al., 2005). VLPs are highly ordered, repetitive 
structures mimicking the native structural assembly and antigenic properties of the parental 
virus. The Hepatitis B vaccine, among others, is an example of a VLP vaccine, which was 
first licensed for use in humans in 1984 by Merk (Recombivax HB®) (Valenzuela et al., 
1982; McAleer et al., 1984; Hilleman, 2001; Hilleman, 2003). 
 
In the present study the filamentous fungi, Aspergillus niger, was considered as an expression 
system for VLP production through expression of the Hepatitis B surface antigen (HBsAg). A. 
niger has become one of several fungal species developed for the production of both 
homologous and heterologous enzymes. As with other fungal species, A. niger is capable of 
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producing high concentrations of proteins (e.g., >20 g.L-1 glucoamylase (GLA); Withers et 
al., 1998). A. niger has also demonstrated the processing of eukaryotic and higher gene 
products in a correctly folded and functional form, efficient disulfide bridge formation and 
does not over-glycosylate heterologous proteins as observed in yeast (Upshall et al., 1987; 
Harvey and McNeil, 1994; Kinghorn and Unkles, 1994). The transformants obtained are 
usually stable, as the incoming DNA readily integrates into the genome upon transformation 
(van den Hondel and Punt, 1991). These advantageous characteristics, combined with the 
available cultivation technologies (Jeenes et al., 1991), have resulted in large scale production 
methods that are substantially cheaper than various other expression systems (Bodie et al., 
1994; Davies, 1994), and are indicative of the potential of A. niger as a host for VLP 
production. 
  
Plüddemann and van Zyl, (2003), demonstrated the ability of A. niger to synthesize and 
assemble complex intracellular Hepatitis B surface antigens (HBsAg) into correctly-folded 
VLPs, under control of the constitutive A. nidulans glyceraldehyde-3-phosphate 
dehydrogenase (gpdAp) promoter. Maximum production levels obtained in controlled batch 
fermentations were a few milligrams per litre culture and were low compared to the 
production of homologous proteins (James et al., 2007). Despite these low levels of 
intracellular HBsAg, high mRNA levels were recorded (Plüddemann and van Zyl, 2003). 
These results suggest that limitations with the production of recombinant HBsAg do not 
appear to be at the level of transcription but rather on a (post)translational level as observed in 
other studies expressing higher recombinant eukaryotic gene products (Jeenes et al., 1994; 
Nyyssönen and Keränen, 1995; Gouka et al., 1997a; Plüddemann and van Zyl, 2003). Various 
reasons have been suggested for these low heterologous protein yields including incorrect 
folding or processing of the protein during posttranslational modification, up regulation of the 
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unfolded protein response (UPR) and Endoplasmic Reticulum associated degradation 
(ERAD), and proteolytic degradation (Archer and Peberdy, 1997; Gouka et al., 1997a; 
Plüddemann and van Zyl, 2003).  
 
To elucidate the issues revolving around these low HBSAg yields we refer to the Hepatitis B 
virus life cycle. In the Hepatitis B virus life cycle, newly synthesised S proteins are carried 
through the secretory pathway of the infected host, resulting in the assembly and maturation 
of the HBsAg in the ER/ Golgi complex (Huovila et al., 1992). This is followed by the rapid 
exportation from the cell (Simon et al., 1988), where HBsAg particles are produced in excess 
of 103- to 106-fold in comparison to the infectious virion (Ganem and Prince, 2004). The 
intracellular accumulation of recombinant HBsAg in A. niger and similarly in S. cerevisiae 
(Hamsa and Chattoo, 1994), P. pastoris (Cregg et al., 1987), H. polymorpha (de Roubin et al., 
1991) and plant cells (Smith et al., 2002), suggests that the production process in the 
abovementioned expression systems differs to that of the Hepatitis B virus life cycle. 
 
Gene fusion is one strategy that can be used to direct production through the secretory 
pathway as is performed in the Hepatitis B virus life cycle. This is achieved by fusing a 
homologous and well secreted protein often termed ‘the carrier protein’ to the N-terminal end 
of the heterologous protein of interest.  Gene fusion has been used successfully for a number 
of expression systems including A. niger to enhance production of higher recombinant 
eukaryotic gene products as was demonstrated for bovine prochymosin (Ward et al ., 1990), 
porcine pancreatic phospholipase A2 (Roberts et al. 1992), human interleukin-6 (Contreras et 
al. 1991; Broekhuijsen et al. 1993), hen egg-white lysozyme (Jeenes et al., 1993), human 
lactoferrin (Ward et al., 1992, Ward et al., 1995), human tissue plasminogen activator (Wiebe 
et al., 2001), phytases from Aspergillus awamori (Martin et al., 2003), and humanized 
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immunoglobulin G1-kappa antibodies (Ward et al., 2004). The observed increases in 
heterologous protein production varied from 5 to 1000 -fold, depending on the protein and 
strain, resulting in heterologous protein levels varying from 1 to 2000 mg.l-1 (Ward et al., 
1990; Contreras et al., 1991; Broekhuijsen et al., 1993; Archer, 1994; Gouka et al., 1997b). 
Besides facilitating target protein localization e.g. secretion (Le Loir et al., 2005) or 
intracellular accumulation (Gordon et al., 2000; Sojikul et al., 2003), additional advantages of 
this method include; (1) identification of the genomic sequences encompassing the coding 
region of the carrier protein by the host cells protein processing machinery, therefore 
encouraging high expression of the fused cassette (Le Loir et al., 2005), (2) aiding 
heterologous protein maturation and stabilization by facilitating translocation and subsequent 
folding in the ER (Gouka et al., 1997b; Bermudez-Humaran et al., 2003), and (3) preventing 
intracellular proteolytic degradation by creating a passage through the fungal protein 
processing pathway for the heterologous protein under the mask of a homologous gene 
product (Gouka et al., 1997b).  
 
In this study we evaluate gene fusion as a strategy to produce correctly folded and assembled 
HBsAg. HBsAg production was directed through the secretory pathway in A. niger as is 
performed in the Hepatitis B virus life cycle. The gene fusion strategy was implemented using 
the highly expressed glucoamylase gene (GlaA) fused to the HBsAg S gene.  The inducible 
glucoamylase promoter (GlaAp) was used to control transcription in the A. niger D15 host. 
The study focuses on the mechanism of the fusion protein and associated HBsAg processing. 
Further objectives include determining (1) the impact of the glucoamylase promoter on 
HBsAg production, and (2) the stability of the HBsAg product in intracellular and 
extracellular extracts. Batch fermentation data is presented to quantify results. 
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MATERIALS AND METHODS 
Strains  
A. niger D15 (uridine auxotrophic (pyrG), protease-deficient (prtT), nonacidifying (phmA) 
mutant) was used as the recipient strain for gene fusion transformations (Gordon et al., 2000). 
A. niger D15 (pBluescript-pyrGamdS) was used as the reference strain (Plüddemann, 2003). 
 
Plasmid and transformation procedures  
The plasmid used for transformation, pAHB19, (bla pyrG amdS GlaAP-GlaASS-GlaAG2-S-
trpCT), constructed by Plüddemann, (2003), contains the A. niger glucoamylase promoter 
(GlaAp), secretion signal fused to a sequence encoding the truncated A. niger glucoamylase 
catalytic domain (GlaAG2) and the Aspergillus nidulans trpC terminator. The S gene is fused 
to the truncated A. niger GlaAG2 form (514 aa) lacking the starch-binding domain 
(Broekhuijsen et al., 1993), and the dibasic proteolytic cleavage site “Lys-Arg” separates the 
GlaAG2 and Hepatitis B sequences resulting in the cleavage of the fusion protein into separate 
proteins by a KEX2-like protease (Broekhuijsen et al., 1993). The A. nidulans acetamidase 
(amdS) and A. niger orotidine-5’-decarboxylase (pyrG) genes are used as selection markers 
(provided by Prof P Punt TNO, Zeist, The Netherlands, Figure 1).   
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Figure 1.  Schematic representation of the pAHB19 expression vector containing the fusion gene that consists of 
the sequence coding for the A. niger GlaAG2 (aa 1-514) and the HBsAg S gene, regulated by the A. niger GlaAp. 
The E. coli β-lactamase (bla), A. nidulans acetamidase (amdS) and A. niger orotidine-5’-decarboxylase (pyrG) 
genes were used as selectable markers. The trpCt (a trifunctional gene in tryptophan biosynthesis) was used as 
the gene terminator. 
A. niger D15 was transformed following the protoplasting method described by Punt and van 
den Hondel (1992), using Novozym 234 (Sigma-Aldrich). Resulting DAHB19 transformants 
were selected for on minimal medium (MM) (Bennett and Lasure, 1991) without uridine 
containing 1.2 M sorbitol as osmotic stabiliser, 1.5 % agar (Oxoid) and 10 mM acetamide as 
sole nitrogen source (Kelly and Hynes, 1985).  Transformants were selected for multicopy 
integration of the expression cassettes through the use of acrylamide plates (Verdoes et al., 
1993).  
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Inoculum preparation 
Fungal spores were obtained from a densely conidiating culture grown on potato dextrose 
agar (PDA) at 30 oC for 120 h and harvested with physiological saline solution (NaCl, 0.9 % 
w.v-1). Shake flask cultures were inoculated with a spore concentration of 1×106 spores.ml−1 
culture. Batch fermentations were inoculated with a shake flask pre-culture amounting to 10 
% of the fermentors’s total working volume.  
 
Media and cultivations  
All cultivations were grown on minimal medium without uridine (Plüddemann and van Zyl, 
2003) containing 3 % (w.w-1) soluble starch or glucose and supplemented with 0.1 % (w.w-1) 
casamino acids (Difco), 0.8 % (w.w-1) tryptone and 0.8 % (w.w-1) yeast extract. For induction 
studies 3 % soluble starch was substituted with 3 % xylose, sucrose, fructose, glucose, 
maltose, maltodextrin, and insoluble starch, respectively. Shake flask cultivations were 
performed in 1 L Erlenmeyer flasks (un-baffled) containing 250 ml medium at 30 °C on a 
rotary shaker (Innova 2300, New Brunswick Scientific, Edison, USA) at 180 rpm. Batch 
fermentations were performed in 2 L bench-top bioreactors (INFORS AG, Switzerland) with 
a working volume of 1.5 L. The fermentation temperature was maintained at 30 °C (± 0.1 °C), 
aeration at 0.8 vvm, dissolved oxygen was maintained above 25 % saturation by varying 
impeller speed (starting rate of 150 rpm), through a cascaded controller. The impellor speed 
was ramped by 200 rpm for 1 min every hour to reduce wall growth. pH was controlled above 
a value of 4 using NH4OH (25 % w.v-1). 
 
Sample preparation 
Shake flasks were sampled in 24 hr increments while batch fermentations were sampled at 
intervals of 3 to 8 h. Samples containing ± 50 g of cultivation medium were withdrawn and 
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biomass concentration was measured by vacuum filtering 25 g  sample on dry and pre-
weighed filters (Whatman no.1), followed by washing with 40 ml 0.9 % (v.w-1) NaCl solution 
and drying to a constant weight at 105 oC for 24 to 48 h. The remaining 25 g sample was 
ground with liquid nitrogen in a mortar and pestle to a fine powder, and an aliquot of 0.3 g 
mycelia powder was stored at −80 °C in a 2 ml microcentrifuge tube. Ground samples were 
suspended in protein extraction buffer with or without 0.1 % Triton X-100 (Plüddemann and 
van Zyl, 2003) and homogenized for 1 min at 4 °C. Cytoplasmic proteins were isolated using 
extraction buffer without the non-ionic detergent Triton X-100, and total intracellular proteins 
including membrane-associated proteins were isolated by the addition of Triton X-100 to the 
extraction buffer. For protein concentration, both intracellular and extracellular fractions were 
precipitated with 30-60 % ammonium sulfate fractionation, followed by size exclusion using a 
10 000 MW spin concentrators (Vivaspin, Sartorius, Göttingen, Germany). 
 
SDS Page and Western Blot  
Proteins were separated in a 12 % SDS polyacrylamide gelelectrophoresis (PAGE) gel (Bio-
Rad, Hercules, CA) and visualised by means of silver staining (ProteoSilver™ Plus Silver 
Stain Kit, Sigma-Aldrich). For Western blotting, proteins were transferred to a polyvinylidine 
difluoride (PVDF) membrane (Hybond-P; Amersham Pharmacia Biotech) in transfer buffer 
[25 mM Tris-HCl (pH 7.5), 192 mM glycine, 15 % (v.v-1) methanol] using a semi-dry transfer 
apparatus (Bio-Rad, Hercules, CA).  The HBsAg primary antibodies were monoclonal mouse 
anti-Hepatitis B surface antigen (1:5000 dilution; DakoCytomation, USA) and secondary 
antibodies were anti-mouse immunoglobulins conjugated to horseradish peroxidase (1:10 000 
dilution).  S. cerevisiae-derived Engerix B Hepatitis B virus vaccine (20 µg.ml-1; 
GlaxoSmithKline Biologicals, Rixensart, Belgium) was used as the reference protein. For the 
immunodetection of glucoamylase, primary polyclonal antibodies raised against glucoamylase 
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(TNO, Zeist, The Netherlands) was used at a dilution of 1:20 000 and secondary antibodies 
were anti-mouse immunoglobulins conjugated to horseradish peroxidase (1:10 000 dilution). 
Amyloglucosidase (Fluka 10113; activity 120 U.mg-1) served as the refernce protein. 
Detection was performed with 1-Step™ TMB-Blotting (Pierce Biotechnology, Rockford, 
USA). 
 
HBsAg concentration determination 
A “sandwich” type enzyme immunoassay based on monoclonal anti-HBsAg (HBsAg 3.0 EIA, 
Bio-Rad, Hercules, CA) was used to quantify completely assembled and properly folded 
HBsAg as per manufacturers specification. 
 
Glucoamylase Activity 
The activity of glucoamylase was measured by the method of Withers et al. (1998) using 
freshly prepared 0.1 % (v.v-1) 4-nitrophenyl-α-D-glucopyranoside (PNPG) (Sigma-Aldrich N-
1377) as substrate in 0.1 M Sodium Acetate buffer (pH 4.3). To commence the reaction, 100 
µl PNPG was added to 50 µl sample (or GlaA standard) in a flat bottom microtitre plate and 
incubated for 20 min at 25 oC. The reaction was terminated by the addition of 150 µl Borax 
(0.1 M Na2B4O7.10 H2O) solution, and absorbance at 400 nm was measured using a BioTek 
Power waveHT microtitre plate reader (BioTek Instruments Inc., USA) referenced with 
distilled water. Background absorbance was normalized with the addition of 150 µl Borax 
solution to 50 µl sample prior to the addition of 100 µl PNPG, in a duplicate assay. The 
measured background absorbance was subtracted from the absorbance readings obtained from 
the incubated samples and converted into glucoamylase activity units using a standard curve 
(Amyloglucosidase Fluka 10113). 
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Glucose Concentration 
Glucose concentration was measured using an HPIC (CarboPac™ PA1 column, Dionex, MA, 
USA) and ACCUTREND glucose strips (Roche Diagnostics Ltd, East Sussex, UK). 
 
Protein analysis 
The concentration of total protein was determined by the Bradford method (Bradford, 1976) 
according to Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA) as per 
manufacturers specification using bovine serum albumin as standard. 
 
RESULTS 
Transformation of GlaAG2::S gene fusion construct into A. niger 
The HBsAg fused gene construct, GlaAG2::S, in expression vector pAHB19 was transformed 
into ± 7.3x109 A. niger D15 protoplasts. A total of 53 uridine prototrophic and acetamide 
utilising transformants were obtained after purification on MM (Bennett and Lasure, 1991) 
containing 10 mM acetamide as sole nitrogen source (Kelly and Hynes, 1985).  Subsequently 
18 positive transformants showing efficient growth and sporulation on MM agar plates 
containing 10 mM acrylamide were selected (Verdoes et al., 1993). 
 
No extracellular HBsAg above a detection limit of 0.32 pg.ml-1 culture broth was observed for 
the 18 transformants screened in triplicate shake flask cultivations (data not shown).  
Intracellular accumulation of HBsAg was observed in 15 transformants. Highest total HBsAg 
production levels (34 µgHBsAg.gDW-1; combined in the membrane associated and non-
membrane fractions) were observed by transformant DAHB19#7 (Figure 2). A high 
percentage of HBsAg was observed in the intracellular membrane fraction (83 %), while the 
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remainder was detected in the intracellular cytoplasmic fraction (5.9 µgHBsAg.gDW-1) from 
transformant DAHB19#7 (data not shown).    
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Figure 2.  Screening of GlaAG2::S gene transformants in shake flask cultivations for HBsAg production. 
Analysis is performed after 96 h of cultivation. Error bars represent the standard deviation of the mean of 
triplicate cultivations. 
 
Production of HBsAg, Glucoamylase and Glucoamylase-HBsAg fused protein by 
transformant DAHB19#7 
Western blot analysis for HBsAg, glucoamylase and glucoamylase-HBsAg fused product 
detection was performed on culture supernatant and intracellular fractions of the highest 
intracellular HBsAg producing GlaAG2::S gene transformant, DAHB19#7. Western blot 
analysis using a monoclonal HBsAg antibody, raised against human serum-derived HBsAg, 
only detected completely assembled and properly folded HBsAg, while unfolded polypeptides 
were not recognized (Sunil Kumar et al. 2005). Results showed the intracellular accumulation 
of a 24 kDa protein species that did not appear in the analysis of the corresponding reference 
Stellenbosch University http://scholar.sun.ac.za
 87 
 
strain sample (Figure 3A). This protein also appeared in the Engerix vaccine HBsAg protein, 
confirming that the 24 kDa protein corresponds to the HBsAg S protein (Figure 3A). The size 
of the glucoamylase-HBsAg fused product is estimated to be ~ 97 KDa and could not be 
detected with monoclonal HBsAg antibodies in both the intracellular cytoplasmic protein 
fractions (data not shown) and in fractions including membrane associated proteins (Figure 
3A).  
 
Western blot analysis for glucoamylase detection, using polyclonal glucoamylase antibodies,  
revealed two protein products in the culture supernatant with molecular masses of 
approximately 90 kDa and 70 kDa, in both the reference strain and GlaAG2::S gene 
transformant DAHB19#7. Quantification through “sandwich” type  ELISA using polyclonal 
glucoamylase antibodies detected an ~ 1.47 fold increase in extracellular glucoamylase 
activity of transformant DAHB19#7 in comparison to the parent strain (data not shown). In 
the intracellular fraction, similar protein bands as well as several smaller products that did not 
appear in the reference strain, were observed in GlaAG2::S gene transformant DAHB19#7 
(Figure 3B). 
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Figure 3. Western blot analysis from shake flask cultivations after 96 h. (A) Immunodetection using 
monoclonal HBsAg antibodies: lane 1, Hepatitis B virus vaccine, Engerix B; lane 2, total intracellular fraction 
from prototrophic reference strain (D15-pyrGamdS); lane 3, total intracellular fraction from GlaAG2::S gene 
transformant DAHB19#7. (B) Immunodetection using polyclonal glucoamylase antibodies;  lane 1, extracellular 
fraction from prototrophic reference strain (D15-pyrGamdS); lane 2, total intracellular fraction from prototrophic 
reference strain (D15-pyrGamdS); lane 3, extracellular fraction from GlaAG2::S gene transformant DAHB19#7; 
lane 4, total intracellular fraction from GlaAG2::S gene transformant DAHB19#7. 
 
Intracellular and extracellular stability of HBsAg in A. niger 
The stability of HBsAg in potential intracellular and extracellular A. niger proteases was 
evaluated by monitoring the concentration of intracellular HBsAg extracts in (1) culture 
filtrate (96 h spent A. niger D15 culture medium), and (2) fresh culturing medium. Total 
intracellular extracts of GlaAG2::S gene transformant DAHB19#7 after 96 h of growth in 
shake flask cultivations was prepared (200 ml solution). 100 ml of the solution was used as 
control in an equal volume of fresh culturing medium, while the remaining 100 ml was re-
introduced into an equal volume of 96 h spent A. niger D15 culture medium. The two 
solutions were incubated at 30 oC for 32 h. Samples taken at 0, 2, 4, 8, 16, 24, and 32 h were 
quantified by ELISA. HBsAg concentrations in spent culture filtrate were reduced by 3 % 
(A) HBsAg Antibodies        (B) Glucoamylase Antibodies 
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after two h, 28 % after eight h and 91 % after 32 h with a degradation rate of 1.16 
µgHBsAg.gDW-1.h-1 (Figure 4). In comparison, intracellular HBsAg concentration in fresh 
medium remained relatively stable with ± 23 % degradation after 32 h at a degradation rate of 
0.22 µgHBsAg.gDW-1.h-1 (Figure 4).  
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Figure 4. Protease susceptibility assay. Concentration of extracted HBsAg concentration (µgHBsAg.gDW-1) (□ ) 
incubated in intracellular extraction buffer at 30 oC and () re-introduced into culture filtrate with intracellular 
extraction buffer and incubated at 30 oC.  Error bars represent standard deviation of the mean of triplicate 
samples. 
 
Impact of glucoamylase promoter on biomass and HBsAg production on various carbon 
sources 
Biomass and HBsAg production by transformant DAHB19#7 on various carbon sources at 30 
oC after 96 h of incubation were determined in triplicate shake flask cultivations (Figure 5). 
Use of insoluble starch, soluble starch and starch derived polysaccharides (maltose and 
maltodextrin) resulted in high specific HBsAg production with the maximum levels of 38 ± 
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1.34 and 36 ± 3.05 µgHBsAg.gDW-1 observed with maltose and maltodextrin, respectively 
Specific HBsAg levels on insoluble and soluble starch were similar and equal to 88 ± 2% of 
that obtained in maltose cultivations (34.16 ± 3.26 and 33.77 ± 2.19 µgHBsAg.gDW-1, 
respectively). Biomass levels were highest in maltodextrin cultures and lowest in insoluble 
starch cultures (10.0 gDW.kgBroth-1 and 7.6 gDW.kgBroth-1, respectively). Glucose cultures 
obtained highest biomass concentrations (10.2 gDW.kgBroth-1) and HBsAg production was 
recorded at 42 % of the levels reached in maltose cultures. Lower biomass levels and trace 
amounts of HBsAg were measured in fructose, sucrose and xylose cultures (< 9.1 gDW.kgBroth-1 
and < 6.5 µgHBsAg.gDW-1, respectively Figure 5). 
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Figure 5.  Analysis of HBsAg and biomass production on various carbon sources after 96 h of shake flask 
cultivation at 30 oC. Shown are data for: grey columns, biomass concentration (gDW.kg Broth-1); white columns, 
specific HBsAg production (µgHBsAg.gDW-1). Error bars represent the standard deviation of the mean of triplicate 
cultivations. 
Evaluating HBsAg production in controlled batch fermentations of transformant DAHB19#7 
Biomass, intracellular HBsAg, extracellular glucoamylase and total cellular protein 
(intracellular and extracellular) production during batch fermentation of transformant 
DAHB19#7 was determined on starch and glucose substrates.  The highest maximum specific 
growth rate (µmax) of 0.08 ± 0.003 h-1 was obtained in batch culture with glucose as carbon 
source, resulting in a maximum biomass concentration of 16.2 ± 0.8 gDW.kgBroth-1 (Figure 6A). 
Glucose depletion was observed after 48 h. In batch fermentation with soluble starch as 
carbon source, a lower µmax was obtained (0.03 ± 0.004 h-1) with a maximum biomass 
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concentration of 13.9 ± 0.6 gDW.kgBroth-1 after 86 h. Residual glucose accumulation was 
observed in the starch-based cultures between 54 and 86 h of cultivation, starting during the 
mid exponential growth phase. Residual glucose accumulation increased to a maximum of 
4.65 ± 1.3 gGluc.kgBroth-1 (61 h), followed by a steady decrease with total depletion 
corresponding to the maximum biomass concentration (86 h; Figure 6A). 
 
Intracellular HBsAg production in glucose batch fermentations was low with a maximum 
production rate of 1.432 µgHBsAg.gDW-1.h-1 and maximum levels of 49 ± 7.6 µgHBsAg.gDW-1 
parallel to glucose depletion (48 h). The maximum HBsAg production levels in batch culture 
with starch at 124.8 ± 14.5 µgHBsAg.gDW-1 were approximately 2.5-fold higher than batch 
fermentations with glucose.  Maximum intracellular HBsAg production rates in starch-based 
batch culture were observed between 39 and 54 h of cultivation (5.8 µgHBsAg.gDW-1.h-1).  
Maximum HBsAg concentration in starch-based batch culture coincided with the onset of 
glucose accumulation, and subsequently decreased during the 54 to 86 hour time frame of the 
culture.  
 
In glucose batch fermentations low extracellular glucoamylase activity was measured with a 
maximum of 0.22 ± 0.02 U.gDW-1and a production rate of 0.007 U.gDW-1.h-1 in the exponential 
growth phase. In starch cultivations, extracellular glucoamylase activity was highest at 0.41 ± 
0.03 U.gDW-1and a maximum production rate of 0.02 U.gDW-1.h-1 between 39 and 54 h of 
cultivation. Similar to the HBsAg production profiles, glucoamylase activity in cultures 
grown on glucose were reduced after glucose depletion, whereas under starch conditions 
glucoamylase activities diminished with the accumulation of residual glucose in the culture 
broth (Figure 6C). 
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Total protein analysis (intracellular and extracellular) in glucose cultivations showed 
maximum protein concentrations of 111 ± 8.7 mgprotein.gDW-1 after 45 h of cultivation and a 
maximum production rate of 2.2 mgprotein.gDW-1.h-1. A lower production rate of 1.23 
mgprotein.gDW-1.h-1 was observed in starch cultivations with a maximum of 113 ± 16.1 
mgprotein.gDW-1after 86 h of cultivation (Figure 6D). 
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Figure 6. Batch fermentations of A. niger GlaAG2::S gene transformant DAHB19#7: Shown is data regarding 
cultivations grown on;  glucose, and ∆ starch. Time course data of: (A) Dry biomass concentration (open 
symbols) and glucose concentration (grey symbols); (B) specific intracellular HBsAg production (open 
symbols); (C) specific extracellular glucoamylase activity (open symbols); and (D) total cellular protein 
(intracellular and extracellular) production are shown (open symbols).  Closed symbols for ∆ and  represent 
glucose depletion in glucose cultivations, while closed symbols for ∆ represent residual glucose in starch 
cultures. Error bars represent the standard deviation of the mean of triplicate cultivations. Points without error 
bars have an associated deviation that is < 10 % of the value of the point. 
 
DISCUSSION 
The aim of this study was to evaluate the strategy of gene fusion as a means of producing 
recombinant HBsAg in A. niger by targeting production through the secretory pathway as is 
performed by the Hepatitis B virus in infected cells. The gene fusion cassette was constructed 
by fusing the highly expressed GlaAG2 gene (Le Gal-Coeffet et al., 1995) to the HBsAg S 
gene. The glucoamylase-HBsAg fused cassette was under transcriptional control of the 
inducible GlaAp and the ubiquitous KEX2 protease cleavage site was introduced between the 
S gene and GlaAG2 to facilitate cleavage (Contreras et al., 1991).   
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Targeting HBsAg through the secretory pathway of A. niger using the gene fusion approach 
resulted in completely assembled and properly folded HBsAg, as recognized by monoclonal 
antibodies raised against human serum-derived HBsAg. Unfolded polypeptides were not 
recognized (Sunil Kumar et al. 2005). HBsAg was localized intracellularly in membrane 
associated extracts, while glucoamylase was secreted. Intracellular accumulation of HBsAg is 
common in S. cerevisiae (Hamsa and Chattoo, 1994), P. pastoris (Cregg et al., 1987), H. 
polymorpha (de Roubin et al., 1991), A. niger (Plüddemann, 2003) and plant cells (Smith et 
al., 2002) and emphasizes alternative processing of HBsAg VLPs in microbial systems in 
comparison to infected cells. The HBsAg is inherently hydrophobic in nature (Vassileva et al., 
2001) and has been reported to progress no further than ER/Golgi in recombinant microbial 
systems (Smith et al., 2002). This results in the dilation of the ER membrane network upon 
HBsAg expression of various recombinant expression systems (Smith et al., 2002), while in 
infected cells the HBsAg buds through the host cell membrane and into the bloodstream. This 
is indicative of the limitations of HBsAg processing in microbial systems in comparison to 
infected cells. 
 
Several breakdown products showing an immunoreactive response to the glucoamylase 
polyclonal antibody, were detected in intracellular extracts. These glucoamylase products did 
not correspond to the starch binding domain (G1) and catalytic domain (G2) glucoamylases 
and did not appear in the corresponding extracellular fraction of transformants or in the 
intracellular fraction of the parent strain. Similar results were documented in the study of 
Plüddemann, (2003) and Conesa et al., (2000) and indicates a level of intracellular 
degradation. Possible explanations to these findings can be attributed to intracellular 
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proteolytic degradation (Jarai et al., 1994; Gouka et al ., 1996) or  the bottlenecks caused by 
unfolded and/or misfolded proteins that accrue within the secretory pathway (Wang, 2005). 
  
The A. niger parent strain to HBsAg producing transformants, A. niger D15 is a non-
acidifying protease deficient strain, which would suggest that degradation due to proteolytic 
activity would be limited. Protease activities in A. niger D15, were reduced by mutagenesis 
and not by specific protease gene deletions, resulting in the reduction but not complete 
deletion of protease activity (Mattern et al., 1992). In addition, the use of complex media 
typically containing peptide nitrogen as used in this study, induces protease production by A. 
niger (Archer et al., 1990; Ahamed et al., 2005; Ward et al., 2006). Productivity of secreted 
egg lysozyme by a recombinant strain of A. niger was reduced in such complex media (Archer 
et al., 1990; Ward et al., 2006). The lack of stability (91 % degradation over 32 hr) of 
intracellular HBsAg extracts re-introduced into 96 hr spent culture filtrate in this study is 
evidence that HBsAg is vulnerable to extracellular protease activity. In contrast, intracellular 
HBsAg production remained relatively stable at 30 oC for 32 hours, where 77 % of the 
HBsAg produced remained correctly folded and assembled.  This would suggest that the 
breakdown products showing an immunoreactive response to glucoamylase were not a 
consequence of fused product degradation by intracellular proteases. 
 
Bottlenecks have been reported to accrue in recombinant microbial systems expressing higher 
eurkaryotic gene products (Gouka et al ., 1996). These are a result of a greater flux/ overload 
of proteins being translocated into the Endoplasmic Reticulum (ER), where the folding, 
assembly, and processing machinery may become saturated, leading to improperly folded 
structures (Ngiam et al., 2000). Unfolded and/or misfolded proteins are prevented from 
leaving the ER (Lodish et al. 1983; Shuster 1991; Parekh et al. 1995; Shusta et al. 1998; 
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Smith et al. 2004) and may explain the breakdown products showing an immunoreactive 
response to the glucoamylase. The accumulation of unfolded and/or misfolded proteins 
induces the up-regulation of the unfolded protein response (UPR) and/or an ER–associated 
protein degradation response (ERAD). The UPR controls the expression of genes of several 
ER-resident chaperones and foldases  and numerous other genes involved in other secretory 
functions (Valkonen et al., 2003), while the ERAD degrades those proteins that fail to reach 
the correct conformation (Conesa et al., 2001). 
 
Immunodetection using a monoclonal HBsAg antibody could not detect the fused GlaAG2::S 
product in intracellular and extracellular fractions. These observations indicate that full 
assembly and maturation of HBsAg occured after cleavage of the fused product in the Golgi 
complex, as it has been reported in A. niger that dibasic cleavage by the KEX2-like processing 
site occurs in the Golgi complex (Brigance et al., 2000). This process differs in infected cells: 
hepatitis B S protein is inserted into the ER membrane and subsequently translocated to the 
ER lumen where disulphide-linked dimers are rapidly formed (Huovila et al., 1992).  These 
dimers are transported to a post-ER/pre-Golgi compartment where the formation of oligomer 
crosslinks occurs, resulting in the formation of pseudoviral particles, which are then exported 
from the cell via vesicular transport (Huovila et al., 1992; Prange and Streeck, 1995). Despite 
the apparent difference in HBsAg processing through the secretory pathway using the gene 
fusion approach in A. niger in comparison to infected cells, results indicate completely 
assembled and properly folded HBsAg.  
  
The inducible glucoamylase promoter had a significant impact on HBsAg production in A. 
niger. HBsAg production was induced highest on starch or its degradation products 
maltodextrin and maltose, concurring with the studies of Carrez et al. (1990), Fowler et al. 
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(1990), van den Hondel et al. (1992), Schrickx et al. (1993), Withers et al., (1998), Santerre 
Henriksen et al. (1999), and Siedenberg et al. (1999). HBsAg production levels of 40 to 50 % 
lower were found in cultivations based on glucose as carbon source. 
 
In controlled batch fermentation using glucose as the carbon source, HBsAg production was 
measured to have a growth associated correlation with biomass production, where biomass 
and HBsAg production ceased after glucose depletion. Similar findings were observed in S. 
cerevisiae (Kim et al., 2009) but not for P. pastoris where a slower growth rate is essential for 
efficient particle assembly (Cregg et al., 1987; Vassileva et al., 2001). The galactose-
inducible GAL1 promoter was used for HBsAg production in S. cerevisiae, while the 
methanol induced AOX1 promoter was used for P. pastoris. This reflects the contrasting 
ability of control promoters have on HBsAg assembly and production in various expression 
systems. Nonetheless, the fundamentals remain the same; under conditions where the 
inducing substrate was depleted, synthesis of HBsAg was apparently down regulated to lower 
constitutive levels (Kim et al., 2009).  
 
Despite highest HBsAg production levels in starch based fermentation, the accumulation of 
residual glucose remains a challenge as this coincided with the reduction in extracellular 
glucoamylase activity and HBsAg production mid-way through the exponential phase. The 
phenomenon of residual glucose accumulation indicates that the rate of starch hydrolysis is 
greater than glucose consumption of the host organism, as discussed in the study of Ganzlin 
and Rinas, (2008). In the presence of the starch substrate, the production of glucoamylase is 
used to catalyze the cleavage of starch into glucose units (starch hydrolysis), which in turn is 
consumed by the host organism. In the event of high glucoamylase production, the rate of 
starch hydrolysis is increased, resulting in an abundant supply of glucose. The high rate of 
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glucoamylase synthesis produced for starch hydrolysis is no longer justified, and 
glucoamylase production is down regulated by the inducible glucoamylase promoter and even 
repressed by catabolite repression if glucose levels reach a certain threshold (Ruijter and 
Visser, 1997). Ganzlin and Rinas, (2008) reported that in A. niger fed-batch cultivations, 
under control of the inducible glucoamylase promoter, when implementing a high maltose 
feed rate, residual extracellular glucose was detected resulting in higher biomass formation 
and lower levels of the reporter protein compared to cultures  fed at a lower feed rate with no 
glucose accumulation. Evidence therefore suggests that through the control of the inducible 
glucoamylase promoter there appears to be a fine balance between the up regulation and down 
regulation of glucoamylase-HBsAg fused gene expression. In order to further enhance HBsAg 
production levels of this system in starch based cultivations, we suggest continuous or fed 
batch fermentation be implemented, where the rate of starch hydrolysis can be equilibrated 
with glucose consumption. 
 
This study serves as a proof-of-concept that by targeting HBsAg production through the 
secretory pathway in A. niger, completely assembled and properly folded HBsAg, is obtained. 
This also demonstrates the potential of A. niger using gene fusion as a candidate expression 
technology for VLP production.  The mechanism of HBsAg processing in A. niger using the 
gene fusion approach, as in other microbial systems, appears to differ from infected cells. As a 
result, bottlenecks within the secretory pathway were evident and remain to be quantified in 
future studies. The induction levels of the glucoamylase promoter affected HBsAg 
production, where the choice of carbon source proved to be significant. Highest HBsAg 
production was observed in starch based cultivations. However, in order to further improve 
HBsAg production, the rate between glucose consumption by the host and hydrolysis of starch 
by glucoamylase requires optimization.  
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ABSTRACT 
The aim of this study was to develop an improved methodology to identify and select high 
Hepatitis B surface antigen (HBsAg) producing transformants. A double mutant Aspergillus 
niger strain, MGG029-∆aamA, lacking two major amylolytic enzymes, glucoamylase and 
acid amylase, was used as the expression host. The expression vector introduced into the host 
included the catalytic domain of A. niger glucoamylase fused to the HBsAg S gene and the 
Aspergillus nidulans Acetamidase gene (amdS) selection marker. This facilitated HBsAg S 
gene expression and HBsAg assembly through the secretory pathway as well as served as a 
medium for selection. In conjunction with conventional selection based on acetamide 
utilization through amdS gene expression, three selection methods for the identification of 
high HBsAg producing transformants were evaluated: (1) selection based on improved growth 
on acrylamide through the expression of the amdS gene resulted in 20 % of selected 
transformants obtaining high HBsAg production levels, (2) selection based on improved 
growth on starch resulted in 40 % of transformants obtaining high HBsAg production levels, 
and (3) selection based on improved extracellular glucoamylase activity using starch as a 
selection pressure resulted in 86 % of transformants obtaining high HBsAg production levels. 
In glucose batch fermentation, two high HBsAg producing transformants were evaluated; high 
biomass producing transformant DAHB 21#20 and a high extracellular glucoamylase 
producing transformant, DAHB 21#40. The growth rate of these two transformants differed 
with highest extracellular glucoamylase and HBsAg production levels observed in the 
“slower-growing high-glucoamylase producing” transformant DAHB 21#40. A strong 
correlation between intracellular HBsAg and secreted glucoamylase was evident for both 
transformants. The high efficiency obtained through selecting for high extracellular 
glucoamylase transformants and the associated correlation between intracellular HBsAg 
production and secreted glucoamylase in batch fermentation reflects the ability of the 
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glucoamylase screen to indirectly quantify high HBsAg producing transformants through 
extracellular glucoamylase determination. 
 
INTRODUCTION 
Virus like particles (VLPs), including the Hepatitis B surface antigen (HBsAg) have been 
efficiently produced in microbial systems such as Pichia pastoris, Hansenula polymorpha and 
Saccaromyces cerevisiae. The filamentous fungus Aspergillus niger has gained much interest 
as an alternative host to the commonly employed yeasts for the production of mammalian and 
higher eukaryotic gene products achieving varying degrees of success (Gwyne et al., 1987; 
Upshall et al., 1987; Ward et al., 1995; Gouka et al., 1997a; Svetina et al., 2000; James et al., 
2007). These accomplishments are largely based on effective strain and cultivation 
improvement strategies that have been developed: vector design and construction, codon 
optimization (Gouka et al., 1996), choice of promoter (Van den Hondel et al., 1991), the 
generation of fusion constructs (Jeenes et al., 1993; Gouka et al., 1997b; Spencer et al., 1998), 
over expression of chaperone proteins (Ngiam et al., 2000; Punt et al., 1998), the isolation of 
protease deficient mutants (Archer and Peberdy, 1997; van den Hombergh et al., 1997), and 
the optimisation of media and cultivation conditions (Schrickx et al., 1993; MacKenzie et al., 
1994; Xu et al., 2000; Conesa et al., 2001; James et al., 2007).   
 
Although the abovementioned strategies have been successful in increasing the production 
levels of heterologous proteins in several A. niger expression systems, often these levels are 
still lower than those obtained for homologous proteins (James et al., 2007). Introducing the 
desired gene product of interest to the fungus host strain and the selection of hyper-producing 
transformants often represents a challenge (Meyer, 2007). The manipulation of genomic DNA 
can be achieved through several methods, one of which is of interest in this context, random 
Stellenbosch University http://scholar.sun.ac.za
 113 
 
integration. This strategy is often favoured due to the ease of implementation, as well as the 
ability to attain high copy number insertions of the gene product of interest (Verdoes et al., 
1993). Significant variance in recombinant gene products is generally expected amongst 
transformants through the implementation of random integration techniques. This is attributed 
to vector copy number and/ or site of integration (Verdoes et al., 1994). It has been shown that 
vector copies generally integrate in only one chromosome (Verdoes et al., 1993), and that 
plasmid vectors can be integrated into regions of the chromosome which are transcribed with 
different efficiencies as suggested in the studies of Thompson and Gasson (2001) and 
Plüddemann and van Zyl (2003). A specific risk of random insertion is the possibility of a 
pleiotropic effect, such as disruption of a chromosomal gene that has a central function and 
thereby the transformation negatively influences growth or production. It is therefore essential 
to screen transformants with the objective of selecting hyper-producing transformants. To 
increase the probability of identifying hyper-producers, these screens require a large number 
of transformants. The cultivation and analysis of a large number of transformants is often 
laborious and time consuming. Furthermore, high value recombinant products are often costly 
to assay. Through the implementation of a screening strategy that allows for the cost effective, 
rapid, robust and high-throughput evaluation of transformants, recombinant production levels 
can be significantly increased. Rational selection techniques, not involving the product of 
interest, but associated biochemical characteristics have been successfully implemented in 
mutagenesis studies. Such techniques involve, for example, direct colony selection after a 
bioassay overlay for better penicillin producers (Vournakis and Elander, 1983), laccase 
production in A. niger using a gene fusion approach (Weenink et al., 2006), and citrate 
specific indicator (R-di-methylaminobenzaldehyde) assays for citrate hyper-producers 
(Mattey, 1992). 
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In this study we aim to develop an improved methodology to identify and select high HBsAg 
producing transformants. The double mutant A. niger strain, lacking two major amylolytic 
enzymes, glucoamylase and acid amylase, grows poorly on starch. However through the gene 
transfer of a glucoamylase gene, growth is restored (Weenink et al., 2006). The expression 
vector introduced into the host organism includes the highly expressed and well secreted 
catalytic domain of A. niger glucoamylase (GlaAG) fused to the HBsAg S gene as well as a 
selection marker, the Aspergillus nidulans Acetamidase gene (amdS).  Three screening 
methods for HBsAg producing transformants are evaluated in conjunction with the 
conventional amdS selection based on acetamide selection; (1) transformant selection based 
on acrylamide utilization through expression of the amdS gene, (2) transformant selection 
based on high growth on starch as reported by Weenink et al. (2006), and (3) transformant 
selection based on high extracellular glucoamylase activity using starch as a selection 
pressure. Batch fermentation data is included to quantify growth, glucoamylase and HBsAg 
production levels of selected high-HBsAg producing transformants.  
 
MATERIALS AND METHODS 
Strains, plasmid and transformation procedures  
A. niger MGG029-∆aamA (provided by Prof. P. Punt, TNO, Zeist, The Netherlands) was used 
as the recipient strain for transformation (Gordon et al., 2000). The plasmid used for 
transformation, pAHB19, (bla amdS GlaAP-GlaASS-GlaAG2-S-trpCT), constructed by 
Plüddemann, (2003), contains the A. niger glucoamylase promoter (GlaAp), secretion signal 
fused to a sequence encoding truncated A. niger GlaAG2 and the A. nidulans trpCT terminator. 
The HBsAg S gene is fused to the truncated A. niger GlaAG2 form (514 aa), lacking the starch-
binding domain (Broekhuijsen et al., 1993), and the dibasic proteolytic cleavage site “Lys-
Arg” separates the GlaAG2 and Hepatitis B S gene sequences resulting in the cleavage of the 
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fusion protein into separate proteins by a Kex2-like protease (Broekhuijsen et al., 1993). The 
A. nidulans amdS gene is used as a selection marker (provided by Prof P Punt TNO, Zeist, 
The Netherlands).   
 
A. niger MGG029-∆aamA was transformed following the protoplasting method of Punt and 
van den Hondel (1992), using Novozym 234 (Sigma-Aldrich). Resulting transformants were 
selected for on minimal medium (MM) (Bennett and Lasure, 1991) containing 1.2 M sorbitol 
as osmotic stabiliser, 1.5 % agar (Oxoid) and 10 mM Acetamide as sole nitrogen source 
(Kelly and Hynes, 1985).   
 
Inoculum preparation, media and cultivations 
Fungal spores were obtained from a densely conidiating culture grown on potato dextrose 
agar (PDA) at 30 oC for 120 h and harvested with physiological saline solution (NaCl, 0.9 % 
w/v). Shake flask cultures were inoculated with a spore concentration of 1×106 spores.ml−1 
culture. Batch fermentations were inoculated with a shake flask pre-culture amounting to 10 
% of the fermentor’s total working volume. All cultivations were grown on MM (Plüddemann 
and van Zyl, 2003) containing 3 % (w.w-1) glucose or soluble starch and supplemented with 
0.1  % (w.w-1) casamino acids (Difco), 0.8  % (w.w-1) tryptone and 0.8  % (w.w-1) yeast 
extract. Shake flask cultivations were performed in 1 L Erlenmeyer flasks (un-baffled) 
containing 250 ml medium at 30 °C on a rotary shaker (Innova 2300, New Brunswick 
Scientific, Edison, USA) at 180 rpm. Fermentations were performed in 2 L bench-top 
bioreactors (INFORS AG, Switzerland) with a working volume of 1.5 L. The fermentation 
temperature was maintained at 30 °C (± 0.1°C), aeration at 0.8 vvm, dissolved oxygen was 
maintained above 25  % saturation by varying impeller speed (starting rate of 150 rpm), 
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through a cascaded controller. The impellor speed was ramped by 200 rpm for 1 min every hr 
to reduce wall growth. pH was controlled above a value of 4 using NH4OH (25 % v.v-1). 
 
Sample preparation 
Shake flasks were sampled in 24 h increments while bioreactor cultivations were sampled at 
intervals of 3 to 8 h. Samples containing ± 50 g of cultivation medium were withdrawn and 
biomass concentration was measured by vacuum filtering 25 g  sample on dry and pre-
weighed filters (Whatman no.1), followed by washing with 40 ml 0.9  % (w.v-1) NaCl 
solution and drying to a constant weight at 105 oC for 24 to 48 h. The remaining 25 g sample 
was ground to a fine powder with liquid nitrogen in a mortar and pestle, and an aliquot of 0.3 
g mycelia powder was stored at −80 °C in a 2 ml microcentrifuge tube. Ground samples were 
suspended in protein extraction buffer with 0.1 % Triton X-100 (Plüddemann and van Zyl, 
2003) and homogenized for 1 min at 4 °C. Total intracellellur proteins including membrane-
associated proteins were isolated by the addition of Triton X-100 to the extraction buffer.  
 
HBsAg concentration determination 
A “sandwich” type enzyme immunoassay based on monoclonal anti-HBsAg (HBsAg 3.0 EIA, 
Bio-Rad, Hercules, CA) was used to quantify completely assembled and properly folded 
HBsAg as per manufacturers specification. 
 
Glucoamylase Activity 
The activity of glucoamylase was measured by the method of Withers et al. (1998) using 
freshly prepared 0.1 % (v.v-1) 4-nitrophenyl-α-D-glucopyranoside (PNPG) (Sigma-Aldrich N-
1377) as substrate in 0.1 M Sodium Acetate buffer (pH 4.3). To commence the reaction, 100 
µl PNPG was added to 50 µl sample (or GlaA standard) in a flat bottom microtitre plate and 
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incubated for 20 min at 25 oC. The reaction was terminated by the addition of 150 µl Borax 
(0.1 M Na2B4O7.10 H2O) solution, and absorbance at 400 nm was measured using a BioTek 
Power waveHT microtitre plate reader (BioTek Instruments Inc., USA) referenced with 
distilled water. Background absorbance was normalized with the addition of 150 µl Borax 
solution to 50 µl sample prior to the addition of 100 µl PNPG, in a duplicate assay. The 
measured background absorbance was subtracted from the absorbance readings obtained from 
the incubated samples and converted into glucoamylase activity units using a standard curve 
(Amyloglucosidase Fluka 10113). 
 
Glucose Concentration 
Glucose concentration was measured using an HPIC (CarboPac™ PA1 column, Dionex, MA, 
USA) and ACCUTREND glucose strips (Roche Diagnostics Ltd, East Sussex, UK). 
 
RESULTS 
Starch non-utilizing A. niger strain 
The starch non-utilizing A. niger strain MGG029-∆aamA lacks the two major amylolytic 
enzymes, glucoamylase and acid amylase (AamA) (Weenink et al., 2006). The double-mutant 
strain grew poorly on starch with a severely reduced growth rate in comparison to A. niger 
strain MGG029, in which only the glucoamylase is deleted (data not shown). Residual growth 
of MGG029-∆aamA is apparent (specific growth rate (µmax) = 0.007 h-1) and is possibly 
sustained by the constitutively low expression of undeleted glucoamylases (0.008 U.gDW-1) 
and other starch degrading enzymes e.g. alpha Glucosidase (Figure 1). 
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Construction of starch utilizing A. niger strain expressing an unfused truncated A. niger 
GlaAG2 gene construct  
For use as a positive control, expression vector pAN56-8 under control of the inducible A. 
niger GlaAp promoter and secretion signal fused to a sequence encoding the truncated A. niger 
GlaAG2 gene was transformed into A. niger MGG029-∆aamA. This A. niger transformant, 
carrying vector pAN56-8 (bla amdS GlaAP-GlaASS-GlaAG2-trpCT), showed improved growth 
on starch, an increased growth rate (0.024 h-1) and high glucoamylase activity (0.073 U.gDW-1) 
in shake flask cultivations (Figure 1).  
 
Construction of starch utilizing A. niger strains expressing a fused GlaAG2::S gene construct  
To produce HBsAg in A. niger, the HBsAg S gene was fused to the GlaAG2 gene. The fusion 
gene GlaAG2::S was placed under control of the inducible GlaAp of A. niger resulting in the 
expression vector pAHB19 (bla amdS GlaAP-GlaASS-GlaAG2-S-trpCT). The A. nidulans amdS 
gene was introduced into the fused gene expression vector, pAHB19, and used as a selection 
marker. Expression vector pAHB19 was transformed into starch non-utilizing A. niger 
MGG029-∆aamA protoplasts resulting in GlaAG2::S fused gene transformants DAHB 21. 
Following transformation, a primary screen on selective medium, containing acetamide was 
implemented (Punt and van den Hondel, 1992). Selection was based on the expression of the 
amdS gene and the associated ability of transformants to utilize acetamide as sole carbon 
and/or nitrogen source (Hynes, 1972; Hynes, 1973). This resulted in the identification of 154 
transformants with improved growth on acetamide and therefore represented potential HBsAg 
producing transformants. These 154 transformants were used to evaluate the three selection 
methods, as a means to identify high HBsAg producers. 
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Application of genetic selection system and identification of high producing HBsAg 
transformants 
To identify high producing HBsAg transformants, three screening methods were evaluated in 
conjunction with conventional selection based on amdS expression and acetamide selection; 
(1) transformant selection based on acrylamide utilization through expression of the amdS 
gene, (2) transformant selection based on high growth on starch, and (3) transformant 
selection based on high glucoamylase activity using starch as a selection pressure. 
 
(i) Conventional amdS selection based on acrylamide utilization  
The 154 acetamide utilizing transformants identified in the primary screen were subjected to a 
secondary screen using acrylamide as the selection pressure. Based on colony size on agar 
plates, ten GlaAG2::S fused gene transformants were selected, representing multicopy number 
gene insertion (Van den Hondel et al., 1992), and preferred site of integration for acetamidase 
production.  
 
These ten GlaAG2::S fused gene transformants (DAHB 21# 2, 9, 20, 28, 32, 45, 58, 89, 114, 
and 139) were cultivated in submerged shake flask cultivations on inducing (starch) MM for 
196 h, where sampling was performed every 24 h (Figure 1). Higher growth rates were 
obtained in the transformants, ranging between 0.015 h-1 to 0.024 h-1, in comparison to the 
starch non-utilizing parent strain MGG029-∆aamA (0.007 h-1). None of the selected 
‘acrylamide utilizing’ transformants proved to have a growth rate higher than the starch 
utilizing A. niger strain expressing the unfused GlaAG2 gene product (Figure 1). Significant 
intracellular HBsAg levels (>25 µgHBsAg.gDW-1) were obtained in two GlaAG2::S fused gene 
transformants (DAHB 21# 20, and 45). Levels were highest in DAHB 21# 20 at 
approximately 52 ± 5.1 µgHBsAg.gDW-1, corresponding to a high growth rate and extracellular 
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glucoamylase activity (0.017 h-1 and 0.049 U.gDW-1, respectively) (Figure 1). No extracellular 
HBsAg was detected in transformants (data not shown). 
 
 
Figure 1.  Screening of selected ‘acrylamide utilizing’ GlaAG2::S fused gene transformants in shake flask 
cultivations for HBsAg production. Analysis is performed after 96 h of cultivation. Shown are data for: grey 
columns, specific intracellular HBsAg production (µgHBsAg.gDW-1); white columns, specific extracellular 
glucoamylase activity (UGlaA.gDW-1); ▲, maximum specific growth rate (µmax, h-1). Error bars represent the 
standard deviation of the mean of triplicate cultivations. Points without error bars have an associated deviation 
that is < 10 % of the value of the point. 
(ii) Transformant selection based on high growth on starch 
The second selection criterion was adopted from Weenink et al. (2006) where the selection 
was based on GlaAG2::S fused gene transformants showing improved growth on starch.  A 10 
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µl drop of a spore solution amounting to 1×105 spores.ml-1 of each transformant was placed on 
solid MM containing 1 % starch as carbon source, incubated for 172 h at 30 oC and then 
stored for 48 h at 4 oC. Photographs followed by area measurements of biomass colonies 
permitted GlaAG2::S fused gene transformant selections (Figure 2).  
 
 
 
 
 
 
 
 
Figure 2.  Screening of GlaAG2::S fused  gene transformants on solid medium containing 1 % starch as carbon 
source for HBsAg production. Each Petri dish (Ø 9 cm) was inoculated with 10µl of a spore solution amounting 
to 1×105 spores.ml-1 of each transformant, incubated for 172 h at 30oC and then stored for 48 h at 4oC. 
Photographs followed by area measurements of biomass colonies and extracellular glucoamylase activity zones 
permitted GLaAG2::S transformant selections (ChemiDoc XRS+ System, Bio-Rad, Johannesburg).  
 
Ten GlaAG2::S fused gene transformants were identified as transformants with growth 
improvement on starch (DAHB 21# 2, 8, 13, 20, 21, 45, 59, 97, 126, and 151). These 
transformants were cultivated (as described above) in submerged shake flask cultivations on 
inducing (starch) MM for 196 h (Figure 3). High biomass levels (data not shown) and growth 
rates ranging between 0.019 h-1 to 0.023 h-1 were recorded. Extracellular glucoamylase 
activity amongst GlaAG2::S transformants varied between 0.027 and 0.049 U.gDW-1, with 
DAHB 21#20 obtaining the highest levels. High intracellular HBsAg levels (>25 µgHBsAg.gDW-
1) were associated with high extracellular glucoamylase activity and were only observed in 
A: Negative Control: 
Starch non-utilizing                          
A. niger strain MGG029 -∆aamA 
B: HBsAg fused gene, 
‘high biomass producing’  
A. niger DAHB 21#20     
 
C: HBsAg fused gene, 
‘High extracellular glucoamylase 
producing’ A. niger DAHB 21#40 
 
U1 U2 
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four GlaAG2::S fused gene transformants (DAHB 21# 20, 21, 45 and 126) (Figure 3). HBsAg 
levels were highest in transformant DAHB 21# 20. No extracellular HBsAg was detected in 
transformants (data not shown). 
 
Figure 3.  Screening of ‘high biomass producing’ GlaAG2::S fused gene transformants in shake flask cultivations 
for HBsAg production. Analysis is performed after 96 h of cultivation. Shown are data for: grey columns, 
specific intracellular HBsAg production (µgHBsAg.gDW-1); white columns, specific extracellular glucoamylase 
activity (UGlaA.gDW-1); ▲, maximum specific growth rate (µmax, h-1). Error bars represent the standard deviation of 
the mean of triplicate cultivations. Points without error bars have an associated deviation that is < 10 % of the 
value of the point. 
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(iii) Transformant selection based on high extracellular glucoamylase activity using starch as 
a selection pressure 
The third transformant selection criterion was based on the hypothesis that a selection based 
on high extracellular glucoamylase activity through a starch selection pressure would correlate 
with high HBsAg production levels. Transformants were cultivated on MM as previously 
described. Area measurements of biomass colonies and extracellular glucoamylase activity 
zones permitted GlaAG2::S transformant selections based on specific extracellular 
glucoamylase activity (mm2Glucoamylase.mm2Biomass Growth-1) (Figure 2). Seven GlaAG2::S fused 
gene transformants were selected with high extracellular glucoamylase activity (DAHB 
21#20, 40, 62, 100, 103, 128, and 145). In liquid shake flask cultivations, all transformants 
produced high levels of extracellular glucoamylase activity, greater than 0.037 U.gDW-1 
(Figure 4), showing an acceptable correlation between specific extracellular glucoamylase 
activity (mm2Glucoamylase.mm2Biomass Growth-1) on agar plates and extracellular glucoamylase 
activity in submerged shake flask data (data not shown).  Transformant DAHB 21#40 
obtained the highest glucoamylase activity, 0.046 U.gDW-1. Six transformants selected (DAHB 
21#20, 40, 100, 103, 128, and 145) achieved high HBsAg production levels greater than 25 
µgHBsAg.gDW-1, with the highest levels obtained from DAHB 21#40 (77 ± 8.0 µgHBsAg.gDW-1) 
(Figure 4). No extracellular HBsAg was detected in transformants (data not shown). Biomass 
levels of ‘high glucoamylase producing’ transformants varied (data not shown). Similarly, the 
growth rates were in the range of 0.014 and 0.021 h -1, with DAHB 21#40 attaining a growth 
rate of 0.015 h -1 (Figure 4). 
Stellenbosch University http://scholar.sun.ac.za
 124 
 
 
Figure 4.  Screening of high extracellular glucoamylase producing GlaAG2::S fused gene transformants in shake 
flask cultivations for HBsAg production. Analysis is performed after 96 h of cultivation. Shown are data for: 
grey columns, specific intracellular HBsAg production (µgHBsAg.gDW-1); white columns, specific extracellular 
glucoamylase activity (UGlaA.gDW-1); ▲, maximum specific growth rate (µmax, h-1). Error bars represent the 
standard deviation of the mean of triplicate cultivations. Points without error bars have an associated deviation 
that is < 10 % of the value of the point. 
 
Efficiency of screening methods for identification and selection of high HBsAg producing 
transformants 
All three screening methods were able to identify HBsAg producing transformants. However, 
there were varying degrees of success in terms of HBsAg production levels and the 
percentage transformants identified as high HBsAg producers from each method. Out of the 
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10 transformants selected through the ‘acrylamide utilizing’ screen through amdS gene 
expression, 20 % were identified as high HBsAg producing transformants (> 25 µgHBsAg.gDW-
1; Table 1). The screening methodology based on selecting for improved growth on starch 
yielding ‘high biomass producing’ transformants identified 40  %, while through the selection 
of high extracellular glucoamylase activity on starch, 86 % of the transformants selected were 
identified as high HBsAg producing transformants (> 25 µgHBsAg.gDW-1 ; Table 1). 
 
Table1: Summary of screening methods evaluated 
Screening strategy No. of 
transformants 
selected from 154 
No. of 
transformants > 25 
µgHBsAg.gDW-1 
Percentage of high  HBsAg 
producing transformants (>25 
µgHBsAg.gDW-1) selected (total 
transformants, 154) 
    1.‘Acrylamide utilization’ through 
amdS expression 
10 2 20  
    
2. ‘high biomass producing’ 10 4 40  
    
3.‘high extracellular 
glucoamylase activity’ 
7 6 86  
    
 
Batch fermentation of two highest HBsAg producing transformants 
From the three screening methodologies evaluated in this study, two high HBsAg producing 
transformants were identified: DAHB 21#20 that was identified using all three selection 
methods and DAHB 21#40 that was recognized while screening for ‘high extracellular 
glucoamylase producing’ transformants. To evaluate and compare the performance of the two 
high HBsAg producing transformants, batch fermentations were conducted. A carbon 
substrate of 3 % glucose in a rich media was used for cultivation to ensure rapid offline 
analysis of carbon consumption. Growth profiling of transformants followed accelerated 
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trends compared to shake flask cultivations (Figure 5A). Maximum biomass concentrations 
and growth rates differed significantly between transformants, with the ‘high biomass 
producing’ DAHB 21#20 obtaining the highest at 17.32  ± 0.73 gDW.kgBroth-1 and 0.11 ± 0.009 
h-1, and ‘high extracellular glucoamylase producing’ DAHB 21#40 obtaining 14.35 ± 1.2 
gDW.kgBroth-1 and 0.08±0.007 h-1, respectively (Figure 5A). Similar glucose consumption rates 
were observed for both transformants, with glucose depletion correlating to maximum 
biomass concentrations (~ 49 h for the ‘high biomass producing’ transformant and ~ 50 h for 
the ‘high extracellular glucoamylase producing’ transformant). Biomass yield coefficients, 
however, differed (YXS ‘high biomass producing’ = 0.56 ± 0.015 gDW.gGlucose-1 and YXS ‘high glucoamylase 
producing’ = 0.51 ±0.02 gDW.gGlucose-1; Figure 5A). Extracellular glucoamylase activity profiles 
followed a growth associated trend, with the highest levels obtained in the ‘high extracellular 
glucoamylase producing’ transformant (0.21 ± 0.021 U.gDW-1) (Figure 5B). Glucoamylase 
activity in the ‘high biomass producing’ transformant reached 67 % of the levels obtained in 
the ‘high extracellular GlaA producing’ transformant (0.14 ± 0.018 U.gDW-1). Similar to the 
extracellular glucoamylase activity profiles, intracellular HBsAg production levels also 
followed a growth associated trend with the highest levels occurring after ~ 50 h (Figure 5C). 
The ‘high extracellular glucoamylase producing’ transformant achieved highest levels of 219 
± 8.5 µgHBsAg.gDW-1, while the ‘high biomass producing’ transformant obtained 68 % of the 
levels obtained in the ‘high glucoamylase producing’ transformant with 143 ± 12.5 
µgHBsAg.gDW-1. The decrease in both extracellular glucoamylase activity and HBsAg 
production levels in transformants correlated to glucose depletion suggesting that glucose as 
carbon source was the rate limiting nutrient. Furthermore, linear correlations between 
intracellular HBsAg and extracellular glucoamylase activity were observed in the two 
GlaAG2::S transformants during the exponential growth phase in glucose batch fermentation 
(Figure 6). The significance of the two correlations were confirmed through linear regression 
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analysis, with pvalues < 0.05 of the x variables and intercepts at a 95 % confidence level and R2 
values ≥ 0.95 explaining more than 95 % of the total variation (Figure 6). However, no 
significant difference was observed between the two correlations (p > 0.05). 
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Figure 5. Glucose batch fermentation of A. niger: Shown is data regarding transformants (carrying the GlaAG2::S 
fusion cassette and controlled by the inducible GlaAp promoter); ∆, ‘fast-growing high-biomass producing’ 
transformant DAHB 21#20; and ○, ‘slow-growing high-glucoamylase producing’ transformant DAHB 21#40. 
Time course data of: (A) Dry biomass concentration (open symbols) and glucose concentration (grey symbols); 
(B) specific extracellular glucoamylase activity (open symbols); (C) specific intracellular HBsAg production 
(open symbols).  Closed symbols for ∆ and ○ represent glucose depletion in glucose cultivations. Error bars 
represent the standard deviation of the mean of triplicate cultivations.  
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Figure 6. Correlation between specific intracellular HBsAg production and specific extracellular glucoamylase 
activity. Shown is data regarding glucose batch fermentation of A. niger transformants: ∆, ‘fast-growing high-
biomass producing’ transformant DAHB 21#20; and ○, ‘slow-growing high-glucoamylase producing’ 
transformant DAHB 21#40 during the exponential growth phase. Error bars represent the standard deviation of 
the mean of triplicate cultivations.  
 
DISCUSSION 
The aim of this study was to develop an improved methodology to identify and select high 
HBsAg producing transformants. Gene fusion, using the expression vector carrying the 
glucoamylase carrier gene fused to the HBsAg S gene as well as the inclusion of the amdS 
selection marker, was used not only to facilitate HBsAg S gene expression and HBsAg 
assembly through the secretory pathway but also to serve as a medium for selection. In 
conjunction with conventional selection based on amdS expression and associated acetamide 
utilization, transformants were screened using varied selection methods; (1) transformant 
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selection based on acrylamide utilization through expression of the amdS gene, (2) 
transformant selection based on high growth on starch as reported by Weenink et al., (2006), 
and (3) transformant selection based on high extracellular glucoamylase activity on starch.  
 
Conventional selection systems, in the form of selectable markers, are often incorporated 
within the plasmid vector carrying the gene product of interest. The majority of these systems 
are based on either complementation of auxotrophic mutant strains with the corresponding 
wild type gene and/ or dominant selection marker genes, which confer resistance to a 
fungicide (reviewed by Van den Hondel and Punt 1991; Turner 1994). The amdS gene, 
inserted into the fused GlaAG2::S gene expression vector, is a commonly used dominant 
marker that encodes the enzyme acetamidase (E.C.3.5.1.4) which hydrolyses acetamide and 
acrylamide. Transformant selection using this approach is directed towards the transformant’s 
ability to produce acetamidase and therefore utilize acetamide or acrylamide as sole carbon 
and/or nitrogen source (Hynes, 1972; Hynes, 1973). In A. nidulans one copy of the amdS gene 
is sufficient for growth on acetamide, however growth on acrylamide is only possible if 
several copies of the gene are present (Van den Hondel et al., 1992).  The identification of 
high HBsAg producing transformants in amdS selection based on acrylamide utilization 
therefore represents transformants with improved acetamidase production.  
The low efficiency of 20 % in identifying high HBsAg producing transformants using this 
approach suggests that there is no strict correlation between acetamidase production and 
HBsAg production. In the study of Plüddemann (2003), amdS selection based on acrylamide 
utilization resulted in the identification of transformants with high transcription levels of the 
fused GlaAG2::S gene, but no extracellular or intracellular HBsAg could be detected. These 
results suggest that limitations with the production of this higher recombinant eukaryotic gene 
product do not appear to be at the level of transcription but rather on a (post)translational level 
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(Plüddemann, 2003). Similar conclusions have been reported (Jeenes et al., 1994; Nyyssönen 
and Keränen, 1995; Gouka et al., 1997a; Plüddemann and van Zyl, 2003). Therefore, any 
correlations that may have existed at a transcriptional level between amdS and fused 
GlaAG2::S gene expression using selection based on acrylamide utilization could differ 
significantly at a posttranslational level, where bottlenecks can accrue through the secretory 
pathway and thus affect the fused glucoamylase-HBsAg products. 
 
The screening criterion proposed by Weenink et al. (2006), regarding ‘high biomass 
producing’ transformants, bases selection on the transformants ability to grow on starch using 
an expression host that lacks two major amylolytic enzymes, glucoamylase and acid amylase. 
Through the expression of the fused GlaAG2::S gene, growth of the transformant on starch is 
obtained through the production of glucoamylase which is required for starch to glucose 
hydrolysis. Thus, improved growth should reflect improved HBsAg production levels using 
starch as a selection pressure. This hypothesis relies on the following assumptions: (1) high 
biomass production reflects high glucoamylase production, and (2) glucoamylase activity is 
proportional to HBsAg production. With a 40 % efficiency in identifying high HBsAg 
producing transformants and a 2-fold improvement in comparison the ‘acrylamide utilizing’ 
screen, suggests that there is merit in the abovementioned hypothesis: high biomass 
production is indicative of higher glucoamylase production levels (Figure 3), and for HBsAg 
production in A. niger, using GlaAG2::S gene fusion, glucoamylase is proportional to HBsAg 
production (Figure 6). But the 40 % success rate in identifying high HBsAg producers also 
indicates that the indirect quantification of HBsAg production in potential HBsAg producing 
transformants through improved growth on starch reflects an inefficiency using this method. 
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The third screening criterion selects specifically for high extracellular glucoamylase 
producing transformants, with the hypothesis that extracellular glucoamylase activity is 
directly proportional to correctly folded and assembled HBsAg. Higher extracellular 
glucoamylase producing transformants were identified in comparison to the ‘high biomass 
producing’ selection criterion and resulted in 86 % of all transformants selected obtaining 
high HBsAg levels, with the highest at 77 µgHBsAg.gDW-1 (DAHB 21#40). Transformants with 
a greater area of glucoamylase activity in relation to the area of biomass produced on starch 
agar selection plates could represent transformants with optimum copy number and preferred 
site of integration for the high expression and production of the fused GlaAG2::S gene product. 
More importantly this could also represent transformants with increased glucoamylase 
secretion efficiency. If this is the case, selecting for high extracellular glucoamylase 
producing transformants could represent transformants with the most efficient processing of 
the fused product. These findings also suggest that by selecting for ‘high biomass’ producing 
transformants, identification of high HBsAg producing transformants may be masked. 
Whether this is indicative of the extra sensitivity incurred by directing selection specifically 
towards the area of glucoamylase activity in relation to the area of biomass produced on starch 
agar selection plates is plausible. However, due to a direct proportional relationship between 
HBsAg production and glucoamylase activity, this has allowed for the indirect quantification 
of HBsAg production through extracellular glucoamylase determination. Any bottlenecks that 
accrue during expression or translation of the fused product in the secretory pathway could 
possibly be reflected in the quantification of extracellular glucoamylase. 
 
From the three selection methods evaluated in this study, two high HBsAg-producing 
transformants were identified; DAHB 21#20 that was identified using all three selection 
methods and DAHB 21#40 that was only recognized while screening for high extracellular 
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glucoamylase. During the cultivation of these two transformants in glucose batch 
fermentations it became more apparent that two distinctive growth phenotypes had been 
identified. Transformant DAHB 21#20, showing evidence of high acetamidase, and biomass, 
production levels, had a higher growth rate and biomass yield coefficient in comparison to the 
high extracellular glucoamylase producing transformant DAHB 21#40, but the HBsAg 
production levels and extracellular glucoamylase levels were lower. The morphologies of the 
two transformants were pelleted and indistinguishable (data not shown), indicating that 
differences in growth rate were not caused by a morphological alteration.  Possible 
explanations for this phenomenon could include variance in plasmid copy number (Verdoes et 
al., 1994), site of integration (Plüddemann, 2003) and/ or posttranscriptional alteration of the 
fused GlaAG2::S gene (Weenink et al., 2006). 
 
HBsAg production and assembly was highest at a lower growth rate in the ‘high glucoamylase 
producing’ transformant. The specific product formation rate of a protein can increase 
consistently with increasing growth rate, as shown for laccase in A. niger (Weenink et al., 
2006), Fab fragment production in Pichia pastoris (Zhang et al., 2005) and β-galactosidase 
production in Escherichia coli (Sanden et al., 2003). Whereas for other proteins, such as α-
galactosidase of P. pastoris, cellobiohydrolase (Pakula et al., 2005), laccase (Rautio et al. 
2007 ) in Trichoderma reesei and HBsAg  in A. niger in this study, the specific product 
formation rate is highest at lower growth rates. Efficient processing of the heterologous 
protein of interest may be compromised by the saturation or overloading of the secretory 
machinery caused by unfolded and/or misfolded proteins, which are prevented from leaving 
the Endoplasmic reticulum (ER) (Lodish et al. 1983; Shuster 1991; Parekh et al. 1995; Shusta 
et al. 1998; Smith et al. 2004; Damasceno et al., 2007). Further investigation is necessary to 
determine the relation between growth rate and HBsAg assembly as a reduced growth rate 
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may enhance the efficiency of A. niger to synthesize and produce HBsAg by alleviating the 
speculated pressures of over expression or unfolded protein overload in HBsAg-producing A. 
niger transformants. 
 
In this study we were able to select and identify high HBsAg producing transformants, using a 
modified/enhanced selection system, based on high extracellular glucoamylase activity using 
starch as a selection pressure. The genetic selection system, making use of the glucoamylase-
HBsAg S gene fusion strategy and a starch non-utilizing A. niger host, increased intracellular 
HBsAg production levels 4-fold compared to levels previously reported (Manuscript 1 of this 
dissertation). Through the production of correctly folded antigenic HBsAg we demonstrate 
that this technology is rapid, robust, and versatile for the production of mammalian and higher 
eukaryotic gene products in A. niger using the fused gene approach and glucoamylase carrier 
protein. Through the application of molecular tools (e.g. modification of chaperone levels), as 
well as the development of cultivation parameters (e.g. exponential fed batch), the reported 
HBsAg production levels are expected to increase significantly. The further development of 
this technology is suggested as it is an exciting candidate for recombinant subunit vaccine 
production in A. niger.  
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ABSTRACT 
The effects of growth rate (µ) in glucose-limited exponential fed-batch fermentations on 
HBsAg production in Aspergillus niger was evaluated, using two HBsAg producing 
transformants, (1) the ‘fast-growing high-biomass producing’ transformant (µmax = 0.11 h-1), 
and (2) the ‘slow-growing high-glucoamylase producing’ transformant (µmax = 0.08 h-1). Both 
transformants made use of the gene fusion approach, using the expression vector containing 
the GlaAG2 carrier gene fused to the HBsAg S gene, under control of the GlaAp promoter. In 
comparison to batch fermentation, glucose-limited exponential fed-batch fermentations at µ ≈ 
µmax, intracellular HBsAg production levels were enhanced by ~ 20 % for both transformants. 
The culturing of the ‘fast-growing high-biomass producing’ transformant, at a reduced µ = 
0.08 h-1, obtained highest specific HBsAg production levels of ~ 240 µgHBsAg.gDW-1. Highest 
intracellular HBsAg production levels in ‘slow-growing high-glucoamylase producing’ 
transformant cultivations of ~ 250 µgHBsAg.gDW-1 were detected at µ ranging between 0.07 < µ 
<0.08 h-1. At low µ, estimated ms formed ~ 25 and 30 % , respectively, of the qs. The high 
non-growth associated substrate consumption for maintenance under these conditions 
potentially limited production of both biomass and proteins. These limitations were reflected 
in the significantly lower biomass levels, extracellular glucoamylase activities and 
intracellular HBsAg production levels for both transformants at µ = 0.03 h-1. HBsAg 
production in relation to extracellular glucoamylase activity was most efficient for both 
transformants at 0.07 < µ <0.08 h-1. Due to significantly higher biomass levels, volumetric 
HBsAg production levels were highest (4483 ± 340 µgHBsAg.kgBroth-1) in ‘fast-growing high-
biomass producing’ transformant fermentations. HBsAg production levels using this approach 
were increased 1.8 fold in comparison to batch fermentations. Thus glucose-limited 
exponential fed-batch fermentation at an optimum µ (0.07 < µ <0.08 h-1) for the current A. 
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niger HBsAg production system may provide a method for efficient HBsAg processing, 
resulting in increased HBsAg production levels.  
 
INTRODUCTION 
In the early 1980s, the first licensed vaccines against the Hepatitis B virus (HBV) became 
available and were produced from the serum of chronic carriers. These serum-derived 
vaccines were effective and safe, but were also expensive and in relatively short supply 
because of the shortage of human carrier plasma that met the requirements for vaccine 
production (Prince and Vnek, 1982). From 1986, advancements in recombinant technology 
have led to the success of current vaccination programs against Hepatitis B through the 
development of effective, recombinant hepatitis B surface antigens (HBsAg) that assemble 
into virus-like particles (VLPs). Initially, the production of such vaccines was restricted to 
baker's yeast, Saccharomyces cerevisiae, but with improvements in gene technology and 
biotechnological methods, alternative expression systems have been identified. This includes 
the methylotrophic yeasts Pichia pastoris and Hansenula polymorpha (Gleeson et al., 1986; 
Roggenkamp et al., 1986; Hollenberg and Gellissen, 1997; Gellissen, 2002) which are 
currently used in the production of several vaccines against different subtypes of the HBV 
(Gellissen and Melber, 1996; Brocke et al., 2005; Melmer et al., 2008).  
 
The filamentous fungi, Aspergillus niger has also emerged as a potential alternative 
expression system for VLP vaccine production due to several advantageous characteristics: 
vector design and construction, codon optimization and choice of promoter (Van den Hondel 
and Punt, 1991; Gouka et al., 1996; Plüddemann and van Zyl, 2003), the generation of fusion 
constructs (Gouka et al., 1997b; Spencer et al., 1998; Plüddemann and van Zyl, 2003; 
Manuscript 1 & 2 of this dissertation), over expression of chaperone proteins (Punt et al., 
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1998; Ngiam et al., 2000), the isolation of protease deficient mutants (Archer and Peberdy, 
1997; van den Hombergh et al., 1997), and the optimisation of media and cultivation 
conditions (MacKensie et al., 1994; Xu et al., 2000; Conesa et al., 2001; James et al., 2007).    
 
It has been previously reported that by targeting HBsAg production through the secretory 
pathway in A. niger, completely assembled and properly folded HBsAg, was obtained 
(manuscript 1 and 2 of this dissertation). This was achieved by implementing a gene fusion 
strategy using the highly expressed catalytic domain of the glucoamylase gene (GlaAG2) fused 
to the HBsAg S gene.  The inducible glucoamylase promoter (GlaAp) was used to control 
transcription. The gene fusion strategy resulted in the cleavage of the fused product by the 
KEX2-like protease, and intracellular accumulation of HBsAg was observed, while 
glucoamylase was secreted (manuscript 1 of this dissertation). However, several breakdown 
products showing an immunoreactive response to the glucoamylase polyclonal antibody were 
detected. Similar results were documented in the study of Plüddemann, (2003) and Conesa et 
al., (2000) and indicated a level of intracellular degradation. Possible explanations to these 
findings were attributed to the bottlenecks that accrue within the secretory pathway (Wang, 
2005). In heterologous expression systems, where there is a greater flux of proteins being 
translocated into the Endoplasmic Reticulum (ER), the folding, assembly, and processing 
machinery may become saturated, leading to improperly folded structures (Ngiam et al., 
2000). 
 
In Manuscript 2 of this dissertation, using a starch substrate as a selection pressure for the 
expression of the GlaAG2 fused to the HBsAg S gene in an A. niger strain lacking native 
glucoamylase and acid amylase, two high HBsAg producing transformants were identified: 
(1) the ‘fast-growing high-biomass producing’ transformant (µmax = 0.11 h-1), and (2) the 
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‘slow-growing high-glucoamylase producing’ transformant (µmax = 0.08 h-1). Highest specific 
and volumetric intracellular HBsAg production correlated to high extracellular glucoamylase 
and was observed in a HBsAg-producing A. niger transformant, with an inherently reduced µ 
(manuscript 2 of this dissertation). This has led to the hypothesis that a reduced µ may 
enhance the efficiency of A. niger to synthesize and produce HBsAg.  
 
In this study, we evaluated the effects of µ in glucose-limited exponential fed-batch 
fermentations on HBsAg production of two HBsAg producing transformants, previous 
identified (Manuscript 2 of this dissertation); (1) the ‘fast-growing high-biomass producing’ 
transformant, DAHB21#20, and (2) the ‘slow-growing high-glucoamylase producing’ 
transformant, DAHB21#40. Through glucose-limited exponential fed batch fermentation the 
effects of µ over a range of 0.03 to 0.1 h-1 on specific and volumetric intracellular HBsAg 
production as well as biomass concentration and extracellular glucoamylase activity were 
evaluated. Additional analysis on the effect of µ in fed batch fermentation on substrate 
consumption (qs) and the maintenance coefficient (ms) is also performed and provides insight 
towards determining the requirements for efficient HBsAg production. 
 
 MATERIALS AND METHODS 
Strains  
Two HBsAg-producing A. niger transformants, which were identified in Manuscript 2 of this 
dissertation, are evaluated in this study; (1) the ‘fast-growing high-biomass producing’ 
transformant, DAHB21#20, and (2) the ‘slow-growing high-glucoamylase producing’ 
transformant, DAHB21#40. These transformants were developed as previously described in 
Manuscript 2 of this dissertation.  
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Inoculum preparation, media and cultivations 
Fungal spores were obtained from a densely conidiating culture grown on potato dextrose 
agar (PDA) at 30 oC for 120 h and harvested with physiological saline solution (NaCl, 0.9 % 
w.v-1). Shake flask cultures were inoculated with a spore concentration of 1×106 spores.ml−1. 
Batch fermentations were inoculated with a shake flask pre-culture amounting to 10 % of the 
fermentor’s total working volume. All cultivations were grown on minimal medium (MM) 
(Plüddemann and van Zyl, 2003) containing 3 % (w.w-1) glucose and supplemented with 0.1 
% (w.w-1) casamino acids (Difco), 0.8 % (w.w-1) tryptone and 0.8  % (w.w-1) yeast extract. 
Shake flask cultivations were performed in 1 L Erlenmeyer flasks (un-baffled) containing 250 
ml medium at 30 °C on a rotary shaker (Innova 2300, New Brunswick Scientific, Edison, 
USA) at 180 rpm. Fermentations were performed in 2 L bench-top bioreactors (INFORS AG, 
Switzerland) with a working volume of 1.5 L. The fermentation temperature was maintained 
at 30 °C (± 0.1°C), aeration at 0.8 vvm, dissolved oxygen was maintained above 25  % 
saturation by varying impeller speed (starting rate of 150 rpm), through a cascaded controller. 
The impellor speed was ramped by 200 rpm for 1 min every hr to reduce wall growth. pH was 
controlled above a value of 4 using NH4OH (25 % w.v-1). 
 
Exponential feed calculations 
Exponential fed-batch cultivations were used to evaluate a range of four different set growth 
rates (µset) (0.03, 0.05, 0.07, 0.08, and 0.1 h-1). During the carbon limited exponential feeding 
phase, the mass of residual glucose in the fermentor (Ms) was maintained close to zero and µset 
was controlled by directly controlling the mass of concentrated glucose substrate added in the 
fed-batch cultivation. This approach of controlling the mass of concentrated glucose substrate 
added in the fed-batch cultivation (equation 3) while Ms ≈ 0, was used to regulate the 
production of biomass in the fermentor (equation 1) through the control of glucose substrate 
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consumption by the filamentous fungi. This results in the control of the µset at a constant value 
under both transient and steady state conditions for biomass concentration (Martinez et al., 
1998; Kim et al., 2000; Cheng et al., 2003; Sun et al., 2007; Chen et al., 2008). 
 
Biomass calculations 
The biomass produced at time 1 (Mx(t1)) was used to calculate a predicted biomass profile for a 
particular µset using the principals of equation 1 (refer to derivations in Appendix A), to 
predict the biomass production at time 2 (Mx(t2)).  
 
)(
)1()2(
12 tt
txtx
seteMM −= µ
       Equation 1. 
 
Assuming the growth yield, YXS is constant throughout the exponential feeding phase, and 
applying the principals of equation 2 to obtain equation 3 (refer to derivations in Appendix 
A), the amount of glucose at a specific time point required for the production of biomass at 
µset, was calculated; 
 
biomassnewproducetoconsumedsubstrateegluofmass
formedbiomassnewofmass
Yxs
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=
  
Equation 2. 
 
           Equation 3. 
 
where Msf(t2) - Msf(t1) is the predicted mass of glucose required at time 2 to produce new 
biomass, Mx(t2) - Mx(t1) at µset. The mass of glucose in the fermentor (Ms) was maintained at 
approximately zero for the duration of the feeding phase, where it was assumed that Ms was 
consumed by the organism as fast as it entered the fermentor to control µset. The amount of 
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glucose fed was controlled and logged by an algorithm on the fermentor digital control unit 
(DCU) which exponentially increased the pump dosage every 10 seconds according to the 
glucose profile calculated (Equation 1 & 3). This data was cross referenced gravimetrically. 
Calculations regarding the exponential feeding methodology are presented in Appendix B. 
 
Rate calculations 
The specific rate of substrate consumption (qs) was calculated using the following rate 
equation, Equation 3: 
s
s
x
rq M=           Equation 3. 
  
Where qs (gGlucose.gDW-1.h-1) is the specific rate of substrate consumption, rs (gGlucose.h-1) is the 
rate at which the substrate is consumed, and MX (gDW) is the mass of biomass cultivated. The 
non-growth-associated maintenance coefficient, ms, (gGlucose.gDW-1.h-1) and YXSmax were 
calculated using the linear equation of substrate utilization, introduced by Pirt (1965) and 
shown in Equation 4. 
maxs s
XS
q mY
µ
− = +          Equation 4. 
 
qs, YXSmax, and ms were estimated by linear regression, assuming that the energy requirement 
for ms and the YXSmax are constant over the different µ and that no metabolites other than 
carbon dioxide and water are produced. 
 
Sample preparation 
Shake flasks were sampled in 24 hr increments while bioreactor cultivations were sampled at 
intervals of 3 to 8 h. Samples containing ± 50 g of cultivation medium were withdrawn and 
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biomass concentration was measured by vacuum filtering 25 g sample on dry and pre-
weighed filters (Whatman no.1), followed by washing with 40 ml 0.9  % (w.v-1) NaCl 
solution and drying to a constant weight at 105 oC for 24 to 48 h. The remaining 25 g sample 
was ground to a fine powder with liquid nitrogen in a mortar and pestle, and an aliquot of 0.3 
g mycelia powder was stored at −80 °C in a 2 ml micro-centrifuge tube. Ground samples were 
suspended in protein extraction buffer with 0.1 % Triton X-100 (Plüddemann and van Zyl, 
2003) and homogenized for 1 min at 4 °C. This was followed by clarification at 13 000 rpm 
and 4 °C. Extraction of supernatant resulted in samples containing total intracellular proteins 
including membrane-associated proteins. 
 
 HBsAg concentration determination 
A “sandwich” type enzyme immunoassay based on monoclonal anti-HBsAg (HBsAg 3.0 EIA, 
Bio-Rad, Hercules, CA) was used to quantify completely assembled and properly folded 
HBsAg as per manufacturers specification. 
 
Glucoamylase Activity 
The activity of glucoamylase was measured by the method of Withers et al. (1998) using 
freshly prepared 0.1 % (v.v-1) 4-nitrophenyl-α-D-glucopyranoside (PNPG) (Sigma-Aldrich N-
1377) as substrate in 0.1 M Sodium Acetate buffer (pH 4.3). To commence the reaction, 100 
µl PNPG was added to 50 µl sample (or glucoamylase standard) in a flat bottom micro-titre 
plate and incubated for 20 min at 25 oC. The reaction was terminated by the addition of 150 µl 
Borax (0.1 M Na2B4O7.10 H2O) solution, and absorbance at 400 nm was measured using a 
BioTek Power waveHT micro-titre plate reader (BioTek Instruments Inc., USA) referenced 
with distilled water. Background absorbance was normalized with the addition of 150 µl 
Borax solution to 50 µl sample prior to the addition of 100 µl PNPG, in a duplicate assay. The 
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measured background absorbance was subtracted from the absorbance readings obtained from 
the incubated samples and converted into glucoamylase activity using a standard curve 
(Amyloglucosidase Fluka 10113). 
 
Glucose Concentration 
Glucose concentration was measured using a high performance ion chromatography (HPIC) 
(CarboPac™ PA1 column, Dionex, MA, USA) and ACCUTREND Glucose strips (Roche 
Diagnostics Ltd, East Sussex, UK). 
 
RESULTS 
Growth regulated, glucose-limited exponential fed-batch fermentation 
The ‘fast-growing high-biomass producing’ transformant, DAHB21#20, and the ‘slow-
growing high-glucoamylase producing’ transformant, DAHB21#40 were cultured under 
glucose-limited exponential fed-batch conditions at various µ (0.03 ± 0.005 – 0.1 ± 0.003 h-1). 
Triplicate fed-batch cultivations were performed for all exponential feeding rates in the range 
of 0.07 and 0.1 h-1, duplicate fermentations were performed for exponential feeding rates of 
0.03 and 0.05 h-1. In glucose batch fermentation the ‘fast-growing high-biomass producing’ 
transformant, DAHB21#20, and the ‘slow-growing high-glucoamylase producing’ 
transformant, DAHB21#40 obtained maximum specific growth rate (µmax) of 0.08 and 0.11 h-
1
, respectively, and YXSmax of  0.56 and 0.51 gDW.gGlucose-1, respectively (Manuscript 2 of this 
dissertation, Table 1). The exponential feed was determined on the amount of glucose 
required at specific time points for the increase in biomass at the desired µ. The exponential 
glucose feed was started upon depletion (between 19 and 21 h) of an initial glucose 
concentration of 10 gGlucose.kgbroth-1 and was stopped after biomass levels ceased to increase 
and residual glucose accumulation was observed in the fermentor. Thereafter, fermentations 
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were monitored and sampled for an additional 10 h before the run was stopped. The residual 
glucose concentration was below the detection limit (5 mmol.lbroth-1) for all cultivations during 
the exponential feeding phase. 
 
Table1: Performance of HBsAg-producing A. niger strains in glucose based batch fermentations (manuscript 2 
of this dissertation) 
A. niger strains Maximum 
growth rate 
[h-1] 
Maximum 
Biomass 
[gDW.kgBroth-1] 
YXS 
 
[gDW.gGlucose-1] 
Maximum 
Glucoamylase 
[U.gDW-1] 
Maximum 
HBsAg 
[µgHBsAg. gDW-1] 
      
‘fast-growing high-biomass 
producing’ transformant, 
DAHB21#20  
0.11 ± 0.009 17.32 ± 0.73 0.56 0.14 ± 0.018 143 ± 12.5 
      
‘slow-growing high-
glucoamylase producing’ 
transformant, DAHB21#40 
0.08 ± 0.007 14.35 ± 1.2 0.51 0.21 ± 0.021 219 ± 8.5 
      
 
Biomass levels were highest in glucose-limited exponential feed cultivations of the ‘fast-
growing high-biomass producing’ transformant at µ above 0.07 h-1 (Figure 1A). Highest levels 
of 18.60 ± 1.1 gDW.kgBroth-1 were recorded at a µ of 0.08 h-1.  In comparison, biomass levels 
were lower in ‘slow-growing high-glucoamylase producing’ transformant fermentations, with 
highest levels recorded at 0.07 h-1 (15.91 ± 0.45 gDW.kgBroth-1). A notable decrease in biomass 
levels was observed between µ of 0.03 and 0.05 h-1 in both transformants (Figure 1A). 
 
Similar extracellular glucoamylase activities were recorded in ‘fast-growing high-biomass 
producing’ and ‘slow-growing high-glucoamylase producing’ transformant cultivations 
between the regulated µ of 0.07 and 0.08 h-1 (Figure 1B). Highest extracellular glucoamylase 
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activities in the exponential fed-batch cultivations of the ‘fast-growing high-biomass 
producing’ transformant were observed at a µ of 0.08 h-1 (0.23 ± 0.02 U.gDW-1). In ‘slow-
growing high-glucoamylase producing’ transformant fed-batch fermentations highest 
glucoamylase activities (0.23 ± 0.03 U.gDW-1) were at a µ of 0.07 h-1. A notable decrease in 
extracellular glucoamylase activity was observed in both transformants at a µ below 0.05 h-1 
(~ 0.1 U.gDW-1 at 0.03 h-1.), and in ‘fast-growing high-biomass producing’ transformant 
cultivations when the µ approached µmax (0.1 h-1; 0.18 ± 0.02 U.gDW-1; Figure 1B). 
 
Intracellular (specific and volumetric) HBsAg production followed similar trends to 
extracellular glucoamylase activities for both transformants. Highest specific and volumetric 
HBsAg production levels were observed in the ‘fast-growing high-biomass producing’ 
transformant exponential fed-batch cultivations at a µ of 0.08 h-1 (241 ± 19 µgHBsAg.gDW-1and 
4483 ± 308 µgHBsAg.kgBroth-1, respectively) (Figure 1C and 1D). Highest specific and 
volumetric HBsAg production levels in ‘slow-growing high-glucoamylase producing’ 
transformant cultivations were obtained at a µ of 0.07 h-1 (251 ± 35 µgHBsAg.gDW-1; 3989 ± 274 
µgHBsAg.kgBroth-1, respectively) (Figure 1C and 1D). In comparison, glucose-limited fed-batch 
fermentations of the ‘slow-growing high-glucoamylase producing’ at a µ of 0.07 h-1 obtained 
highest specific HBsAg production levels (Figure 1C), while cultivations of the ‘fast-growing 
high-biomass producing’ transformant at 0.08 h-1 obtained highest volumetric HBsAg levels 
(Figure 1D).  
 
Figure 1E depicts the ratio of intracellular HBsAg production and extracellular glucoamylase 
activity using the maximum values measured in the various glucose-limited exponential fed-
batch fermentations. This data, reflecting the ratio between maximum intracellular HBsAg 
production and maximum extracellular glucoamylase activity, indicates that between the  µ of 
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0.07 and 0.1 h-1 the glucose-limited exponential fed-batch fermentation of the ‘fast-growing 
high-biomass producing’ transformant achieved a ratio of  ~ 1050 ± 92 µgHBsAg.U-1. A 
decrease in µ resulted in a significant decrease in this ratio to 610 ± 101 µgHBsAg.U-1 at a µ of 
0.03 h-1. Similarly in ‘slow-growing high-glucoamylase producing’ transformant cultivations, 
between the µ of 0.07 and 0.08 h-1, a ratio  between maximum intracellular HBsAg production 
and maximum extracellular glucoamylase activity was equal to that obtained in ‘fast-growing 
high-biomass producing’ transformant cultivations (1045±79 µgHBsAg.U-1). A decrease in µ 
resulted in a significant decrease to a low level of 587±82 µgHBsAg.U-1 at a µ of 0.03 h-1. 
 
From Figure 1F, the following substrate utilization equations were obtained for ‘fast-growing 
high-biomass producing’ (Equation 5) and ‘slow-growing high-glucoamylase producing’ 
(Equation 6) transformant fermentations, respectively: 
 
1.754 0.0195sq µ− = +         Equation 5. 
1.929 0.0245sq µ− = +         Equation 6. 
 
A maximum specific rate of substrate consumption (qsmax) and ms of ~ 0.2 gglucose.gDW-1.h-1 and 
0.0195 gglucose.gDW-1.h-1, respectively was obtained for the ‘fast-growing high-biomass 
producing’ transformant at 0.1 h-1 (Figure 1F, Equation 5). A lower qsmax and ms of ~ 0.18 
gglucose.gDW-1.h-1 and 0.0245 gGlucose.gDW-1.h-1, respectively was obtained for the ‘slow-growing 
high-glucoamylase producing’ transformant cultivations at 0.08 h-1 (Figure 1F, Equation 6). 
The calculated YXSmax at µ of 0.05 h-1 and above correlated with the values initially obtained 
in batch fermentations (Table 1) for both transformants. At lower µ of 0.03 h-1, YXSmax values 
were observed to decrease to ~ 0.4 gDW.gGlucose -1 for both transformants (data not shown). 
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Figure 1. Glucose-limited exponential fed-batch fermentations of A. niger at different µ over a range of 0.03 to 
0.1 h-1: Shown is data regarding two HBsAg-producing A. niger transformants (carrying the GlaAG2::S fusion 
cassette and controlled by the inducible GlaAp promoter); ∆, ‘fast-growing high-biomass producing’ 
transformant DAHB 21#20; and ○, ‘slow-growing high-glucoamylase producing’ transformant DAHB 21#40. 
Depicted are the effects of µ data on: (A) Dry biomass concentration, (B) specific extracellular glucoamylase 
activity, (C) specific intracellular HBsAg production, (D) volumetric intracellular HBsAg production, (E) the 
ratio of intracellular HBsAg production and extracellular glucoamylase activity using the maximum values 
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measured in the various glucose-limited exponential fed-batch fermentations, and (F) specific rate of substrate 
consumption (qs). Error bars represent the standard deviation of the mean. X-axis error bars represent the 
standard deviation of the µ evaluated as calculated from biomass production in the exponential growth phase.  
Triplicate exponential fed-batch fermentations were performed for both transformants over a range of 0.07 to 0.1 
h-1. Data representing cultivations at 0.03 to 0.05 h-1 represent duplicate fermentations. 
 
 
Carbon-limited exponential fed-batch production profiles controlled at µ = 0.08 h-1  
In Figure 2 the production profiles resulting from glucose-limited exponential fed-batch 
fermentations regulated at µ = 0.08 h-1 of the ‘fast-growing high-biomass producing’ 
transformant DAHB 21#20; and the ‘slow-growing high-glucoamylase producing’ 
transformant DAHB 21#40 are shown. Production profiles of biomass (Figure 2A), ln 
(biomass) (Figure 2B), biomass concentration (Figure 2C), specific extracellular 
glucoamylase activity (Figure 2D), specific intracellular HBsAg production (Figure 2E), and 
volumetric intracellular HBsAg production (Figure 2F) are shown.  
 
Figure 2G depicts the correlations between specific intracellular HBsAg production and 
specific extracellular glucoamylase activity of the two transformants. These were shown to be 
similar to the findings in Manuscript 2 of this dissertation.  The significance of the two 
correlations were confirmed through linear regression analysis, with pvalues < 0.05 of the x 
variables and intercepts at a 95 % confidence level and R2 values ≥ 0.96 explained more than 
96 % of the total variation (Figure 2E). No significant difference was observed between the 
two correlations (p > 0.05). 
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Figure 2.  Glucose-limited exponential fed-batch fermentations regulated at µ = 0.08 h-1 of two HBsAg-
producing A. niger transformants (carrying the GlaAG2::S fusion cassette and controlled by the inducible GlaAp 
promoter); ∆, ‘fast-growing high-biomass producing’ transformant DAHB 21#20; and ○, ‘slow-growing high-
glucoamylase producing’ transformant DAHB 21#40. Depicted are the production profiles of: (A) biomass, (B) 
ln (biomass), (C) biomass concentration, (D) specific extracellular glucoamylase activity, (E) specific 
intracellular HBsAg production, (F) volumetric intracellular HBsAg production. Figure 2 (G) depicts the 
correlation between specific intracellular HBsAg production and specific extracellular glucoamylase activity.  
Error bars represent the standard deviation of the mean. Triplicate exponential fed-batch fermentations were 
performed for both transformants. 
 
DISCUSSION 
In this study we assess glucose-limited exponential fed-batch fermentation as a strategy for 
the cultivation of HBsAg producing transformants in A. niger. The effects of µ on HBsAg 
production of two HBsAg producing transformants, previous identified (Manuscript 2 of this 
dissertation), were evaluated; (1) the ‘fast-growing high-biomass producing’ transformant, 
DAHB21#20, and (2) the ‘slow-growing high-glucoamylase producing’ transformant, 
DAHB21#40. Both transformants made use of the gene fusion approach, using the expression 
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vector containing the GlaAG2  carrier gene fused to the HBsAg S gene, which encouraged high 
expression of the fused cassette as well as passage of the HBsAg under the mask of a 
homologous gene product through the fungal secretory pathway (Manuscript 1 and 2 of this 
dissertation). Intracellular HBsAg production was detected in both transformants. In glucose 
batch fermentation highest intracellular HBsAg production was observed in a HBsAg-
producing A. niger transformant, with an inherently reduced µ (‘slow-growing high-
glucoamylase producing’ transformant, DAHB21#40) (manuscript 2 of this dissertation). 
Efficient processing of the heterologous protein of interest may be compromised by the 
saturation or overloading of the processing machinery caused by unfolded and/or misfolded 
proteins, which are prevented from leaving the ER (Lodish et al. 1983; Shuster 1991; Parekh 
et al. 1995; Shusta et al. 1998; Smith et al. 2004; Damasceno et al., 2007). This has led to the 
hypothesis that a reduced µ may enhance the efficiency of A. niger to synthesize and produce 
HBsAg, resulting in improved production levels. 
 
Detailed analyses of glucose-limited exponential fed-batch fermentations of the ‘fast-growing 
high-biomass producing’ and ‘slow-growing high-glucoamylase producing’ transformants 
were performed to elucidate the effects of µ on HBsAg production in A. niger . The µ studied 
(0.03–0.1 h-1) covered the range from a low µ to a rate approaching µmax of each transformant. 
Glucose-limited exponential fed-batch fermentations were successfully implemented as a 
means of controlling the µ at a constant level. Continuous fermentations are conventionally 
implemented to acquire such control, however due to the long residence times, associated wall 
growth and difficulties in obtaining homogeneity in filamentous fungi cultivations, 
exponential fed-batch fermentations were preferred. The exponential feed allowed for 
accurate µ control and a homogenous cultivation allowed for accurate dry weight 
determinations for µ verification. 
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Results of this study indicate that glucose-limited exponential fed-batch fermentation had a 
significant effect on HBsAg production in A. niger using the GlaAG2::S gene fusion approach 
and GlaAp promoter. Higher intracellular HBsAg production levels were obtained in glucose-
limited fed-batch fermentations cultivated at µ  ≈  µmax in comparison to glucose batch 
fermentations of both transformants. At a µ ≈ µmax, ‘slow-growing high-glucoamylase 
producing’ transformant fed-batch fermentations at 0.08 h-1 and ‘fast-growing high-biomass 
producing’ transformant fed-batch fermentations at 0.1 h-1 obtained increased volumetric 
HBsAg production levels of ~ 17 % and 34 %, respectively, in comparison to that obtained in 
batch fermentations (Table 1 and Manuscript 2 of this dissertation). It has been previously 
reported that under control of the inducible GlaAp promoter, glucose acts as a strong inducer 
at low concentrations but exhibits reduced induction efficiency or repression at higher 
concentrations, by carbon catabolite repression (Ruijter and Visser, 1997; Ganzlin and Rinas, 
2008). Thus glucose-limited exponential fed-batch fermentation for the current A. niger 
HBsAg production system may provide a method of ensuring high GlaAp induction efficiency 
while avoiding catabolic repression, resulting in increased HBsAg production levels.  
 
Specific growth rate had a significant effect on the ‘fast-growing high-biomass producing’ 
transformant, using the GlaAG2::S gene fusion approach, with regards to HBsAg production in 
A. niger. Maximum specific and volumetric HBsAg production levels were obtained by 
reducing the µ by 70 % (0.08 h-1) of the µmax in glucose-limited exponential fed-batch 
fermentation. Under these conditions, a 35 % increase in volumetric HBsAg production was 
measured in comparison to cultivations controlled at µ = 0.1 h-1 (µ ≈ µmax). Specific 
production of proteins has been reported to increase consistently with increasing µ, as shown 
for Fab fragment production in Pichia pastoris (Zhang et al., 2005) and β-galactosidase 
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production in Escherichia coli (Sanden et al., 2003). This protein production characteristic is 
typically observed in growth-associated product formation. For other proteins, such as HBsAg 
in P. pastoris (Cregg et al., 1987), cellobiohydrolase (Pakula et al., 2005), and laccase (Rautio 
et al. 2007) in Trichoderma reesei, specific production is highest at lower µ. It has been 
suggested that during methanol-induced expression of HBsAg from the AOX1 promoter in P. 
pastoris, a slower µ is essential for efficient HBsAg assembly (Cregg et al., 1987). This is not 
evident in HBsAg production in A. niger using the GlaAG2::S gene fusion approach, as a 
significant reduction in HBsAg production levels was observed for both transformants at 
lower µ (µ ≤ 0.05 h-1). 
 
Growth rate regulation in glucose-limited fed-batch fermentations of the ‘slow-growing high-
glucoamylase producing’ transformant did not result in similar % increases as observed in 
‘fast-growing high-biomass producing’ transformant cultivations. An insignificant increase of 
8 % (p > 0.05) in volumetric HBsAg production was observed in ‘slow-growing high-
glucoamylase producing’ transformant fed-batch fermentations cultured at µ = 0.07 h-1 in 
comparison to cultivations controlled at µ = 0.08 h-1 (µ ≈ µmax). These findings indicate that 
HBsAg production was not efficient at the intrinsic growth rate (µ = 0.1 h-1) of the ‘fast-
growing high-biomass producing’ transformant, while HBsAg processing in ‘slow-growing 
high-glucoamylase producing’ transformant at µ = 0.08  h-1 was closer to optimal.  
 
HBsAg production in relation to extracellular glucoamylase activity was most efficient for 
both transformants at 0.07 < µ < 0.08 h-1, as reflected by the ratio between maximum 
intracellular HBsAg and maximum extracellular glucoamylase. This was a significant increase 
of ~ 20 % for both transformants to that obtained in glucose batch fermentation (Manuscript 2 
of this dissertation). In glucose-limited exponential fed-batch fermentation, at lower µ (µ < 
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0.07 h-1), the ratio between maximum intracellular HBsAg and maximum extracellular 
glucoamylase was reduced. It is noteworthy that for HBsAg production in A. niger, using the 
GlaAG2::S gene fusion approach under transcriptional control of GlaAp, a directly proportional 
correlation existed between intracellular HBsAg production and extracellular glucoamylase in 
batch fermentation (Manuscript 2 of this dissertation).  Similar correlations between 
intracellular HBsAg production and glucoamylase activity were observed for both 
transformants in glucose-limited exponential fed-batch fermentations as observed at µ = 0.08 
h-1. With the decrease in µ and the associated decrease in extracellular glucoamylase, it 
appears that the processing and/ or processing efficiency of the fused glucoamylase-HBsAg 
product was reduced. However, HBsAg production was reduced at a higher rate than 
extracellular glucoamylase with the decrease in µ (µ < 0.07 h-1), as reflected by the ratio 
between maximum intracellular HBsAg and maximum extracellular glucoamylase. This could 
also suggest that at lower µ the maturation and assembly of HBsAg was affected after the 
fused protein was cleaved, resulting in  a higher proportion of immature/ unassembled HBsAg 
products in relation to correctly folded glucoamylase. It is therefore concluded that through 
glucose-limited exponential fed-batch fermentation at an optimum µ using the GlaAG2::S gene 
fusion approach, HBsAg production efficiency of both transformants was highest.  
 
The reduction in biomass and protein production levels at low specific µ was attributed to the 
maintenance requirements of the cells.  As µ was reduced, so was the specific glucose 
consumption rate. At a µ = 0.03 h-1, 0.077 gGlucose.gDW-1.h-1 and 0.083 gGlucose.gDW-1.h-1 was 
consumed for ‘fast-growing high-biomass producing’ and ‘slow-growing high-glucoamylase 
producing’ transformant fed-batch fermentations, respectively, of which the estimated ms 
formed ~ 25 and 30 % respectively of the qs. The high non-growth associated substrate 
consumption for maintenance under these conditions would potentially limit production of 
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both biomass and proteins. These limitations are reflected in the low biomass levels, 
extracellular glucoamylase activities and intracellular HBsAg production levels for both 
transformants at µ = 0.03 h-1.  
 
Intracellular HBsAg production levels were improved in glucose-limited fed-batch 
fermentation for both transformants. At optimum µ, specific HBsAg production were highest 
(251 ± 35 µgHBsAg.gDW-1) in the ‘slow-growing high-glucoamylase producing’ transformant. 
Lower specific HBsAg production levels of 241 ± 19 µgHBsAg.gDW-1 were obtained in ‘fast-
growing high-biomass producing’ transformant fermentations at optimum µ. However, due to 
higher biomass levels, volumetric HBsAg production levels were highest (4483 ± 340 
µgHBsAg.kgBroth-1) in ‘fast-growing high-biomass producing’ transformant fermentations. This 
is approximately a 1.8 fold increase in comparison to HBsAg production levels obtained in 
glucose batch fermentations (2500 µgHBsAg.LBroth-1) (Manuscript 2 of this dissertation). 
 
It is therefore concluded that due to the nature of the growth-associated HBsAg production 
through GlaAG2::S gene fusion approach under transcriptional control of GlaAp, production 
levels were highest when biomass production was optimal. Growth rate was observed to be a 
critical factor influencing HBsAg production and its efficiency in relation to extracellular 
glucoamylase activity, where highest levels were observed at a reduced and optimal µ (0.07 < 
µ <0.08 h-1).  Thus glucose-limited exponential fed-batch fermentation at an optimum µ (0.07 
< µ <0.08 h-1) for the current A. niger HBsAg production system provides a method for 
efficient HBsAg processing, resulting in increased HBsAg production levels.  
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ABSTRACT 
HBsAg production targeted through the secretory pathway in A. niger using glucoamylase-
HBsAg gene fusion resulted in limitations/ bottlenecks at a (post)translational thereby 
negatively affecting HBsAg production. This was demonstrated through the increase in 
HBsAg production levels resulting from the over-production of chaperones/ foldases. The 
over-production of CLX and PDI resulted in the highest percentage increase (88 % and 107 
%, respectively) and therefore reflected their critical involvement with regards to efficient 
HBsAg assembly using gene fusion. The combinations of BiP and associated combinations 
with CLX and PDI failed to improve HBsAg production levels. Reductions of up to 40 % 
where observed upon BiP over-production and therefore indicated unfavourable responses 
towards HBsAg assembly and production, which were triggered upon BiP over-expression 
using gene fusion. In glucose batch fermentations, transformants over-producing PDI obtained 
highest levels (305 ± 29.8 µgHBsAg.gDW-1) in comparison to CLX transformants 264 ± 32.2 
µgHBsAg.gDW-1). In glucose-limited exponential fed-batch fermentations HBsAg production 
levels in transformants over-producing CLX and PDI were enhanced to similar levels in 
comparison to batch fermentations. Highest HBsAg production levels of 352 ± 21.3 
µgHBsAg.gDW-1(6237.2 ± 437.2 µgHBsAg.kgBroth-1) and 330.2 ± 24.4 µgHBsAg.gDW-1 (5760.4 ± 
531.9 µgHBsAg.kgBroth-1) in CLX and PDI over-expressing transformants were observed. A 
significant increase in HBsAg production efficiency in relation to extracellular glucoamylase 
activity was observed in CLX cultivations at a reduced and optimized growth rate, reaching 
similar levels to PDI cultivations under similar conditions (~ 1330 µgHBsAg.U-1 and 1360 
µgHBsAg.U-1, for the CLX and PDI carbon-limited exponential fed-batch fermentations, 
respectively), and indicated the associated positive affects on HBsAg production efficiency 
through CLX over-production and cultivation at a reduced and optimum growth rate. These 
findings, together with the potential application of the solid-state glucoamylase screen for the 
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identification of high HBsAg producers over-producing chaperones/ foldases, demonstrates its 
usefulness and application as a technology for other heterologous proteins and recombinant 
VLPs. 
 
INTRODUCTION 
Filamentous fungi have a large protein production capacity and have therefore been developed 
for the industrial production of both homologous and heterologous gene products (Archer and 
Peberdy, 1997). The fungal species, Aspergillus niger, has been investigated as an alternative 
option to the commonly employed yeasts for the production of the Hepatitis B (Hep B) 
vaccine. This system is based on recombinant fused-gene expression technology which 
facilitates the recombinant production and assembly of the Hepatitis B surface antigen 
(HBsAg). The native and well secreted catalytic domain of the glucoamylase gene was fused 
to the HBsAg S gene (Plüddemann, 2003), encouraging high expression of the fused cassette 
(Le Loir et al., 2005) as well as potentially preventing intracellular proteolytic degradation by 
creating a passage through the secretory pathway for the production of the heterologous 
protein under the mask of a homologous gene product (Gouka et al., 1997; Manuscript 1 & 2 
of this dissertation). Expression of the GlaAG2::S fusion gene in these transformants resulted 
in the secretion of glucoamylase into the extracellular medium of the production host, while 
HBsAg production was localized intracellularly and was observed to be associated with the 
membraneous fraction (Manusript 1 of this dissertation). A substantial level of intracellular 
glucoamylase product degradation was also observed. A possible explanation for these 
findings can be attributed to the saturation or overloading of the processing machinery caused 
by unfolded and/or misfolded proteins, which are prevented from leaving the Endoplasmic 
reticulum (ER), as noted elsewhere in the literature (Lodish et al. 1983; Shuster 1991; Parekh 
et al. 1995; Shusta et al. 1998; Smith et al. 2004; Damasceno et al., 2007).  
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The rate and efficiency of protein folding and assembly in the ER determines the overall rate 
of transport through the secretory pathway (Hammond and Helenius 1994). In A. niger using 
the GlaAG2::S gene fusion approach, a reduced growth rate (~0.08 h-1), in glucose-limited 
exponential fed-batch fermentations, resulted in improved HBsAg production levels 
(Manuscript 3 of this dissertation). Similar observations have been reported previously (Gu et 
al., 1991; Kirk and Piper, 1994). It has been suggested that during methanol-induced 
expression of HBsAg from the AOX1 promoter in Pichia pastoris, a significantly reduced 
growth rate is essential for efficient HBsAg assembly (Cregg et al., 1987). This was not 
evident in HBsAg production in A. niger using the GlaAG2::S gene fusion approach, as a 
significant reduction in HBsAg production levels was observed at lower growth rates (≤ 0.05 
h-1). HBsAg production was therefore most efficient at a reduced and optimized growth rate 
(Manuscript 3 of this dissertation).  
 
The over-production of certain helper proteins has become a plausible strategy in enhancing 
heterologous protein production. The genes for several ER chaperones and foldases have been 
isolated from filamentous fungi; namely immunoglobulin binding protein (BiP) (van Gemeren 
et al., 1997); protein disulfide isomerase (PDI) (Jeenes et al., 1997; Ngiam et al., 2000); and a 
family of calnexins (CLX) (Conesa et al., 2002). By direct physical interaction, these helpers 
promote the correct folding of newly synthesized polypeptides and ensure that misfolded 
chains or aggregates are removed from the ER (Ellgaard and Helenius, 2003; van Anken & 
Braakman, 2005). A number of studies have analyzed the effects of altering the levels of ER 
chaperone expression on heterologous protein secretion. Harmsen et al. (1996) reported a 20-
fold increase in the amount of extracellular prochymosin when BiP was over-expressed in 
Saccharomyces cerevisiae and similarly the studies of Damasceno et al. (2007) demonstrated 
a 3-fold increase in a single-chain antibody fragment in P. pastoris. CLX over-expression 
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enhanced the levels of functional serotonin transporter produced using the baculovirus 
expression system (Tate et al., 1999).  Similarly, CLX over-expression increased manganese 
peroxidase levels in A. niger 5-fold (Conesa et al., 2002). The over-expression of PDI resulted 
in the increase in yields of acid phosphatase (4-fold) (Robinson et al., 1994), human platelet-
derived growth factor B homodime (10-fold) (Robinson et al., 1994), human 
apolipoprotein(a) KV kringle fragment (Cha et al., 2006) and beta-glucosidase in S. cerevisiae 
(Powers and Robinson, 2007), as well as an antibody Fab fragment against human 
immunodeficiency virus type 1 in P. pastoris (Gasser et al., 2007). In addition, secreted levels 
of a single-chain antibody fragment increased 2-fold when either BiP or PDI were over-
expressed, and 8-fold when both chaperones were over-expressed in yeast (Shusta et al. 
1998).  
 
In A. niger using the GlaAG2::S gene fusion approach, the positive effect of a reduced and 
optimized growth rate on HBsAg production, together with the intracellular accumulation of 
HBsAg and intracellular glucoamylase degradation products, suggests that limitations/ 
bottlenecks, at a (post)translational level in the secretory pathway, are negatively affecting 
production. In this paper we are testing the hypothesis that such limitations occur, and can be 
demonstrated by increases in HBsAg production through over-expression of chaperones/ 
foldases. The effects of over-producing the chaperones BiP and CLX, the foldase PDI, and the 
combinations thereof on the production of recombinant HBsAg are evaluated in A. niger 
expressing the GlaAG2::S gene. Three HBsAg-producing A. niger transformants, varying in 
maximum specific growth rate and specific HBsAg production, were used as hosts for 
expressing modified levels of bipA, pdiA, clxA genes and combinations thereof. 
Transformants expressing modified chaperone and foldase levels created from these three A. 
niger host strains were evaluated for intracellular HBsAg, extracellular glucoamylase activity, 
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and biomass production. To compare the strategies of growth regulated cultivations and 
modifying chaperone levels as a means of enhancing HBsAg production levels in A. niger, 
highest HBsAg producing transformants expressing modified chaperone and foldase levels 
were evaluated in batch and glucose-limited exponential fed batch fermentations. As an 
additional objective of this study the potential application of the solid-state glucoamylase 
screen using starch as a selection pressure (previously described in Manuscript 2 of this 
dissertation) for the identification of high HBsAg producers over-producing chaperones/ 
foldases, was evaluated. 
 
MATERIALS AND METHODS 
Strains and plasmids  
Three HBsAg-producing A. niger transformants previously identified (Manuscript 1 & 2 of 
this dissertation), using the gene fusion strategy, were evaluated; (1) the uridine auxotrophic 
(pyrG), protease-deficient (prtT), nonacidifying (phmA) mutant A. niger D15, DAHB19#7 
(Manuscript 1 of this dissertation), as well as (2) the ‘fast growing high biomass producing’ 
DAHB21#20 (Manuscript 2 of this dissertation), and (3) the ‘slow growing high 
glucoamylase producing’ DAHB21#40 both derived from the A. niger MGG029-∆aamA 
strain (Manuscript 2 of this dissertation). To modify the levels of BiP, CLX, PDI, and 
combinations thereof, the following plasmids were used as transforming vectors: plasmid 
pAN7-1, containing the hygromycin selection marker (Punt et al., 1987), GlaAp-bipA/hph, 
carrying the A. niger bipA gene under the control of the A. niger glucoamylase promoter 
(GlaAp) and the hygromycin selection marker, and GlaAp-clxA, and GlaAp-pdiA, under control 
of the A. niger GlaAp promoter and carrying the A. niger CLX gene (clxA) and protein PDI 
gene (pdiA), respectively (Ngiam et al., 2000; Conesa et al., 2002). 
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Fungal transformations 
Selected A. niger strains were transformed with GlaAp-bipA/hph, GlaAp-clxA (in combination 
with pAN7-1), and GlaAp-pdiA (in combination with pAN7-1) (Punt et al., 1992; Ngiam et 
al., 2000; Conesa et al., 2002), and followed the protoplasting method described by Punt and 
van den Hondel (1992), using Novozym 234 (Sigma-Aldrich). Resulting transformants were 
selected for resistance to hygromycin B (HmB) on minimal medium (MM) (Bennett and 
Lasure, 1991) containing 1.2 M sorbitol as osmotic stabiliser, 1.5 % agar (Oxoid) and 0.1 % 
(v.v-1) HmB (Punt et al., 1987).  
 
Inoculum preparation, media and cultivations 
Fungal spores were obtained from a densely conidiating culture grown on potato dextrose 
agar (PDA) at 30 oC for 120 h and harvested with physiological saline solution (NaCl, 0.9 % 
w.v-1). For high-throughput screening of fungal transformants in submerged cultivations, pre-
weighed 50 ml Falcon tubes (Falcon, Becton Dickinson, Lincoln Park, USA) where 
inoculated with spores amounting to 1×105 spores.ml−1, final volume. Cultivations were 
incubated at 30 °C on a rotary shaker (Innova 2300, New Brunswick Scientific, Edison, USA) 
at 300 rpm. Each Falcon tube represented one sample time, thus 15 replicates insured 
triplicate analysis in increments of 24 h from 48 to 144 hours. Shake flask cultures were 
inoculated with a spore concentration of 1×106 spores.ml−1. Batch fermentations were 
inoculated with a shake flask pre-culture amounting to 10 % of the fermentor’s total working 
volume. All cultivations were grown on minimal medium (MM) (Plüddemann and van Zyl, 
2003) containing 3 % (w.w-1) glucose and supplemented with 0.1 % (w.w-1) casamino acids 
(Difco), 0.8 % (w.w-1) tryptone and 0.8 % (w.w-1) yeast extract. Shake flask cultivations were 
performed in 1 L Erlenmeyer flasks (un-baffled) at 30 °C on a rotary shaker (Innova 2300, 
New Brunswick Scientific, Edison, USA) at 180 rpm. Fermentations were performed in 2 L 
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bench-top bioreactors (INFORS AG, Switzerland) with a working volume of 1.5 L. The 
fermentation temperature was maintained at 30 °C (± 0.1°C), aeration at 0.8 vvm, dissolved 
oxygen was maintained above 25  % saturation by varying impeller speed (starting rate of 150 
rpm), through a cascaded controller. The impellor speed was ramped by 200 rpm for 1 min 
every hour to reduce wall growth. pH was controlled above a value of 4 using NH4OH (25 % 
w.v-1). 
 
Exponential feed 
A growth rate of 0.08 h-1 was maintained by manipulating the exponential feed rate in 
glucose-limited exponential fed-batch fermentations. During the carbon limited exponential 
feeding phase, the mass of residual glucose in the fermentor (Ms) was maintained close to 
zero and µset was controlled by directly controlling the mass of concentrated glucose substrate 
added in the fed-batch cultivation. This approach of controlling the mass of concentrated 
glucose substrate added in the fed-batch cultivation (equation 3) while Ms ≈ 0 was used to 
regulate the production of biomass in the fermentor (equation 1) through the control of 
glucose substrate consumption by the filamentous fungi. This results in the control of the µset 
at a constant value under both transient and steady state conditions for biomass concentration 
(Martinez et al., 1998; Kim et al., 2000; Cheng et al., 2003; Sun et al., 2007; Chen et al., 2008). 
 
Biomass calculations 
The biomass produced at time 1 (Mx(t1)) was used to calculate a predicted biomass profile for a 
particular µset using the principals of equation 1 (refer to derivations in Appendix A), to 
predict the biomass production at time 2 (Mx(t2)).  
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Assuming the growth yield, YXS is constant throughout the exponential feeding phase, and 
applying the principals of equation 2 to obtain equation 3 (refer to derivations in Appendix 
A), the amount of glucose at a specific time point required for the production of biomass at 
µset, was calculated; 
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where Msf(t2) - Msf(t1) is the predicted mass of glucose required at time 2 to produce new 
biomass, Mx(t2) - Mx(t1) at µset. The mass of glucose in the fermentor (Ms) was maintained at 
approximately zero for the duration of the feeding phase, where it was assumed that Ms was 
consumed by the organism as fast as it entered the fermentor to control µset. The amount of 
glucose fed was controlled and logged by an algorithm on the fermentor digital control unit 
(DCU) which exponentially increased the pump dosage every 10 seconds according to the 
glucose profile calculated (Equation 1 & 3). This data was cross referenced gravimetrically. 
Calculations regarding the exponential feeding methodology are presented in Appendix B. 
 
Sample preparation 
For high-throughput screening of fungal transformants, samples were centrifuged (10 000 
rpm), supernatant fractionated and cell wet mass calculated. Wet mycelia was then suspended 
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in protein extraction buffer with 0.1% Triton X-100 (Plüddemann and van Zyl 2003) and 
homogenized for 1½ min at 4°C. 
 
Fermentation cultivations were sampled at intervals of 3 to 8 h. Samples containing ± 50 g of 
cultivation medium were withdrawn and biomass concentration was measured by vacuum 
filtering 25 g sample on dry and pre-weighed filters (Whatman no.1), followed by washing 
with 40 ml 0.9% (w.v-1) NaCl solution and drying to a constant weight at 105 oC for 24 to 48 
h. The remaining 25 g sample was ground to a fine powder with liquid nitrogen in a mortar 
and pestle, and an aliquot of 0.3 g mycelia powder was stored at −80 °C in a 2 ml micro-
centrifuge tube. Ground samples were suspended in protein extraction buffer with 0.1 % 
Triton X-100 (Plüddemann and van Zyl, 2003) and homogenized for 1 min at 4 °C. This was 
followed by clarification at 13 000 rpm and 4 °C. Extraction of supernatant resulted in 
samples containing total intracellular proteins including membrane-associated proteins. 
  
HBsAg concentration determination 
A “sandwich” type enzyme immunoassay based on monoclonal anti-HBsAg (HBsAg 3.0 EIA, 
Bio-Rad, Hercules, CA) was used to quantify completely assembled and properly folded 
HBsAg as per manufacturers specification. 
 
Glucoamylase Activity 
The activity of glucoamylase was measured by the method of Withers et al. (1998) using 
freshly prepared 0.1 % (v.v-1) 4-nitrophenyl-α-D-glucopyranoside (PNPG) (Sigma-Aldrich N-
1377) as substrate in 0.1 M Sodium Acetate buffer (pH 4.3). To commence the reaction, 100 
µl PNPG was added to 50 µl sample (or glucoamylase standard) in a flat bottom micro-titre 
plate and incubated for 20 min at 25 oC. The reaction was terminated by the addition of 150 µl 
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Borax (0.1 M Na2B4O7.10 H2O) solution, and absorbance at 400 nm was measured using a 
BioTek Power waveHT micro-titre plate reader (BioTek Instruments Inc., USA) referenced 
with distilled water. Background absorbance was normalized with the addition of 150 µl 
Borax solution to 50 µl sample prior to the addition of 100 µl PNPG, in a duplicate assay. The 
measured background absorbance was subtracted from the absorbance readings obtained from 
the incubated samples and converted into glucoamylase activity using a standard curve 
(Amyloglucosidase Fluka 10113). 
 
Glucose Concentration 
Glucose concentration was measured using high performance ion chromatography (HPIC) 
(CarboPac™ PA1 column, Dionex, MA, USA) and ACCUTREND Glucose strips (Roche 
Diagnostics Ltd, East Sussex, UK). 
 
RESULTS 
Transformation of chaperone and foldase constructs into A. niger strains 
To study the effect of modifying the levels of BiP, Calnexin, PDI and combinations thereof on 
the production of HBsAg by A. niger, expression cassettes containing bipA, clxA and pdiA 
genes were placed under control of the strong and regulated inducible glucoamylase promoter 
(GlaAp). Three HBsAg-producing strains expressing the GlaAG2::S gene fusion cassette were 
used as hosts for transformation: (1) A. niger D15, DAHB19#7 (Manuscript 1 of this 
dissertation), as well as (2) the ‘fast growing high biomass producing’ DAHB21#20 
(Manuscript 2 of this dissertation), and (3) the ‘slow growing high glucoamylase producing’ 
DAHB21#40 (Manuscript 2 of this dissertation). These three HBsAg-producing transformants 
were super-transformed with various combinations of GlaAp-bipA/hph, GlaAp-clxA, GlaAp-
pdiA, and pAN7-1 (Punt et al., 1992; Ngiam et al., 2000; Conesa et al., 2002).  
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Screening of HBsAg producing A. niger transformants expressing modified levels of 
chaperone and foldase gene constructs  
Transformants, 526 in number, were obtained from agar plates containing minimal medium 
and HmB. After three passages on starch, acrylamide and HmB solid state cultivations, 104 
transformants were selected, based on improved growth using starch, acrylamide and HmB as 
selection pressures (data not shown).  
 
Effect of chaperone and foldase over-expression on HBsAg production 
The 104 transformants selected in solid state cultures were screened further for increased 
HBsAg production in liquid cultivations, containing starch as carbon source. To establish the 
effects of chaperone and foldase over-expression on HBsAg production in A. niger, the 
maximum specific HBsAg production levels for all transformants over-expressing the various 
chaperones and foldases were determined. Intracellular accumulation of HBsAg was observed 
in all transformants. No extracellular HBsAg above a detection limit of 0.32 pg.ml-1 culture 
broth was detected (data not shown).  
 
Results indicated that 67 % of transformants over-expressing the BiP chaperone had a 
negative influence on HBsAg production (Figure 1) with a highest reduction of up to 40 % 
(Table 3). 33 % of transformants suggested an improvement in HBsAg production (Figure 1), 
with the highest HBsAg production levels amounting to a 17.4 % increase (Figure 2). 
However, with an average standard deviation of ± 20 % amongst all samples analysed with 
the ‘sandwich’ ELISA method, it can be concluded that there was no significant difference in 
HBsAg production between the above mentioned BiP over-producing transformant and the 
control/ parent transformant.  
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A high percentage of transformants over-producing PDI and CLX (78 % and 70 %, 
respectively) obtained similar or increased HBsAg production levels in comparison to the 
HBsAg producing parent transformants (Figure 1). Of these transformants over-producing 
PDI and CLX, 33 % and 35 %, respectively obtained HBsAg production increases ≥ 25 % 
(Figure 1). Highest HBsAg production increases in transformants over-producing PDI and 
CLX were 107 % and 88 %, respectively (Figure 2). No significant difference was observed 
between the maximum HBsAg production levels in CLX and PDI over-producing 
transformants (DAHB 21#20 PDI 7, 107 ± 23.9 % and DAHB 21#20 CLX 2, 88 ± 19.8 %), as 
indicated by the t-test for two independent samples (tobserved=0.949, pvalue = 0.443). 
 
PDI/ CLX over-producing transformants obtained a maximum HBsAg percentage increase of 
43 % (Figure 2), where 22 % of transformants over-producing PDI/CLX affected HBsAg 
production with an increase greater than 25 % (Figure 1). The co-expression of BiP/ PDI, BiP/ 
CLX and BiP/ PDI/ CLX resulted in maximum HBsAg production level increases of 19.6 %, 
29.2 %, and 18.5 %, respectively (Figure 2). In many cases over-producing the 
abovementioned chaperones in these combinations resulted in the decrease in HBsAg 
production of up to 30 % (Figure 3).  
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Figure 1: Percentage transformants, over-producing various chaperones and combinations thereof, showing; (in 
white bars) similar or increased HBsAg production levels in comparison to the parent HBsAg producing 
transformants, (in grey bars) an increase in  HBsAg production levels ≥ 25 % in comparison to the parent HBsAg 
producing transformants. Reference points of HBsAg increase are calculated from the maximum HBSAg levels 
of parent transformants DAHB 19#7, DAHB 21#20 and DAHB 21#40. Cultures were grown in 50 ml Falcon 
tubes with a 25 ml working volume. Cultures were inoculated with ±5×105 spore/ml, and incubated at 30 oC 
under shaking conditions of 300 rpm. HBsAg production was measured in increments of 24 hours from 48 to 144 
hours. Data represents 6 replicated cultivations with standard deviations less than 20 %.  
Stellenbosch University http://scholar.sun.ac.za
 185 
 
 
0
40
80
120
BiP PDI
CLX
BiP/
 PDI
BiP/
 CLX
PDI/
 CLX
BiP/
 PDI/
 CLX
Chaperone over-expressing transformants
M
ax
im
u
m
 
%
 
In
cr
ea
se
 
in
 
H
B
s
A
g 
Pr
o
du
ct
io
n
 
Figure 2: Maximum percentage HBsAg increases from transformants over-producing various chaperones and 
combinations thereof. Reference points of HBsAg increase are calculated from the maximum HBsAg production 
levels of parent transformants DAHB 19#7, DAHB 21#20 and DAHB 21#40. Data represents 6 replicated 
cultivations with standard deviations less than 20%.  
 
To determine the effect of choice of A. niger expression host with regards to chaperone and 
foldase over-expression on HBsAg production, HBsAg production levels for each host strain 
were compared. Through the over-production of BiP, CLX, PDI and combinations thereof in 
A. niger D15 19#7, highest HBsAg production increases of 41 % over-producing CLX were 
measured (Figure 3A). In comparison, 16 % of the DAHB 21#20 and DAHB 21#40 strains 
over-producing BiP, CLX, PDI and combinations thereof, obtained HBsAg production levels 
equal or higher than 41 %. In the ‘slow growing high glucoamylase producing’ DAHB 21#40 
strains over-producing BiP, CLX, PDI and combinations thereof, highest HBsAg production 
increases of 48 % over-producing PDI  were measured (Figure 3B). In comparison, 18 % of 
the ‘fast growing high biomass producing’ DAHB 21#20 strains over-producing BiP, CLX, 
PDI and combinations thereof, obtained HBsAg production levels equal or higher than 48 %. 
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Highest HBsAg production increases of 107 % in DAHB 21#20 over-producing PDI were 
recorded (Figure 3B). Statistical analysis using the t-test for two independent samples 
comparing the maximum HBsAg percentage increases of each host strain revealed a 
insignificant difference between A. niger D15 19#7 and A. niger MGG029-∆aamA DAHB 
21#20 (Pvalues > 0.05), while a significant difference was observed between A. niger MGG029-
∆aamA DAHB 21#20 and MGG029-∆aamA DAHB 21#40 (Pvalues < 0.05). 
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Figure 3: Comparison of percentage HBsAg increases between (A) chaperone over-producing transformants 
derived from A. niger D15 19#7 and A. niger MGG029-∆aamA (DAHB 21#20 and DAHB 21#40), (B) 
chaperone over-producing transformants derived from A. niger MGG029-∆aamA DAHB 21#20 and DAHB 
21#40. Reference points of HBsAg increase are calculated from the maximum HBSAg levels of parent 
transformants DAHB 19#7, DAHB 21#20 and DAHB 21#40. Data represents 6 replicated cultivations with 
standard deviations less than 20 %.  
B 
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Evaluation of intracellular HBsAg production in relation to extracellular glucoamylase 
In Figure 4 data representing the percentage changes in intracellular HBsAg production levels 
and the percentage changes in extracellular glucoamylase activity between DAHB 21#20 and 
DAHB 21#40 over-producing BiP, CLX, PDI and combinations thereof, are evaluated. Of 
these transformants 24 % obtained a percentage increase in intracellular HBsAg production 
levels ≥ 25 %. 64 % of these transformants, representing a significant increase in intracellular 
HBsAg production were observed to have a percentage increase in extracellular glucoamylase 
acitivity ≥ 25 %. The significance of the correlation between the percentage changes in 
intracellular HBsAg production levels and the percentage changes in extracellular 
glucoamylase activity was  confirmed through linear regression analysis (pvalue < 0.05), where 
an R2 value = 0.66 explained 66 % of the total variation (Figure 4). 
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Figure 4: Percentage changes in intracellular HBsAg in relation to percentage changes in extracellular 
glucoamylase activity between DAHB 21#20 and DAHB 21#40 over-producing BiP, CLX, PDI and 
combinations thereof. Data represents 6 replicated cultivations with standard deviations less than 20 %. 
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Batch fermentation of two highest HBsAg producing transformants 
From the liquid culture screen, two high HBsAg producing transformants were identified; the 
A. niger MGG029-∆aamA DAHB 21#20 strain expressing CLX and PDI (DAHB 21#20 PDI 
7 and DAHB 21#20 CLX 2). To evaluate and compare the performance of the two high 
HBsAg producing transformants, triplicate batch fermentations were conducted. Results are 
summarized in Table 1. A carbon substrate of 3 % glucose in a rich media was used for 
cultivation to ensure rapid offline analysis of carbon consumption. Similar biomass 
concentration profiles were observed between transformants, with the CLX obtaining the 
highest at 17.43 ± 0.73 gDW.kgBroth-1 and a maximum growth rate of 0.098 ± 0.009 h-1, while 
PDI fermentations obtained maximum biomass levels of 16.6 ± 1.3 gDW.kgBroth-1 and a 
maximum growth rate of 0.106 ± 0.007 h-1. Similar glucose consumption rates (data not 
shown) and biomass yield coefficients (YXS), were also observed (YXS ‘CLX’ = 0.55 ± 0.025 
gDW.gGlucose-1 and YXS ‘PDI’ = 0.56 ± 0.018 gDW.gGlucose-1; Table 1). Glucoamylase for both 
cultures were observed to be secreted, and reached maximum levels of 0.21 ±0.024 U.gDW-1 in 
CLX fermentations and 0.23 ±0.019 U.gDW-1 in PDI fermentations. Highest HBsAg 
production levels were observed in PDI fermentations (305 ± 29.8 µgHBsAg. gDW-1) while CLX 
fermentations levels obtained maximum levels of 264 ± 32.2 µgHBsAg. gDW-1. Similarly to the 
liquid screening cultivations, no extracellular HBsAg was detected. Linear correlations 
between intracellular HBsAg and extracellular glucoamylase activity, with R2values ≥ 0.87 were 
observed in the two GlaAG2::S transformants during the exponential growth phase in glucose 
batch fermentation (data not shown). The ratio between maximum intracellular specific 
HBsAg production and maximum extracellular specific glucoamylase activity was higher in 
PDI cultivations, where levels of 1326.1 ± 117.9 µgHBsAg.U-1 were observed. In CLX 
cultivations a ratio of 1257.1 ± 134.4 µgHBsAg.U-1 was recorded (Table 1). 
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Table 1: Performance of HBsAg-producing A. niger strains over-producing CLX and PDI in glucose based batch fermentations. 
A. niger strains Growth rate 
[h-1] 
Maximum 
Biomass 
[gDW.kgBroth-1] 
Yxs 
[gDW.gGlucose-1] 
Maximum 
Glucoamylase 
[U.gDW-1] 
Maximum HBsAg 
[µgHBsAg. gDW-1] 
Intracellular HBsAg/ extracellular 
glucoamylase ratio 
[µgHBsAg. U-1] 
       
A. niger 
MGG029-∆aamA 
DAHB 21#20 CLX 2 
0.098 ± 0.009 17.43 ± 1.0 0.55 ± 0.025 0.21± 0.024 264 ± 32.2 1257.1 ± 134.4 
 
      
A. niger 
MGG029-∆aamA 
DAHB 21#20 PDI 7 
0.106 ± 0.007 16.61 ± 1.3 0.56 ± 0.018 0.23 ± 0.019 305 ± 29.8 1326.1 ± 117.9 
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Growth regulated, glucose-limited exponential fed-batch fermentations of two highest HBsAg 
producing transformants 
To determine the effects of growth rate on HBsAg production in transformants over-
producing CLX and PDI, carbon-limited exponential fed batch fermentations were conducted. 
Triplicate fed-batch cultivations were performed at a growth rate of 0.08 h-1. The exponential 
feed rate was calculated on the initial biomass produced after an initial glucose charge of 10 
g.kg-1 culture medium was exhausted. Upon depletion (between 19 and 20 h) of the initial 
glucose the exponential feed was executed and was stopped after biomass levels ceased to 
increase and residual glucose accumulation was observed. Thereafter, fermentations were 
monitored and sampled for an additional 10 h before the run was stopped.  In all cultivations 
during the exponential feeding phase the residual glucose concentration was controlled below 
the detection limit of 5 mmol.lbroth-1.  
 
Similar biomass concentration profiles were observed between transformants, with the CLX 
obtaining the highest at 18.19 ± 1.4 gDW.kgBroth-1, while PDI fermentations obtained maximum 
biomass levels of 18.59 ± 1.6 gDW.kgBroth-1 (Figure 5C). Growth rates, calculated from total 
biomass data (Figure 5A), of 0.079 ± 0.02 and 0.075 ± 0.01  h-1 were calculated for CLX and 
PDI fermentations, respectively, and were noted to be similar to that of the required rate of 
0.08 h-1(Figure 5B). Similar biomass yield coefficients (YXS), were also observed (~ 0.56 
gDW.gGlucose-1) (data not shown). Extracellular glucoamylase activity profiles followed a 
growth associated trend (Figure 5D), with the highest levels obtained of 0.26 ±0.023 U.gDW-1 
and 0.24 ±0.022 U.gDW-1 in the CLX and  PDI over-expressing transformants, respectively. 
Similar to the extracellular glucoamylase activity profiles, intracellular HBsAg production 
levels also followed a growth associated trend with the highest levels occurring after ~ 52 h 
(Figure 5E). The CLX over-expressing transformant achieved highest specific levels of 352 ± 
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21.3 µgHBsAg.gDW-1, while the PDI over-expressing transformant obtained levels of 330.2 ± 
24.4 µgHBsAg.gDW-1. Highest volumetric HBsAg production levels were 6237.2 ± 437.2 
µgHBsAg.kgBroth-1 and 5760.4 ± 531.9 µgHBsAg.kgBroth-1 in CLX and PDI over-expressing 
transformants, respectively (Figure 5F). Similarly to batch fermentations, no extracellular 
HBsAg was detected (data not shown). A linear correlation between intracellular specific 
HBsAg production and extracellular specific glucoamylase activity was observed in both 
CLX and PDI over-expressing fermentations (Figure 5G). 
The significance of the two correlations were confirmed through linear regression analysis, 
with pvalues < 0.05 of the x variables and intercepts at a 95 % confidence level and R2 values ≥ 
0.90 explained more than 90 % of the total variation (Figure 5E). No significant difference 
was observed between the two correlations (p > 0.05). From Figures 5B and 5 C, the ratio 
between the maximum intracellular HBsAg production levels and maximum extracellular 
glucoamylase activity were similar, at ~ 1330 µgHBsAg.U-1 and 1360 µgHBsAg.U-1, for the CLX 
and PDI carbon-limited exponential fed-batch fermentations, respectively. 
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Figure 5. Glucose-limited exponential fed-batch fermentations of A. niger at a growth rate of 0.08 h-1: Shown is 
data regarding two HBsAg-producing A. niger MGG029-∆aamA transformants (carrying the GlaA::S fusion 
cassette and controlled by the inducible GlaAp promoter); □, CLX over-expressing transformant DAHB 21#20 
CLX2; and ○, PDI over-expressing ‘transformant DAHB 21#20 PDI7. Depicted are the effects of specific µ data 
on: (A) Dry biomass, (B) ln (biomass), (C) biomass concentration, (D) specific Glucoamylase activity, (E) 
specific HBsAg production, (F) volumetric HBsAg production, and (G) the ratio between intracellular HBsAg 
and extracellular glucoamylase activity.  Error bars represent the standard deviation of the mean.  Triplicate 
exponential fed-batch fermentations were performed for both transformants. 
 
DISCUSSION 
Previously described in this dissertation, HBsAg production was realized by targeting HBsAg 
production through the secretory pathway in A. niger, resulting in completely assembled and 
properly folded HBsAg (Manuscript 1 of this dissertation). This was achieved by 
implementing a gene fusion strategy using the highly expressed catalytic domain of the 
glucoamylase gene (GlaAG2) fused to the HBsAg S gene. This has the advantage of 
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encouraging high expression of the fused cassette (Le Loir et al., 2005) as well as passage of 
the target protein under the mask of a homologous gene product through the fungal secretory 
pathway (Gouka et al., 1997). Expression of the GlaAG2::S fusion gene in A. niger 
transformants resulted in the intracellular accumulation of HBsAg associated with the 
membranous fraction. Glucoamylase was secreted from the production host, although with a 
substantial level of intracellular glucoamylase product degradation (Manusript 1 of this 
dissertation). These findings together with the positive effect of a reduced and optimized 
growth rate on HBsAg production as observed in Manuscript 3 of this dissertation, suggests 
that limitations/ bottlenecks, at a (post)translational level in the secretory pathway, are 
negatively affecting production. This has led to the hypothesis that such limitations occur in 
the current A. niger system, and can be demonstrated by increases in HBsAg production 
through the over-production of BiP, CLX, PDI, and the combinations thereof. In this study we 
explore the effects of over-production of BiP, CLX, PDI, and the combinations thereof as a 
means of reducing the speculated bottlenecks in the secretory pathway and therefore enhance 
HBsAg production. 
 
The over-production of BiP, CLX, PDI, and the combinations thereof significantly influenced 
HBsAg production efficiency through the expression of the GlaAG2::S fusion gene. HBsAg 
production levels were enhanced by up to 107 %, and in other cases were even reduced by 40 
%. These findings reflect the varied responses in HBsAg production resulting through the 
over-production of these chaperones/ foldases.  Furthermore, significant variance in HBsAg 
production levels was observed amongst chaperones over-expressing transformants carrying 
similar chaperone gene products. This was attributed to vector copy number (Verdoes et al., 
1994) and/ or site of integration (Verdoes et al., 1993). However, the maximum percentage 
increase in HBsAg production levels over-expressing the various chaperones/ foldases reflects 
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the capability of these chaperones/ foldases in facilitating HBsAg production through the 
secretory pathway when over-produced correctly and at an optimum amount. 
 
The over-production of CLX, PDI, and combinations thereof significantly increased HBsAg 
levels by 88 %, 107 %, and 43 %, respectively. These findings suggest that the functions of 
CLX and PDI in the secretory pathway may be critical for efficient HBsAg production using 
the GlaAG2::S fusion gene.  
CLX is glycan-dependent molecular chaperone and is a major component of the ER quality 
control system. CLX has several intracellular functions; (1) facilitates the folding of 
glycosylated protein by slowing folding events and allowing them to occur in a controlled 
manner (Helenius et al., 1997; Conesa et al., 2002), (2) retains immature or unassembled 
structures in the ER, (3) prevents aggregation, and (4) potentially aids in the sorting of 
malformed substrates for degradation (Pearse and Hebert, 2009). The positive effect of CLX 
over-expression on HBsAg production suggests its participation in the maturation of HBsAg . 
The fact that CLX potentially stabilizes protein folding by slowing folding events, allowing 
them to occur in a controlled manner, may be a significant attribute which may also explain 
the increase in HBsAg production levels at a reduced and optimized growth rate as observed 
in Manuscript 2 of this dissertation. 
The foldase, PDI, from the thioredoxin superfamily, is known to be an essential protein that 
catalyzes the oxidation, reduction, and isomerization of disulfide bonds (Laboissiere et al., 
1995; Wilkinson and Gilbert 2004). PDI behaves as a chaperone as it inhibits the aggregation 
of misfolded proteins (Gilbert, 1997; Wang, 1998; Ferrari and Soling, 1999). HBsAg is a 
conformational antigen which is critically dependent on disulfide bonds between cysteine 
groups in HBsAg (Mangold et al., 1997). Thus, the increase in HBsAg production levels 
Stellenbosch University http://scholar.sun.ac.za
 199 
 
caused by the over-expression of PDI could induce increased levels of disulfide bond 
formation activity between inter or intra-molecules of HBsAg (Kim et al. 2009). 
 
HBsAg-producing transformants over-expressing the bipA gene did not significantly improve 
HBsAg levels.  In fact, HBsAg production was reduced in a high percentage of transformants 
(67 %) where a reduction in HBsAg production of up to 40 % was observed. Similar results 
have been reported, where over-expression of the bipA gene failed to improve production 
levels of fungal cutinase in A. niger (van Gemeren et al., 1998), and significantly reduced 
manganese peroxidase levels in A. niger (Conesa et al., 2002). These reports are contradictory 
to previously reported studies (Harmsen et al., 1996; Shusta et al. 1998; Damasceno et al., 
2007). The variety in results could be attributed to the multi-functionality of the BiP 
chaperone as well as the inherent characteristics of the recombinant gene product of interest. 
BiP is classified as an Hsp70 class heat shock protein and is involved in several functions in 
the ER: (1) assists in protein folding, (2) is involved in translocation, and (3) assists in the ER-
associated degradation (ERAD) pathway (Brodsky et al., 1999; Gething, 1999; Matlack et al., 
1999). The inherent characteristics of the recombinant GlaAG2::S fused gene product can 
potentially be sensitive or unresponsive to the above mentioned functions.  
 
Molinari et al. (2002) observed a sequential involvement of the CLX and BiP/PDI chaperone 
systems in mammalian cells. CLX bound to newly synthesized proteins and thus facilitated 
folding as well as prevented aggregation and premature degradation. BiP and PDI were also 
involved in this phase, but were also essential in directing terminally misfolded proteins, after 
their release from CLX, for degradation in the ERAD pathway (Molinari et al., 2002). A 
similar synergistic effect between BiP and PDI was reported by (Shusta et al., 1998). 
However, the joint over-expression of bipA, clxA, pdiA and combinations thereof did not 
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result in a significant increase in HBsAg production levels. Similar results were observed in 
the study of Damasceno et al. (2007) where the joint over-expression of BiP and PDI failed to 
improve the production of a single-chain antibody fragment in P. pastoris (Damasceno et al. 
2007). Assuming that BiP, PDI and CLX have similar functions in A. niger as in in 
mammalian cells, together, with the fact that the joint over-expression of bipA, pdiA, clxA and 
combinations thereof resulted in an insignificant increase in HBsAg production levels, while 
the joint over-expression of pdiA and clxA genes resulted in a 43 % increase, suggests that 
unfavorable responses are triggered upon BiP over-expression resulting in the failure to 
improve HBsAg production levels. Furthermore, the fact that in some cases a reduction in 
HBsAg production levels was observed upon BiP over-expression may indicate that BiP has a 
pronounced function in directing premature HBsAg for degradation in the ERAD pathway. 
 
The over–production of the chaperones/ foldases improved the production efficiency of 
glucoamylase-HBsAg product by either facilitating the expression and production of 
glucoamylase-HBsAg, glucoamylase, or HBsAg. Highest percentage increases in HBsAg 
were observed when both intracellular HBsAg and extracellular glucoamylase activity were 
improved significantly. These findings together with the substantial level of intracellular 
glucoamylase product degradation observed (Manusript 1 of this dissertation) and high 
expression levels of the GlaAG2::S gene observed in the study of Plüddemann, (2003) suggest 
that limitations in the secretory pathway occur at a posttranslational level before the cleavage 
of the fused glucoamylase-HBsAg product. 
 
The choice of strain together with the inherent characteristics of the product of interest are 
critical factors contributing towards product yield, as noted by Punt et al., 1998; Tate et al., 
1999; Ngiam et al., 2000; Wang and Ward 2000; Conesa et al., 2001. In this study, highest 
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percentage increases in HBsAg production levels through the over-production of chaperones/ 
foldases were obtained from transformants produced from the ‘fast growing, high biomass 
producing’ transformant (DAHB 21#20) derived from A. niger strain, MGG029-∆aamA. 
These findings together with the improved HBsAg production levels obtained through a 
reduced and optimized growth rate in carbon-limited exponential fed-batch fermentations, it is 
speculated that limitations/ bottlenecks, in the secretory pathway, were significant in the ‘fast 
growing, high biomass producing’ transformant (DAHB 21#20) in comparison the ‘slow 
growing high glucoamylase producing’ (DAHB 21#40) and A. niger D15 transformants. 
However, further studies are required to confirm this by define the processing mechanisms of 
HBsAg using gene fusion, the limitations/ bottlenecks in the secretory pathway, and other 
complex processes influencing production efficiency, including the UPR/ ERAD responses 
and chaperone interactions. The use of fluorescent proteins as a carrier protein for HBsAg 
production, together with microscopy and ‘omics’ technologies may provide the necessary 
information required to unravel these mysteries of the A. niger secretory pathway.   
 
It has previously been reported that a reduced and optimized growth rate has a positive affect 
on HBsAg production levels (Manuscript 3 of this dissertation). The positive affect of CLX 
on HBsAg production levels is possibly explained in the ability to stabilize protein folding by 
slowing folding events (Helenius et al., 1997; Conesa et al., 2002) and therefore a synergestic 
effect between growth rate and CLX facilitation on the fused GlaAG2::S gene may be 
apparent. In glucose batch fermentations, transformants over-producing PDI obtained highest 
levels (305 ± 29.8 µgHBsAg.gDW-1) in comparison to CLX transformants 264 ± 32.2 
µgHBsAg.gDW-1). The intracellular HBsAg production efficiency in relation to extracellular 
glucoamylase activity was highest in PDI batch fermentations as reflected by the ratio 
between maximum intracellular HBsAg production levels and maximum extracellular 
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glucoamylase activities. In glucose-limited exponential fed-batch fermentations HBsAg 
production levels in transformants over-producing CLX and PDI were enhanced to similar 
levels in comparison to batch fermentations. Highest HBsAg production levels of 352 ± 21.3 
µgHBsAg.gDW-1(6237.2 ± 437.2 µgHBsAg.kgBroth-1) and 330.2 ± 24.4 µgHBsAg.gDW-1 (5760.4 ± 
531.9 µgHBsAg.kgBroth-1) in CLX and PDI over-expressing transformants were observed. A 
significant increase in HBsAg production efficiency in relation to extracellular glucoamylase 
activity was observed in CLX cultivations at a reduced and optimized growth rate in 
comparison to batch fermentations, reaching similar levels to PDI fed-batch fermentations (~ 
1330 µgHBsAg.U-1 and 1360 µgHBsAg.U-1, for the CLX and PDI carbon-limited exponential fed-
batch fermentations, respectively). These findings signify the associated positive affects on 
HBsAg production efficiency through CLX over-production and cultivation at a reduced and 
optimum growth rate.  
 
As an additional objective of this study we evaluate the potential use of the solid state 
screening method selecting for high extracellular glucoamylase previously described in 
Manuscript 2 of this dissertation. In this dissertation (Manuscript 2), selecting for high 
extracellular glucoamylase producing transformants in solid state cultivation using starch as a 
selection pressure resulted in the selection of high intracellular HBsAg producing 
transformants. This method of selection was not implemented in this study as a starch 
selection pressure was less sensitive to the A. niger D15 transformants producing native 
amylases. This strategy may have been implemented with the A. niger MGG029-∆aamA 
transformants lacking native glucoamylase and acid amylase. However, it was hypothesized 
that in cases where only glucoamylase or HBsAg production was improved through the over–
production of chaperones/ foldases, the use of the glucoamylase screen would result in either 
false positive or masked results, thereby reducing the overall efficiency of the screen. 
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However, results indicate that by selecting for a percentage increase in extracellular 
glucoamylase activity ≥ 25 %, a high efficiency of transformants (72 %) manifesting 
improved HBsAg production levels of ≥ 25 % was obtained. These findings, together with the 
acceptable correlation between solid state and liquid cultures (Manuscript 2 of this 
dissertation), suggests the suitable application of the solid state screening method selecting for 
high extracellular glucoamylase for the identification of high HBsAg producers resulting from 
the over–production of chaperones/ foldases. 
 
It can therefore be concluded that by targeting HBsAg production through the secretory 
pathway in A. niger using the gene fusion approach limitations/ bottlenecks at a 
(post)translational level become evident, negatively affecting HBsAg production. This was 
demonstrated through the increase in HBsAg production levels resulting from the over-
production of chaperones/ foldases. The over-production of CLX and PDI resulted in the 
highest percentage increase and therefore reflects their critical involvement with regards to 
efficient HBsAg assembly using gene fusion. Further investigation is required to determine 
optimum copy number and site of integration of these chaperones/ foldases, where site 
directed integration of these genes may result in further improved production levels. The 
kinetic and specificity of these interactions may also contribute significantly towards the 
knowledge of the overall mechanism of HBsAg expression and assembly using gene fusion.  
The associated positive effects of CLX over-production and cultivation at a reduced and 
optimized growth rate also requires further investigation, where a continuous cultivation using 
starch as a selection pressure at a reduced and optimum dilution rate may provide a platform 
for enhanced extracellular activity and associated intracellular HBsAg production levels. The 
potential application of the glucoamylase screen using starch as a selection pressure for the 
identification of high HBsAg producers over-producing chaperones/ foldases, together with 
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the positive affects of PDI, CLX and growth rate on HBsAg production, demonstrates its 
usefulness and application as a technology for other heterologous proteins and recombinant 
VLPs. 
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CONCLUSIONS & FUTURE PROSPECTS 
This study serves as a proof-of-concept that by targeting HBsAg production through the 
secretory pathway in A. niger through gene fusion, completely assembled and properly folded 
HBsAg, is obtained. Gene fusion of the highly expressed catalytic domain of glucoamylase 
fused to the HBsAg S gene, resulted in the secretion of glucoamylase, while, similar to other 
recombinant microbial systems, HBsAg accumulated intracellularly in membrane associated 
fractions (Manuscript 1 of this dissertation). These findings together with (1) the intracellular 
accumulation of intracellular glucoamylase degradation products (2) the positive affects of a 
reduced and optimized growth rate on HBsAg production and (3) the increases in HBsAg 
production through over-expression of chaperones/ foldases, suggests that limitations/ 
bottlenecks in the secretory pathway using gene fusion as a ‘stand alone’ technology, are 
negatively affecting production. These limitations or inefficiencies in HBsAg production 
using the gene fusion approach can be reduced, thereby enhancing HBsAg production, by 
incorporating the following technologies described in this dissertation;  
 
1. Improved selection of high HBsAg producing transformants using starch as a selection 
pressure and extracellular glucoamylase to indirectly quantify HBsAg production 
levels (Manuscript 2 of this dissertation) 
The successful enhancement of HBsAg production levels was largely based on the 
development of effective transformants. This was achieved through the development of an 
improved methodology using the gene fusion technology to identify and select high HBsAg 
producing transformants (Manuscript 2 of this dissertation). The high efficiency obtained 
through selecting for high extracellular glucoamylase transformants and the associated 
correlation between intracellular HBsAg production and secreted glucoamylase in batch 
fermentation reflects the ability of the glucoamylase screen to indirectly quantify high HBsAg 
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producing transformants through extracellular glucoamylase determination. This system was 
shown to be robust and allowed for high-through put screening of several hundred 
transformants. In principle, this method can be applied to any heterologous protein that is 
secreted as a fusion with the glucoamylase protein in A. niger MGG029-∆aamA transformants 
lacking native glucoamylase and acid amylase. 
 
2. A reduced and optimum growth rate through glucose-limited exponential fed-batch 
fermentations (Manuscript 3 of this dissertation) 
The development of glucose-limited exponential fed-batch fermentations for the controlled 
culturing of HBsAg producing A. niger transformants had a positive affect on HBsAg 
production (Manuscript 3 of this dissertation). HBsAg production levels using this approach 
were increased 1.8 fold in comparison to batch fermentations. Thus glucose-limited 
exponential fed-batch fermentation at an optimum µ (0.07 < µ <0.08 h-1) for the current A. 
niger HBsAg production system provides a method for efficient HBsAg processing, resulting 
in increased HBsAg production levels.  
 
3. Modifying the chaperone/ foldase levels  
By modifying the levels of chaperones/ foldases in HBsAg producing transformants, HBsAg 
production was affected (Manuscript 4 of this dissertation). The over-production of CLX and 
PDI resulted in the highest percentage increase (88 % and 107 %, respectively) and therefore 
reflected their critical involvement with regards to efficient HBsAg assembly using gene 
fusion. The combinations of BiP and associated combinations with CLX and PDI failed to 
improve HBsAg production levels. Reductions of up to 40 % where observed upon BiP over-
production and therefore indicated unfavorable responses towards HBsAg assembly and 
production, which were triggered upon BiP over-expression using gene fusion.  
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The integration of these approaches together with the gene fusion strategy into A. niger 
resulted in the significant increase in HBsAg production as summarized in Table 1. 
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Table 1: Approaches and associated intracellular HBsAg production levels in A. niger. Values represent the maximum volumetric intracellular 
HBsAg production levels obtained in each approach evaluated. 
 
Strategy Strain Specific intracellular 
HBsAg production 
[µgHBsAg.gDW-1] 
Volumetric intracellular 
HBsAg production 
[µgHBsAg.kgBroth-1] 
Gene fusion* A. niger D15 34 297 
Strain selection* A. niger MGG029-aamA strain (slow-growing high 
glucoamylase producing transformant) 
77 712 
Strain selection  incorporating 
modified chaperone/ foldase levels* 
A. niger MGG029-aamA strain (fast-growing high 
biomass producing transformant) over-producing PDI 
108 1049 
Batch fermentation A. niger MGG029-aamA strain (slow-growing high 
glucoamylase producing transformant) 
219 3140 
Carbon-limited exponential fed-
batch fermentation 
A. niger MGG029-aamA strain (fast-growing high 
biomass producing transformant)  
241 4483 
Batch fermentation incorporating 
modified chaperone/ foldase levels 
A. niger MGG029-aamA strain (fast-growing high 
biomass producing transformant) over-producing PDI 
305  5102 
Carbon-limited exponential fed-
batch fermentation incorporating 
modified chaperone/ foldase levels 
A. niger MGG029-aamA strain (fast-growing high 
biomass producing transformant) over-producing CLX 
352 6237 
* Shake flask cultivation using starch as carbon source 
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Further improvement in HBsAg production yields may be obtained by implementing the 
following approaches: 
 
Holistic approaches that will define the processing mechanisms of HBsAg using gene fusion, 
the limitations/ bottlenecks in the secretory pathway, and other complex processes influencing 
production efficiency, including the UPR/ ERAD responses and chaperone interactions. The 
use of fluorescent proteins as a carrier protein for HBsAg production may provide the 
necessary information required to unravel the mysteries of the A. niger secretory pathway.  
Not only can these technologies be used to study protein trafficking under different 
conditions, but they have also been of use in elucidating the relationships between different 
organelles in a noninvasive manner. The use of multiple different fluorochromes allows the 
observation of interactions between organelles and between proteins. The ‘omics’ 
technologies will also provide a platform through the overall analysis of gene expression 
(transcriptomics), protein (proteomics) and metabolite (metabolomics) production at the level of 
the complete organism.  Together with advanced microscopy technologies, and fluorescent 
proteins as a carrier protein for HBsAg production, these technologies will add value in 
visualizing metabolic pathways and protein–protein interactions in living systems and hence 
direct research towards further strategies to improve HBsAg protein production levels.  
 
Investigations regarding the optimum copy number and site of integration of the HBsAg fused 
gene and chaperones/ foldases may also provide  significant information contributing towards 
site directed gene transfer techniques, which may lead to improve HBsAg protein production 
levels. 
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A mutagenesis-based selection program with classical genetic strain improvement coupled to 
the extracellular glucoamylase screen may provide a selection of host strains manifesting 
increased HBsAg production and efficient processing. 
 
As already mentioned, glucose-limited exponential fed-batch proved to be a suitable 
cultivation strategy inducing high HBsAg production levels. However in Manuscript 2 it was 
shown that through the transcriptional control of the GlaAp promoter, starch as a carbon 
substrate and its degradation products induced highest specific HBsAg production levels. 
Despite highest HBsAg production levels in starch based fermentation, the accumulation of 
residual glucose remains a challenge as this coincided with the reduction in extracellular 
glucoamylase activity and HBsAg production mid-way through the exponential phase. The 
phenomenon of residual glucose accumulation indicates that the rate of starch hydrolysis is 
greater than glucose consumption of the host organism. In order to further enhance HBsAg 
production levels of this system in starch based cultivations, a possible solution would be to 
implement a continuous or fed batch fermentation, where the rate of starch hydrolysis can be 
equilibrated with glucose consumption. Another possible solution would be to use the 
constitutive A. nidulans glyceraldehyde-3-phosphate dehydrogenase (gpdA) promoter to 
control transcription. However, if the rate of starch hydrolysis and glucose consumption by 
the organism is not maintained using starch as a carbon substrate, the residual glucose 
concentration will accumulate and limitations in the form of catabolic repression may appear. 
 
To determine the effectiveness of this technology and the HBsAg production levels required 
for this process to be economically viable, the following studies are required:  
Immunogenic studies in animals to benchmark results to those acquired in other microbial 
systems. 
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Conceptual process designs and scale-up studies as well as cost assessments to determine the 
production costs and product prices. 
 
This study has clearly shown that the filamentous fungus Aspergillus is an effective 
alternative host for the production of HBsAg. The knowledge gained from this dissertation 
has contributed not only towards further developing A. niger as an expression host for 
heterologous protein production, but also to the VLP technology in which it is expressed.  
With further knowledge of the processing mechanisms of HBsAg as well as studies 
investigating HBsAg production efficiency, HBsAg production levels will potentially improve 
further. This is an exciting venture, as this work paves the way for the investigation of 
Aspergillus as a potential host for the heterologous production of proteins from viruses such 
as HIV-1, HPV and rotavirus for the development of subunit vaccines to address the 
increasing health risk posed by these viruses, especially in Africa.   
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APPENDIX A 
EXPONENTIAL FED-BATCH BIOMASS AND FEED EQUATION DERIVATIONS 
 
In the exponential fed-batch cultivations the concentration of residual glucose in the fermentor, during 
the carbon limited exponential feeding phase, was maintained close to zero and the set growth rate 
(µset) was controlled by directly controlling the amount of concentrated glucose substrate added in the 
fed-batch cultivation. This approach of controlling the amount of concentrated glucose substrate added 
in the fed-batch cultivation (equation 3), while glucose residual concentration was maintained at zero, 
was used to regulate the production of biomass in the fermentor through the control of glucose 
substrate consumption by the filamentous fungi. This results in the control of the µset at a constant 
value under both transient and steady state conditions for biomass concentration (Martinez et al., 1998; 
Kim et al., 2000; Cheng et al., 2003; Sun et al., 2007; Chen et al., 2008). 
 
The equations for the carbon limited exponential feeding phase are derived from first principal mass 
balances. 
 
Biomass balance 
 
A biomass balance over the fed-batch bioreactor yields: 
            
          Equation 1. 
 
          Equation 2. 
 
          Equation 3. 
 
 
x
x VC
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dVC
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          Equation 4. 
 
which upon rearrangement using the principal that 1/X = d(lnX)/dX results in: 
 
          Equation  5. 
 
where µ
 
is the specific growth rate (h-1), V is the fed-batch reactor culture volume (L), and Cx 
is the biomass concentration (gDW.L-1).  
 
The dilution rate D (h-1) therefore equates to:  
 
          Equation  6. 
 
And upon rearrangement of Equation 5 & 6, Equation 7 describes the general condition for µ 
using (Ramfrez et al., 1994). 
 
          Equation 7. 
 
Equation 7 can be simplified to Equation 12 by applying the following derivation:  
 
          Equation 8. 
 
However,         Equation 9. 
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Where Mx is the total biomass (gDW) in the fed-batch reactor. Therefore from Equation 8 and 
Equation 9; 
          Equation 10. 
 
And from equation 9, 10 and 2, Equation 11 is obtained. 
 
          Equation 11. 
 
Upon re-arrangement of Equation 11, Equation 12 describes the general condition for µ using Mx. 
 
          Equation 12. 
 
Equation 12 is therefore a simplified equivalence to Equation 7, where 
dt
Md x )(ln
 in Equation 12 
incorporates both D and 
dt
Cd x )(ln
 term in Equation 7 (refer to Equation 13) and is the general 
equation used to measure µ at µset. 
           
Equation 13. 
 
 
Glucose substrate balance 
 
The glucose substrate balance yields; 
 
Equation 14. 
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Where Cs is the glucose substrate concentration in the reactor, Vsf is the volume of the feed 
added to the reactor, Csf is the concentrated glucose substrate concentration in the feed and qs 
is the specific glucose consumption rate (gGlucose.gDW-1.h-1).  
 
Using the principals of Equation 9; 
 
Equation 15. 
 
Where Ms is the glucose substrate mass in the reactor, and Msf is the mass of the feed added to 
the reactor. 
 
In glucose-limited exponential fed batch cultivations when a variable glucose exponential feed 
(concentrated) is implemented to maintain a µset  ≤ µmax, the mass of the glucose substrate in 
the reactor must be equal to zero upon commencement of the feed  and must remain so for the 
entire feeding phase, with the assumption that Ms is consumed by the organism as fast as it 
enters the reactor. This was confirmed for all cultivations (Dissertation, Manuscript 3, line 18 
& 19, pg 148). Therefore, 
 
Equation 16. 
 
And from Equation 14, Equation 17 and 18 is achieved; 
 
   and      Equation 16. and Equation 17.
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Therefore to determine the amount of glucose required for the exponential growth of Mx, 
dividing Equation 11 by Equation 17 yields; 
 
Equation 18. 
 
Where Yxs (gDW.gglucose-1) is the biomass yield coefficient. Therefore the amount of Msf at time 
t2 required for Mx at time t2 at a controlled µ is; 
 
Equation 19. 
 
And Mx(t2) is derived from equation 12; 
 
)(
)1()2(
12 tt
txtx
seteMM −= µ
       Equation 20. 
 
Where Mx(t2) can be predicted assuming biomass production at µset. 
 
And by combining equation 20 into equation 19 yields; 
 
          Equation 21. 
 
Equation 21 is the general equation used for determining the mass of concentrated glucose 
feed required for consumption to produce the desired mass of biomass and therefore control µ 
at µset and Equation 12 is the general equation used to measure µ at µset. 
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APPENDIX B 
 
EXPONENTIAL FED-BATCH METHODOLOGY AND TYPICAL CALCULATIONS 
 
In this section an account of the application of the methodology described in Appendix A, to 
determine the exponential glucose feed so as to control µset, to experimental fed-batch cultures 
is provided. Experimental data discussed here represents data shown in Manuscript 3 
regarding glucose limited exponential fed batch cultivations of the fast growing high biomass 
producing transformant DAHB21#20 at the set specific growth rate (µset) = 0.08 h-1. 
 
The exponential fed-batch cultivations comprised of two phases; firstly a batch phase, 
followed by an exponential feeding phase. The batch phase was terminated after an initial 
charge of glucose (10 gglucose/kgbroth) was depleted as estimated by the sudden increase in 
dissolved oxygen. This was the signal used to initiate the exponential feed as described 
previously (Yamane and Shimizu, 1984; Paalme et al., 1990; Riesenberg et al., 1991; Yamane 
et al., 1992; Yang et al., 1992 and Ramfirez et al., 1997). The feed profile was terminated 
when residual glucose accumulation was observed in the fermentor, at the end of the fed-batch 
phase. The feed profile was predetermined using data from the sources in Table 1. 
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Table 1: Parameters associated with the fast growing high biomass producing transformant DAHB21#20 used 
for exponential feed determination 
 
The estimated biomass concentration (determined from previous batch fermentations) at the 
start of the fed batch phase, Cx(1) = 2.2 gDW.Lbroth-1, was used to determine the total amount of 
biomass Mx(1) in the reactor at the start of the fed batch phase by multiplying by the reactor 
volume at start of fed-batch phase, V(1) = 1.3 Lbroth to obtain Mx(1) = 2.86 gDW. Mx(1) and the 
specific growth rate to be maintained during fed-batch phase, µset, together with Equation 20 
in Appendix A were used to obtain a predetermined biomass profile (Figure 1).  
Parameters Source 
Biomass yield coefficient, Yxs (gDW.gglucose-1) 0.56 Batch data 
Glucose feed concentration, Csf (gglucose.L-1) 150 Specified 
Biomass concentration at start of fed-batch phase, Cx(1) (gDW.Lbroth-1) 2.2 Batch data 
Reactor volume at start of fed-batch phase, V(1) (Lbroth) 1.3 Specified 
Set specific growth rate during fed-batch phase, µset (h-1)  0.08 Specified 
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Figure 1: Predicted biomass production Mx(t) during exponential feeding phase. 
 
A typical calculation, considering time point 1 (21.5 h) and time point 2 (30 h), is as follows: 
 
)(
)()(
12
12
tt
txtx
seteMM −= µ
 (Appendix A, Equation 20)     Equation 1 
 
6.5.86.2 )5.2130(08.0)( 2 ==
−eM tx gDW       Equation 2 
 
And similarly, to determine Mx(t3) considering time point 2 (30 h) and time point 3 (33 h), is as 
follows: 
 
12.7.6.5 )3033(08.0)( 3 ==
−eM tx gDW       Equation 3 
 
The general equation for the predicted total amount of biomass at time point i+1 (Mx(i+1)) can 
then be described as in Equation 4. 
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And to predict the amount of biomass in the fermentor in equal increments of 10 seconds 
(Equation 5) an identical profile to Figure 1 is obtained: 
 
           Equation 5 
 
Using the predicted Mx(t) data (Figure 1) and the biomass yield coefficient, Yxs (gDW.gglucose-1) 
(Table1), together with Equation 21 from Appendix A, a profile of the mass of glucose 
required for consumption (Msf(t)), from the start to the end of the feed, to produce the desired 
mass of biomass at µset was determined (Figure 2). 
 
A typical calculation to determine Msf(t2), considering time point 1 (21.5 h) and time point 2 
(30 h), is as follows: 
 
     (Appendix A, Equation 21)    Equation 6 
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And similarly, to determine Msf(t3) considering time point 2 (30 h) and time point 3 (33 h), is 
as follows: 
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−eM tsf gglucose     Equation 8 
 
 
Figure 2: Predicted mass of glucose Msf(t) required during exponential feeding phase to control µ at µset. 
 
Thus the mass of glucose required to be pumped in to the vessel is determined. For example, 
considering time point 2 (30 h) and time point 3 (33 h), the mass of new biomass generated 
between time point 3 and time point 2 (∆Mx(3-2)) at the µset = 0.08 h-1 is described as Equation 
9. 
 
∆Mx(3-2) = Mx3 - Mx2 = 7.12 – 5.6 = 1.62 gDW      Equation 9 
 
And the mass of glucose required to maintain the new biomass generation between time point 
3 and time point 2 (∆Msf(3-2)) at the µset = 0.08 h-1 is described as Equation 10. 
 
74.297.471.7)()()( 2323 =−=−=∆ − tsftsftsf MMM   gglucose   Equation 10 
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Using the method of Equation 10, a profile of the mass of glucose required to be pumped in 
every 10 seconds during the feeding phase is then determined (Figure 3) i.e. ∆Msf(i+1)  = 
Msf(i+1) - Msf(i), and can be defined a the predicted mass of glucose required to be pumped in 
the fermentor in 10 second intervals (Equation 11): 
 
 
                 Equation 11 
 
 
Figure 3: Predicted mass of glucose ∆Msf(t) required to be pumped in every 10 seconds during exponential 
feeding phase to control biomass growth (∆Mx(t)) at µset. 
 
With a 150 g.L-1 concentrated glucose feed resevior (Table 1) a profile of the volume of 
glucose to be added to the reactor, ∆Vsf(t)  is determined. A typical calculation, considering the 
mass of glucose to be added between time point 2 and time point 3, ∆Msf(3-2) = 2.74, to 
determine ∆Vsf(3-2), is as follows: 
   
Equation 12 
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               mlglucose    Equation 13 
 
 
 
 
Figure 4: Predicted volume of glucose ∆Vsf(t) (glucose concentration of feed reservoir at Csf = 150 gglucose.L-1) to 
be pumped in every 10 seconds during exponential feeding phase to control biomass growth (∆Mx(t)) at µset. 
 
The predicted volumetric feed profile ∆Vsf(t) as a function of time in 10 second increments 
shown in Figure 4 is described in Equation 14, where 0,0076  is the initial volume ∆Vsf(1)  in 
ml to be pumped into the vessel at the start of the feeding phase. 
 
          Equation 14 
 
And similarly to Equation 11 for the predicted mass of glucose required to be pumped in the 
fermentor (∆Msf(i+1)), the predicted volume of glucose required to be pumped in the fermentor 
in 10 second intervals (∆Vsf(i+1)) can be defined as in Equation 15. 
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Equation 15 
 
Once the predicted volumetric glucose feed profile to be added to the fermentor every 10 
seconds ∆Vsf(t) is determined (Figure 4), the Infors fermentor substrate pump is calibrated with 
respect to a particular silicon tube diameter (Figure 5). 
 
 
Figure 5: Typical Infors fermentor substrate pump calibration curve. 
 
The required volumetric glucose feed profile (∆Vsf(t))  (Figure 4) is then converted into the 
required pump set-point Psf(t) using the standard curve in Figure 5 (Figure 6). A typical 
calculation is as follows: consider the initial volume ∆Vsf(1) in ml to be pumped into the vessel 
at the start of the feeding phase, 0.0076 ml (Figure 4). Using the pump calibration curve in 
Figure 5 the pump set point is determined (Equation 14). 
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Figure 6: Predicted Infors substrate pump set-point profile (Psf(t)) required during exponential feeding phase to 
control µ at µset. 
 
An algorithm was then programmed into the Infors Fermentor software batch recipe using the 
data calculated from Figure 7, where the pump set-point profile was calculated to be 
9.594e0.08t. The term, 9.594 is the initial pump set-point at the beginning of the exponential 
phase (Psf(1)) and was programmed to increase by a factor of 1.000222 every 10 seconds 
(Equation 15). The term 1.000222 is calculated from the e0.08t term whereby 1.000222 = 
e0.08(10/60/60) to obtain ‘t’ with respect to 10 second increments. 
 
          Equation 17 
 
 
Thus, to determine the pump set-point (Psf) as a function of Mx(t) Equation 18 and 19 are 
derived from Equations 16, 12, and 6, where the term ( )ii tte −+1.µ  is a function of 10 second 
increments. 
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          Equation 18 
 
          Equation 19 
 
Mx(t) profile Correction Calculations 
 
Therefore, as already mentioned (Exponential Fed-batch Methodology and Typical 
Calculations), once the initial charge of glucose (10 gglucose/kgbroth) was depleted in the batch 
phase, as estimated by the sudden increase in dissolved oxygen, the exponential feed was 
initiated. Samples were taken in increments ranging between 3 and 8 hours. Due to the size of 
the fermentor, together with the high concentration of the glucose feed and the associated 
small dosage requirements of the feed to control µ at µset, the loss of volume in the reactor due 
to sampling was not assumed negligible and was accounted for. The following calculations 
are a typical account of the methods used to adjust the pump set-point, in response to reactor 
volume changes by sampling. Consider time point 2, where according to Equation 20 in 
Appendix A and Mx1 = 2.86 gDW in Figure 1, (Mx2)before sampling = 5.6 gDW is the predicted 
biomass after 8.4 hours from the commencement of the exponential feed, before sampling, 
with an associated biomass concentration (Cx2)before sampling = 5.6 gDW/1.3 L = 4.3  gDW.Lbroth-1. 
After sampling, ~49 ml of culture broth was removed from the fermentor. Assuming (Cx2)before 
sampling = (Cx2)after sampling = (Cx2)sample, biomass after sampling can be adjusted, (Mx2)after sampling = 
(Mx2)before sampling - (Cx2)sample . Vsample = 5.4 gDW. The adjusted (Mx2)after sampling is then used to 
correct  the required feed ∆Vsf by adjusting the associated pump set-point Psf (Equation 19). 
Thus prior to sampling, Mx2 was predicted to be 5.6 gDW with an associated feed pump setting 
Psf = 18,769%. With the associated loss of biomass due to sampling, (Mx2)after sampling was 
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predicted to be 5.4 gDW with an associated feed pump setting (as calculated by Equation 19) 
Psf =(3.345).(5.4)+0.0377=18.100%. Thus, from this time point onwards, a revised profile for 
the predicted Mx(t), ∆Vsf(t), and Psf(t) was determined to control µ at µset. This profile was 
maintained until the next sampling time was performed, where upon, similarly to the 
procedures described above, the associated loss of biomass due to sampling was again revised 
and the Psf adjusted. 
 
Thus Figure 7 illustrates the comparison between; (1) the predicted Mx(t) profile without 
sample volume adjustment, (2) the predicted Mx(t) profile with sample volume adjustment, and 
(3) the Mx(t) profile as determined from the dry weight analysis. 
 
 
Figure 7: Mx(t) profile during exponential feeding phase to control µ at µset of; (1) the predicted Mx(t) profile 
without sample volume adjustment, (2) the predicted Mx(t) profile with sample volume adjustment, and (3) the 
Mx(t) profile as determined from the dry weight analysis. 
 
Figure 8 portrays the ∆Vsf(t) profile during exponential feeding phase to control µ at µset of; (1) 
the predicted ∆Vsf(t) profile without sample volume adjustment, and (2) the predicted ∆Vsf(t) 
profile with sample volume adjustment. 
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Figure 8: ∆Vsf(t) profile during exponential feeding phase to control µ at µset of; (1) the predicted ∆Vsf(t) profile 
without sample volume adjustment, and (2) the predicted ∆Vsf(t) profile with sample volume adjustment. 
 
Figure 9 portrays the Msf(t) profile during exponential feeding phase to control µ at µset of; (1) 
the predicted Msf(t) profile without sample volume adjustment, and (2) the predicted Msf(t) 
profile with sample volume adjustment. 
 
 
Figure 9: Msf(t) profile during exponential feeding phase to control µ at µset of; (1) the predicted Msf(t) profile 
without sample volume adjustment, and (2) the predicted Msf(t) profile with sample volume adjustment. 
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Figure 10 portrays the Psf(t) profile during exponential feeding phase to control µ at µset of; (1) 
the predicted Psf(t) profile without sample volume adjustment, and (2) the predicted Psf(t) 
profile with sample volume adjustment. 
 
 
Figure 10: Psf(t) profile during exponential feeding phase to control µ at µset of; (1) the predicted Psf(t) profile 
without sample volume adjustment, and (2) the predicted Psf(t) profile with sample volume adjustment. 
 
To verify µ, the ln(Mx(t)) profiles of Figure 7 are determined (Figure 11). From Figure 11 it is 
evident that the predicted ln(Mx(t)), predicted without sample volume adjustment, obtained a 
controlled µ = 0.08 h-1 with an associated initial ln(Mx(1)) of 1.051. The predicted ln(Mx(t)), 
taking into account volume adjustment due to sampling, was also controlled at µ = 0.08 h-1 
with an associated initial ln(Mx(1)), which ranged between 0,926 and 1,051 and changed every 
time the Mx(t) data was adjusted to account for the loss of biomass from sampling. In 
comparison, the Mx(t) data resulting from the dry weight analysis obtained a controlled µ = 
0.082 h-1 with an associated initial ln(Mx(1)) of 0.789 and an acceptable deviation of 0.02 off 
the set-point of µset = 0.08 h-1. 
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Figure 11: ln(Mx(t)) profile during exponential feeding phase to control µ at µset of; (1) the predicted ln(Mx(t)) 
profile without sample volume adjustment, (2) the predicted ln(Mx(t))  profile with sample volume adjustment, 
and (3) the ln(Mx(t)) profile as determined from the dry weight analysis. 
 
The approach of controlling the amount of concentrated glucose substrate added in the fed-
batch cultivation (equation 3), while glucose residual concentration was maintained at zero, 
results in the control of the µset at a constant value under both transient and steady state 
conditions for biomass concentration (Martinez et al., 1998; Kim et al., 2000; Cheng et al., 
2003; Sun et al., 2007; Chen et al., 2008). The equations derived in Appendix A together with 
the typical calculations described in this section of the fast growing high biomass producing 
transformant DAHB21#20 to control µset = 0.08 h-1, gives an account of the implementation of 
the Exponential Fed-batch methodology to execute the exponential fed-batch cultivations 
described in Manuscript 3 and Manuscript 4 of this dissertation. 
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